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Autophagy requires the biogenesis of autophagosomes (APs), which are large 
multilamellar vesicles that sequester cytoplasmic substrates and undergo a maturation 
process that ultimately leads to their fusion with lysosomes. Previous studies have 
suggested that local production of phosphatidylinositol-3-phosphate (PI3P) by class III 
phosphatidylinositol 3-kinase (PI3K) (i.e., Vps34) is required for AP biogenesis at 
specialized sites of the endoplasmic reticulum called "omegasomes". Although Vps34 is 
the sole source of PI3P in budding yeast, mammalian cells can produce PI3P through 
alternate pathways, including direct synthesis by the class II PI3Ks; however, the 
physiological relevance of these alternate pathways in the context of autophagy is 
unknown. To address this question, we generated Vps34 knock-out mouse embryonic 
fibroblasts (MEFs) and analyzed the impact of Vps34 deletion on autophagy in 
mammalian cells. Using a novel higher affinity 4x-FYVE finger PI3P-binding probe, we 
found a Vps34-independent pool of PI3P accounting for 35% of the total amount of this 
lipid species by biochemical analysis. Importantly, WIPI-1, an autophagy-relevant PI3P 
probe, still formed some puncta upon starvation-induced autophagy in the Vps34 knock-
out MEFs. Additional characterization of autophagy by electron microscopy as well as 
protein degradation assays showed that while Vps34 is important for starvation-induced 
autophagy there is a significant component of functional autophagy occurring in the 
absence of Vps34. Given these findings, class II PI3Ks (α and β isoforms) were examined 
 
 
as potential positive regulators of autophagy. Depletion of class II PI3Ks reduced 
recruitment of WIPI-1 and LC3 to AP nucleation sites and caused an accumulation of the 
autophagy substrate, p62, which was exacerbated upon the concomitant ablation of 
Vps34. Our studies indicate that while Vps34 is the main PI3P source during autophagy, 
class II PI3Ks also significantly contribute to PI3P generation and regulate AP 
biogenesis.  
In addition, we used a lipidomic approach to capture the lipid profile of cells in 
the presence and absence of Vps34 under steady-state and during starvation-induced 
autophagy. Lipidomics is an emerging powerful tool with the potential to identify new 
interconnected metabolic lipid networks as well as generate new hypotheses. Here, we 
identified a new relationship between Vps34 and cholesterol homeostasis. Additionally, 
we identified specific changes in lysolipids during autophagy.  
Lastly, we investigated whether the retromer complex plays a role in autophagy. 
Retromer is a protein complex that binds PI3P on the endosomal membrane and mediates 
retrograde trafficking of transmembrane proteins from the endosome to the trans-Golgi 
network. Recent studies have shown a downregulation of this complex associated with 
sporadic Alzheimer’s disease (AD) and have demonstrated aberrant trafficking and 
processing of APP, a pathological feature of AD, as a result of retromer deficiency. 
Because retromer is important for maintaining endo-lysosomal system function, we 
hypothesized that it promote efficient autophagy and may contribute to the dysfunctional 
autophagy observed in AD when impaired. Using standard autophagy assays, such as 
assessing LC3 conjugation and puncta formation, our preliminary studies suggest a 
negative regulatory role for retromer in autophagy. Additionally, we observed a strong 
 
 
association of retromer with Atg9, an autophagy-related gene transmembrane protein that 
is believe to traffic lipids to the growing autophagosome membrane and recycle 
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Chapter 1: Introduction 
1.1 Autophagy in health and disease 
All eukaryotic cells require constant surveillance and quality-control mechanisms in 
order to ensure that damaged proteins and organelles are eliminated. Additionally, 
efficient removal of excessive cellular components and the ability to synthesize new 
components in response to intra- and extracellular cues allows cells to continuously adapt 
and optimally function. Given the importance of degradative capacity in the health and 
viability of a cell, it is not surprising that multiple degradative pathways have evolved. 
While these pathways do provide some redundancy in function, it is clear they have also 
developed in specialized ways, which we are still only beginning to understand. The two 
most important modes of cellular degradation include the ubiquitin-proteasome and the 
lysosomal systems (Ciechanover, 2005; Goldberg, 2003). While the ubiquitin-proteasome 
system degrades proteins in a highly selective manner, the lysosomal system has a more 
diverse degradative capacity in its ability to degrade cytosolic and transmembrane 
proteins, organelles and foreign material by in-bulk, nonselective or selective 
mechanisms (Ciechanover, 2005; Yang and Klionsky, 2010). Greater understanding of 
such homeostatic, quality control processes is not only of basic science interest, but also 
of clinical interest since the misregulation of these pathways can cause various disease 
pathologies. In fact, identifying new therapeutic targets for degradation pathways is 
currently of high interest. This work focuses on better understanding the lysosomal form 
of degradation with a specific focus on the macroautophagy pathway. 
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1.1.1 Types of autophagy 
The lysosome was originally believed to be an organelle dedicated to the degradation of 
products internalized by endocytosis or phagocytosis, however, first evidence that the 
lysosome was also responsible for degrading cytosolic content emerged over four 
decades ago. Two independent groups reported the presence of cytosolic content, 
specifically mitochondria and endoplasmic reticulum, within membrane-bound vesicles 
in rat kidney cells and hepatocytes (Ashford and Porter, 1962; Clark, 1957; Novikoff, 
1959). Shortly after, it was discovered that these membrane bound vesicles also contained 
lysosomal hydrolases (Novikoff and Essner, 1962). In 1963, Christian de Duve, who 
previously discovered lysosomes, noted that the sequestering vesicles were related to 
lysosomes and coined this catabolic process "autophagy," meaning “self-eating.” (De 
Duve and Wattiaux, 1966; Yang and Klionsky, 2010). Autophagy is broadly defined as a 
cellular degradative pathway that involves the delivery of cytoplasmic components to the 
lysosome (Deter et al., 1967; Klionsky, 2007; Mizushima, 2007). Once delivered to the 
lysosome, cytosolic components are digested by hydrolases and released back into the 
cytosol in the form of macromolecules for reuse by the cell (Klionsky, 2007; Mizushima, 
2007; Singh and Cuervo, 2011; Yang and Klionsky, 2010). Future studies thereafter 
focused on understanding the mechanism by which the cytosolic content gets delivered to 
the lysosome. So far, three distinct modes of delivery have been observed and 
characterize the three types of autophagy: chaperone-mediated autophagy, 
microautophagy and macroautophagy (Fig. 1.1). 
Chaperone-mediated autophagy (CMA) greatly differs from the other two 
forms of autophagy in both its method of cargo selection and lysosomal delivery. In 
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CMA, proteins containing a consensus motif (e.g., KFERQ or sequences biochemically 
similar) are recognized by a specific CMA machinery, such as the heat shock-cognate 
chaperone of 70kDa (Hsc70) and lysosome-associated membrane protein type-2A 
(LAMP-2A) receptor, and are individually targeted to the lysosomal membrane where 
they are subsequently translocated into the lumen for degradation (Arias and Cuervo, 
2011; Chiang et al., 1989; Dice, 1990; Kaushik and Cuervo, 2012). In CMA, protein 
degradation is regulated through the exposure of the targeting motif during protein 
misfolding, complex disassembly or post-translational modification (Kaushik and 
Cuervo, 2012; Lv et al., 2011; Thompson et al., 2009). The cytosolic chaperone protein, 
Hsc70, binds this motif, facilitates further protein unfolding and delivers the selected 
protein to the LAMP-2A receptor on the lysosomal membrane (Agarraberes and Dice, 
2001; Arias and Cuervo, 2011; Chiang et al., 1989; Cuervo, 2010; Cuervo and Dice, 
1996; Cuervo et al., 1995; Kaushik and Cuervo, 2012). At the lysosomal membrane, a 
subset of co-chaperones further assist in unfolding the substrate protein and LAMP-2A 
undergoes transient multimerization to form a pore through which the protein translocates 
(Agarraberes and Dice, 2001; Bandyopadhyay et al., 2008; Kaushik and Cuervo, 2012). 
Although CMA is, in part, similar to the ubiquitin-proteosome system in its ability to 
selectively degrade individual proteins, its regulation differs in that CMA degradation is 
determined by the accessibility of an intrinsic motif rather than the addition of a tag such 
as ubiquitin. Interestingly, it is a form of degradation that has so far only been observed 
in mammals, suggesting that this quality-control pathway has been adapted specifically 
for requirements of higher eukaryotes (Arias and Cuervo, 2011; Kaushik and Cuervo, 
2012). Although CMA occurs constitutively, it becomes upregulated during prolonged 
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nutrient scarcity (Cuervo et al., 1995; Wing et al., 1991) and, particularly, in the presence 
of oxidative stress and denaturing conditions (Arias and Cuervo, 2011; Cuervo et al., 
1999; Finn and Dice, 2005; Kaushik and Cuervo, 2012; Kiffin et al., 2004).   
Microautophagy involves the direct delivery of cytoplasmic contents to the 
lysosome through the invagination of the limiting membrane of vacuoles (in plant and 
fungi) or lysosomes (in mammals) (Li et al., 2012; Mijaljica et al., 2011). In yeast, the 
vacuolar membrane undergoes inward tubular invaginations followed by scission at the 
tips to form luminal microautophagic vesicles, a process reminiscent of the biogenesis of 
multivesicular bodies (Li et al., 2012; Mijaljica et al., 2011). Microautophagy is capable 
of nonselective as well as the selective degradation of specific organelles, including 
mitochondria (micromitophagy), nucleus (piecemeal microautophagy) and peroxisomes 
(micropexophagy) (Li et al., 2012; Mijaljica et al., 2011). In mammals, the sequestration 
structure appears to have several forms, including arm-like projections around cytosolic 
content, lysosomal wrapping around the cytosol as well as intralysosomal vesicles (Li et 
al., 2012; Mijaljica et al., 2011). Microautophagy also appears to be both nonselective 
and selective in mammalian cells; however, only selectivity towards proteins has been 
observed so far (Mijaljica et al., 2011). Specifically, a microautophagy-like process 
named endosomal microautophagy was described which entailed the delivery of 
cytoplasmic cargo containing a KFERQ motif into intraluminal vesicles of late 
endosome/multivesicular bodies (MVBs) via a non-canonical ESCRT (Endosomal 
sorting complex required for transport)-pathway and its subsequent degradation in the 
lysosome(Ahlberg and Glaumann, 1985; Sahu et al., 2011). Like CMA, microautophagy 
is a constitutively active process that is upregulated during times of stress, such as 
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nutrient scarcity and oxidation (Li et al., 2012; Mijaljica et al., 2011). In addition, it has 
also been proposed that microautophagy plays a role in maintaining lysosome size and 
membrane homeostasis (Li et al., 2012). Microautophagy is by far the most understudied 
form of autophagy and much remains unknown about this process. 
Macroautophagy, the best characterized autophagy pathway, requires the 
biogenesis of autophagosomes (APs), which are large double-membrane vesicles that 
sequester cytoplasmic substrates and ultimately fuse with the endolysosomal 
compartment, allowing for degradation of their cargo. Initially, macroautophagy was 
believed to be an in-bulk, non-specific degradative process; however, more recent studies 
have identified its role in selective degradation of specific proteins, organelles and 
foreign material, such as pathogens (Klionsky et al., 2007). The focus of this thesis work 
is to understand the regulation of macroautophagy, therefore, a more detailed overview of 
the role, regulation and mechanism of this key cellular process will be expanded upon in 
the sections below.  
Although these three forms of autophagy coexist simultaneously in mammalian 
cells and all rely on lysosomal degradation, each has its own, distinct degradative role 
important for maintaining optimal cell function. In addition to better understanding the 
individual forms of autophagy, there is growing interest in understanding the signaling 
crosstalk between these different forms of autophagy. Recently, some studies have 
demonstrated bidirectional crosstalk and signaling between CMA and macroautophagy 
(Koga et al., 2011; Massey et al., 2006). For instance, when one pathway is impaired, the 
other may be upregulated to compensate (Koga et al., 2011; Massey et al., 2006). Less is 
known about the extent of compensation by microautophagy, however. Understanding 
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the mechanistic details that are shared or different among these pathways is key to 
developing novel ways to modulate cellular degradation in disease states. 
1.1.2 Role of macroautophagy in cellular homeostasis 
Macroautophagy, the “classical” form of autophagy (hereafter referred to as autophagy), 
is a homeostatic process that ensures cellular quality control through the efficient 
turnover of long-lived proteins and damaged organelles. Functional autophagy is 
essential for health and survival of all cells and plays a particularly critical role in 
maintaining the health of non-dividing cells, such as differentiated neurons and 
myocytes, which are unable to dilute any accumulated toxic structures by means of cell 
division and, therefore, largely rely on autophagic function (Mizushima et al., 2008; 
Singh and Cuervo, 2011; Yang and Klionsky, 2010). Under steady-state conditions, 
autophagy occurs at low, basal levels; however, it can be upregulated in response to cell 
stressors such as nutrient deprivation, free radicals, irradiation, accumulated misfolded 
proteins and microbial invasion (Mizushima and Komatsu, 2011; Mizushima et al., 2008; 
Rubinsztein et al., 2012b; Singh and Cuervo, 2011).  
In addition to “housekeeping” and cleaning cellular waste, one of the major 
functions of autophagy is its contribution to energy homeostasis by helping maintain a 
balance between synthesis and turnover of cellular components. Bulk degradation of 
proteins and organelles by APs during autophagy enables rapid cellular adaptation in 
response to environmental changes (Levine and Kroemer, 2008; Mizushima et al., 2011; 
Singh and Cuervo, 2011). For instance, when energy deprivation and nutrient scarcity is 
sensed, autophagy is upregulated to promote the catabolism of proteins, organelles, 
membranes and, in some cases, lipid droplets, which provides metabolic substrates for 
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adenosine triphosphate (ATP) energy production and new protein synthesis almost 
immediately for the cell (Levine and Kroemer, 2008; Mizushima et al., 2011; Singh and 
Cuervo, 2011). Notably, autophagy not only plays a role in cellular survival, but also 
organismal survival through its ability to mobilize nutrients and energy during fasting 
periods (e.g., in the early neonatal phase before breastfeeding is established) (Komatsu et 
al., 2005; Kuma et al., 2004; Singh and Cuervo, 2011).  
1.1.3 Autophagy dysfunction in disease 
The cytoprotective effects of autophagy are not only important for ensuring efficient cell 
functioning, but also in preventing a variety of disease states. Situations of insufficient as 
well as excessive levels of autophagy can be harmful for cells. For example, several 
neurodegenerative diseases, including Alzheimer’s, Parkinson’s and Huntington’s 
disease, all exhibit toxic protein aggregates, a typical symptom of impaired autophagy 
(Levine and Kroemer, 2008; Mizushima et al., 2008; Mizushima et al., 2011; Yang and 
Klionsky, 2010). Insufficient autophagy and the build-up of toxic protein aggregates has 
also been linked to pathophysiologies in other, non-neuronal pathologies, including 
myopathies (e.g., Danon disease, sporadic inclusion body myositis, limb girdle muscular 
dystrophy type B) and liver disease (e.g., α1-antitrypsin deficiency) (Levine and 
Kroemer, 2008; Mizushima et al., 2008; Mizushima et al., 2011; Yang and Klionsky, 
2010). Lastly, it has been observed that cells defective in both autophagy and apoptosis 
are particularly susceptible to tumorigenesis. This finding can be explained by the fact 
that when there is decrease in the clearance of toxic proteins and organelles, DNA 
damage occurs and subsequent oncogene activation arises that can lead to uncontrolled 
growth and cause various cancers. On the contrary, enhanced autophagy can also promote 
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tumor survival in tumor microenvironments of high metabolic stress, such as hypoxia and 
nutrient deprivation (e.g., in the core of the tumor) (Levine and Kroemer, 2008; 
Mizushima et al., 2008; Mizushima et al., 2011; Yang and Klionsky, 2010). Appropriate 
balance and regulation of autophagic activity is critical.  
Interestingly, all aging cells display a progressive accumulation of damaged 
proteins and organelles, which correlates with a decline in macroautophagy and CMA 
function observed with age (Del Roso et al., 2003; Donati et al., 2001; Levine and 
Kroemer, 2008; Mizushima et al., 2011; Yang and Klionsky, 2010). Although the 
hierarchy of these hallmark features of aging cells remains unknown, they both certainly 
contribute to cellular dysfunction. In fact, caloric restriction, an inducer of autophagy, 
helps delay aging manifestations, likely through countering this stereotypical decline in 
autophagy and protein accumulation (Cavallini et al., 2008; Levine and Kroemer, 2008; 
Melendez et al., 2003; Mizushima et al., 2011; Yang and Klionsky, 2010). 
Currently, there is growing interest in pharmacologically targeting the autophagy 
pathway to alleviate symptoms of impaired or misregulated cellular degradation 
pathways seen in aging and several diseases. For instance, stimulating autophagy in 
neurodegenerative diseases where there is a substantial accumulation of protein 
aggregates, such in as Huntington’s disease, may not only improve symptoms, but overall 
disease outcome. Alternatively, inhibition of autophagy in cancers where autophagy 
promotes tumor growth under metabolic stress could be very beneficial. So far, most 
modulators of autophagy target this process through an indirect manner that also affects 
other pathways in the cell. For instance, lysosomal inhibitors (e.g., chloroquine), which 
impair autophagic function, or mammalian target of rapamycin complex 1 (mTORC1) 
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pathway inhibitors (e.g., rapamycin), which prevent growth signaling pathways and 
upregulate autophagy, are drugs commonly used in clinical trials to modulate autophagy 
(Harris and Rubinsztein, 2012; Rubinsztein et al., 2012a). In the future, it will be 
important to develop new autophagy-specific targeting strategies in order to more directly 
modulate this process. 
1.2 Autophagy process and machinery 
Although APs were initially discovered in mammalian cells by electron microscopy, it 
was not until 40 years later that significant progress was made in our molecular 
understanding of this process (Yang and Klionsky, 2010). In the late 1990’s, Yoshinori 
Ohsumi’s group showed that the morphology of APs in S. cerevisiae were similar to that 
in mammals and performed the first genetic screens for mutants defective in protein 
turnover (Takeshige et al., 1992; Tsukada and Ohsumi, 1993; Yang and Klionsky, 2010). 
In addition to the screens performed by Yoshinori’s groups and others in the budding 
yeast S. cerevisiae, contemporaneous screens were also carried out in methylotrophic 
yeasts Pichia pastoris and Hansenula polymorpha for mutants defective in protein 
degradation, peroxisome degradation (pexophagy) and delivery of vacuolar hydrolases 
(the cytoplasm-to-vacuole targeting (Cvt) pathway) (Harding et al., 1996; Harding et al., 
1995; Klionsky et al., 2003a; Sakai et al., 1998; Thumm et al., 1994; Titorenko et al., 
1995). Atg1 was the first autophagy-related gene (Atg) identified, which was followed by 
the identification of over 30 Atgs (Klionsky et al., 2003a; Matsuura et al., 1997; 
Mizushima et al., 2011; Suzuki et al., 2007). Several, but not all, of the genes identified 
to be essential for macroautophagy are critical to the other degradative pathways as well 
(Harding et al., 1996; Klionsky et al., 2003a). Importantly however, most of the 
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autophagy genes identified in these screens possess a clear homolog in higher eukaryotes 
and several are well-defined orthologs (Mizushima et al., 2011). Among the Atg proteins 
identified, a core subset of proteins is required for AP formation and has been divided 
into four groups: 1) the Atg1-Atg13-Atg17 kinase complex; 2) the class III 
phosphatidylinositol 3-kinase (PI3K) complex, including Vps34, Vps15, Atg6/Vps30 and 
Atg14; 3) the Atg8 and Atg12 ubiquitin-like protein conjugation systems; and 4) the Atg9 
transmembrane protein and its cycling system (Yang and Klionsky, 2010). Epistasis 
analysis in S. cerevisiae has demonstrated that the Atg proteins orchestrate AP biogenesis 
in a regulated, hierarchical manner that is largely conserved from yeast to mammals 
(Itakura and Mizushima, 2009; Suzuki et al., 2007; Yang and Klionsky, 2010). 
1.2.1 Signaling and regulation of autophagy 
Considering the diversity of autophagy inducers, the fact that there are multiple signaling 
pathways that regulate this process is expected. The best-characterized and most central 
pathway of autophagy regulation is the mammalian target of rapamycin complex 1 
(mTORC1) pathway (Fig. 1.2). Apart from the classical mTORC1 pathway, several other 
mTOR-independent regulators of autophagy have been identified, including a cAMP-IP3 
pathway, a Ca
2+
-calpain pathway, ceramide and other bioactive sphingolipids, reactive 
oxygen species as well as various apoptotic regulators (He and Klionsky, 2009; 
Ravikumar et al., 2010b); however, only regulation by mTORC1 will be discussed below. 
mTORC1 is a nutrient and energy-sensing protein kinase that integrates multiple 
signaling inputs and promotes anabolic processes such as cell growth, cell-cycle 
progression and protein synthesis (Chen and Klionsky, 2011; Zoncu et al., 2011). Upon 
growth factor stimulation (e.g., insulin), receptor tyrosine kinases undergo 
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autophosphorylation and activation and subsequently stimulate the PI3K-Akt/PKB 
(protein kinase B)-TOR pathway (also known as the Akt pathway) (Chen and Klionsky, 
2011; Zoncu et al., 2011). Specifically, the class I PI3K phosphorylates PI(4,5)P2 to 
PI(3,4,5)P3 at the plasma membrane, which recruits both PKB (Akt) and its activator 
phosphoinositide-dependent kinase 1 (PDK1) (Chen and Klionsky, 2011; Zoncu et al., 
2011). At the plasma membrane, PDK1 phosphorylates and activates PKB which, in turn, 
phosphorylates and inhibits the tuberous sclerosis complex 1/2 (TSC1-TSC2) (Chen and 
Klionsky, 2011; Inoki et al., 2002; Manning et al., 2002; Potter et al., 2002; Zoncu et al., 
2011). During growth factor stimulation, the small GTPase Ras is also activated and 
stimulates both the PI3K-Akt/PKB-TOR and ERK pathways, which also phosphorylate 
and inhibit the TSC1-TSC2 complex (Ma et al., 2005; Zoncu et al., 2011). When active, 
the TSC1-2 complex acts as a GTPase-activating protein for Rheb (Ras homologue 
enriched in brain), a small GTP-binding protein that activates mTORC1 in its GTP-bound 
form (Chen and Klionsky, 2011; Garami et al., 2003; Huang and Manning, 2008; Inoki et 
al., 2003; Tee et al., 2003; Zhang et al., 2003a; Zoncu et al., 2011). Therefore, 
phosphorylation and inhibition of the TSC1/2 complex promotes Rheb-GTP binding and 
activation of mTORC1 (Chen and Klionsky, 2011; Garami et al., 2003; Huang and 
Manning, 2008; Inoki et al., 2003; Tee et al., 2003; Zhang et al., 2003a; Zoncu et al., 
2011). Amino acids also play a critical role in mTORC1 activation, however, the 
mechanism by which amino acids are sensed and regulate mTORC1 is still under study 
(Zoncu et al., 2011). In the presence of amino acids, mTORC1 associates with an 
activated Rag (Ras-related GTPase) heterodimer and Raptor (regulatory-associate protein 
of mTOR)  on the late endosome/lysosome membrane, increasing its proximity to Rheb 
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(Kim et al., 2008; Sancak et al., 2010; Sancak et al., 2008; Zoncu et al., 2011). Recent 
evidence indicates that relocalization of mTORC1 to the lysosome is indeed necessary for 
its regulation(Sancak et al., 2010; Saucedo et al., 2003; Stocker et al., 2003; Zoncu et al., 
2011).  
mTORC1 activation promotes cellular anabolism and restricts catabolic processes 
such as autophagy (Chen and Klionsky, 2011; Zoncu et al., 2011). Specifically, mTORC1 
activates S6 kinase 1 (S6K1) and eIF4E-binding protein 1 (4E-BP1), which regulates 
translation initiation as well as translation rate to control protein synthesis (Ma and 
Blenis, 2009; Zoncu et al., 2011). mTORC1 also positively regulates synthesis of 
ribosomal RNAs and proteins through S6K1 (Mayer et al., 2004). Importantly, mTORC1 
simultaneously inhibits autophagy by phosphorylating and inhibiting upstream autophagy 
activators like Atg13 in yeast or Atg13 and unc-51-like kinase (Ulk1/2, the mammalian 
homologue of Atg1) in mammals (Chen and Klionsky, 2011; Zoncu et al., 2011) (Fig. 3). 
However, autophagy is never either ‘on’ or ‘off’ (Musiwaro et al., 2013). Instead, a 
gradient activity level likely exists, ensuring that basal autophagy can still occur even 
during growth conditions. Although our current understanding of basal autophagy 
regulation is largely unknown, it was suggested that S6K1 downregulates growth factor 
receptor signaling to inactivate mTORC1 (Scott et al., 2004). In fact, this negative 
feedback loop may contribute to the basal level of autophagy observed under nutrient-
rich conditions (Klionsky et al., 2005; Scott et al., 2004). 
During nutrient scarcity and energy depletion, mTORC1 is inactivated to slow 
growth and stimulate ‘recycling’ programs such as autophagy (Chen and Klionsky, 2011; 
Zoncu et al., 2011). Specifically, mTORC1 is inactivated in response to situations of 
13 
 
growth factor withdrawal (PI3K-PKB-TOR pathway and Ras-ERK pathways), amino 
acid withdrawal and a decreased ATP/AMP ratio (AMPK pathway) (Chen and Klionsky, 
2011; He and Klionsky, 2009; Zoncu et al., 2011). In yeast, TORC1 inactivation leads to 
dephosphorylation of Atg13, enabling it to form a complex with Atg1, Atg17, Atg31 and 
Atg29 to initiate autophagy (Fig. 1.3) (Kamada et al., 2000; Yang and Klionsky, 2010). 
In mammals, the autophagy initiation complex, which includes Ulk1/2, Atg13, FIP200 
(focal adhesion kinase family interacting protein of 200 kD, also known as the 
mammalian homolog of Atg17) and Atg101, is constitutively stable and is regulated 
through mTORC1 binding and phosphorylation (Hara et al., 2008; Hosokawa et al., 
2009a; Hosokawa et al., 2009b; Jung et al., 2009). During mTORC1 activation, mTORC1 
associates with the autophagy initiation complex and phosphorylates Atg13 and Ulk1/2 to 
inhibit the complex. In contrast, mTORC1 inhibition causes its dissociation, leading to 
dephosphorylation of Atg13 and Ulk1/2 and complex activation (Chen and Klionsky, 
2011; Hosokawa et al., 2009a; Jung et al., 2009; Zoncu et al., 2011).  In both yeast and 
mammals, activated Atg1 complexes are targeted to pre-autophagosomal membranes to 
initiate autophagy (Chen and Klionsky, 2011; He and Klionsky, 2009). 
1.2.2 Autophagosome biogenesis 
1.2.2.1 Origin of the AP membrane 
A key feature of autophagy is the biogenesis of large double membrane AP vesicles. Two 
models have been proposed to explain the source of AP membrane. The first model 
suggests that the membrane is formed by de novo lipid synthesis (Juhasz and Neufeld, 
2006; Kovacs et al., 2007), whereas the second, more popular model suggests that AP 
membrane is derived from pre-existing organelles. These two models, however, are not 
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mutually exclusive. Curiously, no organelle markers or transmembrane proteins have 
been observed on APs (Fengsrud et al., 2000; Stromhaug et al., 1998), suggesting that if 
AP membranes are, in fact, derived from other organelles, a significant amount of 
membrane reorganization and protein sorting and/or retrieval is required.   
Although the source of membrane has yet to be defined, it is clear that the AP 
originates from different locations in yeast and higher eukaryotes. In yeast, all APs 
originate from a single site near the vacuole termed the preautophagosomal structure or 
the phagophore assembly site (PAS) (Suzuki et al., 2001). Specifically, Atg9-positive 
tubulo-vesicular structures derived from the secretory pathway are seen clustered near the 
vacuole and are believed to fuse to create the PAS and supply membrane to the growing 
APs (Mari et al., 2010; Rubinsztein et al., 2012b; Yamamoto et al., 2012). On the 
contrary, in mammals, there is no single site of AP formation. In fact, the origin of the 
AP membrane has been under intense debate in the field and evidence suggests that it is 
likely generated from multiple membrane sources, including the ER (Hayashi-Nishino et 
al., 2009; Yla-Anttila et al., 2009), mitochondria (Hailey et al., 2010), Golgi (Nishida et 
al., 2009), plasma membrane (Ravikumar et al., 2010a) and recycling endosome 
(Longatti et al., 2012). So far the ER is the most convincing and extensively studied site 
of AP formation, particularly during starvation-induced autophagy. Using live-cell 
microscopy and three-dimensional electron microscopy (EM) tomography, cup-shaped 
projections from the ER, termed omegasomes (for their Ω shape), have been observed 
(Axe et al., 2008; Hayashi-Nishino et al., 2009; Yla-Anttila et al., 2009). In fact, growing 
phagophores have been visualized by EM between juxtaposed ER membranes and in 
connection to the ER (Hayashi-Nishino et al., 2009; Ueno et al., 1991; Yla-Anttila et al., 
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2009). More recently, AP biogenesis has been proposed to occur specifically at sites of 
contact between ER and mitochondria, or the mitochondria associated membrane (MAM) 
(Hamasaki et al., 2013). Additionally, there has been new evidence suggesting that Atg-
positive (e.g., Atg16 and Atg9) vesicles derived from the plasma membrane undergo 
heterotypic fusion and serve as AP precursors to promote AP biogenesis, a model 
reminiscent of the fusion between Atg9 vesicles to generate membrane for APs in yeast 
(Moreau et al., 2011; Puri et al., 2013).  
Despite diversity in AP origin, AP formation universally requires: (i) an initiation 
step in which an isolation membrane (IM) cisterna begins to wrap around the cytoplasm; 
(ii) an elongation step during which the membrane increases in size; and (iii) a 
completion step in which the membrane fuses around a section of the cytoplasm to form a 
double membrane AP and its machinery is largely conserved between yeast and 
mammals (Fig. 1.4). 
1.2.2.2 Initiation step 
During autophagy stimulation, the activated Ulk1/2 (Atg1) autophagy complex 
relocalizes to the nucleation site on the IM (Fig. 1.5) (Weidberg et al., 2011). Following 
the recruitment of the Ulk1/2 (Atg1) complex, Atg14, a predominantely ER resident 
protein, clusters at the nucleation site and recruits the other members of the class III 
phosphatidylinositol 3-kinase (PI3K) complex (Vps34, Vps15, Beclin 1 (the mammalian 
homolog of Vps30/Atg6), and Atg14) (Sun et al., 2008; Zhong et al., 2009). Here, the 
class III PI3K, Vps34, plays a critical role in catalyzing the conversion of 
phosphatidylinositol to phosphatidylinositol 3-phosphate (PI3P) (Backer, 2008). 
Localized production of the bioactive lipid, PI3P, is necessary for the recruitment of 
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several essential downstream effectors that orchestrate AP biogenesis (Dall'Armi et al., 
2013; Knaevelsrud and Simonsen, 2012; Obara et al., 2006; Petiot et al., 2000; Sun et al., 
2008). Historically, PI3P synthesis by Vps34 has been shown to be critical for regulating 
autophagy (Blommaart et al., 1997; Burman and Ktistakis, 2010; Dall'Armi et al., 2013; 
Itakura et al., 2008; Kihara et al., 2001b; Knaevelsrud and Simonsen, 2012; Matsunaga et 
al., 2010; Matsunaga et al., 2009; Noda et al., 2010; Obara et al., 2008a; Petiot et al., 
2000; Zeng et al., 2006; Zhong et al., 2009); however, in this dissertation we sought to 
better understand the regulation of autophagy by PI3Ks and PI3P in mammalian 
autophagy. A more detailed discussion of PI3P and Vps34 will follow in the sections 
below.  
1.2.2.3 Membrane elongation 
After an IM is established, the membrane elongates around cytoplasmic content to form a 
functional AP. In yeast, the AP membrane undergoes expansion through the delivery of 
vesicles from the Atg9 compartment (Mari et al., 2010; Rubinsztein et al., 2012b; 
Yamamoto et al., 2012). In mammals, it appears that the membrane expansion largely 
occurs through continuous membrane input from organelle membranes of various origins, 
at least in the case of AP biosynthesis at the ER (Hayashi-Nishino et al., 2009; Yla-
Anttila et al., 2009). Moreover, Atg9, the only transmembrane Atg protein, has been 
shown to constitutively cycle between the TGN and endosome during steady-state 
conditions and relocalize to the recycling endosome (RE) during autophagy, where it has 
been proposed to shuttle membrane to the growing AP membrane via transient kiss-and-
run fusion events (Orsi et al., 2012; Young et al., 2006; Zavodszky et al., 2013). As 
mentioned above, fusion of Atg16 and Atg9 positive vesicles derived from the plasma 
17 
 
membrane and trafficked to the recycling endosome may also be a way to provide 
membrane to the growing AP (Puri et al., 2013).  
Both the Atg8 [the yeast homolog of microtubule-associated protein 1 light chain 
3 in mammals (MAP1LC3, hereafter referred to as LC3)] and Atg12 ubiquitin-like 
conjugation systems have been shown to be particularly important for this elongation step 
(although one study suggested that AP-like structures can form independently of Atg 
ubiquitin-like conjugation in response to certain stimuli) (Fig. 1.6) (Geng and Klionsky, 
2008; Ichimura et al., 2000; Mizushima et al., 1998; Nishida et al., 2009). During 
autophagy stimulation, Atg12 and Atg8 are activated by an E1-like enzyme (Atg7) and 
are conjugated by an E2-like enzyme (Atg10 and Atg3, respectively) to either Atg5 or 
phosphatidylethanolamine (PE), respectively (Geng and Klionsky, 2008; Mizushima et 
al., 1998; Ohsumi and Mizushima, 2004). Conjugated Atg5-12 is recruited to IM by 
Atg16 (the yeast homolog of Atg16L1 in mammals) to form an Atg5-12-16 complex 
(Mizushima et al., 2003), which subsequently recruits Atg8 and acts as an E3-like 
ubiquitin ligase facilitating the conjugation of Atg8 (LC3-I) to PE on the AP membrane 
(Fujita et al., 2008b; Geng and Klionsky, 2008; Hanada et al., 2007; Suzuki et al., 2007). 
The addition of the PE moiety to Atg8 (LC3-I) causes its conversion from a soluble Atg8 
(LC3-I) form to a membrane bound Atg8-PE (LC3-II) form (Geng and Klionsky, 2008; 
Xie et al., 2008); however, recent work has shown that unlipidated LC3 can also be 
membrane-bound on the recycling endosome (Knaevelsrud et al., 2013). Both Atg8-PE 
(LC3-II) and the Atg5-Atg12-Atg16 complex localize to the expanding membrane until 
AP completion (Geng and Klionsky, 2008; Mizushima et al., 2001; Mizushima et al., 
2003). Studies have demonstrated that members of the conjugation system are 
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particularly important for the expansion step (Mizushima et al., 2001; Sou et al., 2008; 
Xie and Klionsky, 2007). Yeast lacking Atg8 produce smaller APs (Abeliovich et al., 
2000; Kirisako et al., 1999), whereas mammals lacking LC3 produce APs of inconsistent 
sizes (Weidberg et al., 2010). In fact, levels of Atg8 have been shown to be upregulated 
during autophagy stimulation in yeast (Huang et al., 2000; Nakatogawa et al., 2007).  
 In mammals, several homologues of yeast Atg8 have been identified, including 
LC3 (LC3A, LC3B, LC3B2, LC3C), Golgi-associated ATPase enhancer of 16kDa 
(GATE-16) and γ-amin-butyric acid receptor-associated protein (GABARAP, 
GABARAPL1) (Shpilka et al., 2011; Weidberg et al., 2011). Although GABARAP and 
GATE-16 were initially discovered for their roles in non-autophagy-related trafficking 
and SNARE-mediated fusion, each of these Atg8-related proteins undergo the same 
ubiquitin-like conjugation reaction described above and are found within APs during 
autophagy (Shpilka et al., 2011; Weidberg et al., 2011). A recent study has shown that the 
various Atg8 proteins may have specific functions in the autophagy process (Weidberg et 
al., 2010). For instance, LC3 may promote membrane elongation, whereas 
GABARAP/GATE-16 may act at the more downstream steps of AP closure and Atg5-
Atg12-Atg16 complex (Weidberg et al., 2010). However, additional experiments will be 
required to understand why multiple Atg8 proteins have evolved in higher eukaryotes and 
their role(s) in autophagy.  
In addition to membrane expansion, the growing AP must undergo a certain 
degree of curvature prior to its closure. It has been proposed that asymmetric distribution 
of lipids and proteins may induce membrane curvature; however, proteins with 
specialized, curvature inducing and stabilizing domains may also be required (Longatti 
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and Tooze, 2009). So far, BIF-1 (also known as endophilin B1) is a promising candidate 
given it contains a curvature sensing and driving N-BAR domain that has been shown to 
be required for AP formation (Reggiori and Klionsky, 2005; Takahashi et al., 2007). 
Additionally, mammalian Atg14L/Barkor, contains a Barkor/Atg14(L) AP targeting 
sequence (BATS)  
domain that preferentially binds curved membranes containing PI3P; however, whether 
this domain promotes curvature has not been tested yet (Fan et al., 2011). Future studies 
are required to better elucidate how both AP curvature and, consequently, its size are 
established.    
1.2.3.4 Double-membrane vesicle closure  
Once the growing AP membrane has formed a cup-like structure, its ends must seal to 
form a double membrane vesicle. Since depletion of Atg8 homologues or blocking its 
lipidation results in “open” APs, it has been hypothesized that Atg8-PE/LC3-II promotes 
AP closure (Fujita et al., 2008a; Weidberg et al., 2010). Moreover, in vitro biochemical 
analysis has demonstrated that Atg8-PE/LC3-II can homo-oligomerize in trans on 
membranes, suggesting that Atg8 may play a tethering role between two membranes 
(Nakatogawa et al., 2007). Although Atg8/LC3 may serve as a tether factor, the 
mechanism of membrane fission still remains unknown. One study proposed a fusogenic 
role for Atg8 (Nakatogawa et al., 2007); however, another group demonstrated that this 
finding is largely attributable to the artifical lipid composition of the liposomes used  
(i.e., high PE concentration)  rather than the fusogenic capacity of Atg8/LC3 (Nair et al., 
2011). A couple of hypotheses have been proposed to explain AP closure: 1) the lipid 
composition at the tips of the AP is energetically unstable, such that mere tethering by 
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Atg8 or another means promotes lipid mixing and fusion; or 2) fusogens [e.g., SNAREs 
(soluble N-ethylmaleimide-sensitive fact-attachment protein receptor)] are recruited to 
the site of fusion either by Atg8 or by another means to promote fusion (Jotwani et al., 
2012). In fact, several SNAREs were recently identified to be important for AP 
biogenesis, specifically in promoting homotypic fusion events between vesicles and 
membrane elongation during AP biogenesis in both yeast (e.g., Sso2p, Tlg2, Sec9p, 
Sec22p, Ykt6p) (Nair et al., 2011) and mammals (e.g., VAMP7, syntaxin-7, syntaxin-8, 
VTI1B) (Moreau et al., 2011); however, it has yet to be determined whether SNAREs are 
important for AP closure as well. Nevertheless, upon AP vesicle closure, the Atg5-
Atg12-Atg16 complex dissociates from the vesicle and Atg4 proteolytically releases the 
Atg8-PE/LC3-II present on the external surface (Mizushima et al., 2001; Mizushima et 
al., 2003). Notably, some Atg8-PE/LC3-II still remains on the inner surface of the AP 
and is degraded only upon fusion of the AP with the lysosome, making it a reliable 
marker for APs (Geng and Klionsky, 2008; Jotwani et al., 2012; Kirisako et al., 1999; 
Tanida et al., 2008).  
1.2.3 Autophagosome maturation 
While APs are able to fuse directly with the vacuole in yeast, higher eukaryote APs 
require a maturation step prior to fusing with the lysosome (Eskelinen, 2005). During 
maturation, APs fuse with the endosomal system, including early endosomes, MVBs, and 
late endosomes, to become amphisomes (Fengsrud et al., 1995; Liou et al., 1997; 
Simonsen and Tooze, 2009; Tooze et al., 1990) (Figure 4). It has been hypothesized that 
fusion with these endocytic compartments allows APs to acquire machinery required for 
lysosomal fusion, such as fusogenic factors and proton pumps (Berg et al., 1998; Gordon 
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and Seglen, 1988; Kovacs et al., 1982; Simonsen and Tooze, 2009; Tooze et al., 1990; 
Yamamoto et al., 1998). Perturbation of endosome function, such as disruption of the 
ESCRT (endosomal sorting complex required for transport) pathway responsible for 
MVB formation, results in a massive accumulation of nascent APs that are unable to fuse 
with the endo-lysosomal system (Lee et al., 2007; Nara et al., 2002; Simonsen and Tooze, 
2009)  
Much of our understanding of AP fusion along the endo-lysosomal system is 
derived largely from other cellular membrane trafficking events, which rely on Rab 
GTPases, membrane-tethering complexes and SNAREs (soluble N-ethylmaleimide-
sensitive fact (NSF)-attachment protein receptor) to mediate fusion. In both yeast and 
mammals, the small GTPase Rab7 (the yeast homolog of Ypt7) has been implicated in 
coordinating fusion of the AP with the vacuole or endo-lysosomal system, respectively 
(Jager et al., 2004; Mayer and Wickner, 1997). For instance, lipid synthesis of PI3P along 
the endosomal system is important for the activation of Rab7 and the recruitment of 
tethering complexes such as C-VPS/HOPS complex that mediate AP-endosomal fusion 
(Liang et al., 2008b). Since yeast APs do not undergo a maturation step, the SNARE 
proteins implicated in AP-vacuole fusion, include Vam3 (Darsow et al., 1997), the 
SNAP-25 homologue Vam7 (Sato et al., 1998), and the yeast orthologue of the NSF 
protein, Sec18 (Ishihara et al., 2001). Likewise, in mammals, SNARE proteins mediate 
AP-lysosome fusion and include SNAP-29, VAMP7, VAMP8 and VTI1B (Fader et al., 
2009; Furuta et al., 2010). Recently, mammalian syntaxin 17 was the first SNARE 
protein identified that localizes to the AP membrane and mediates AP-lysosomal fusion 
through its interaction with lysosomal SNARES (Itakura et al., 2012b).  
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In mammals, APs are formed at peripheral sites and require transportation to 
reach both the endosomal and lysosomal compartments, located in the perinuclear region 
near the microtubule-organizing center (MTOC) (Jahreiss et al., 2008; Monastyrska et al., 
2009). In mammals, AP transport relies on microtubule- and dynein-dynactin motor 
complexes to facilitate fusion events with the endo-lysosomal system and delivery to the 
lysosome(Aplin et al., 1992; Fass et al., 2006; Jahreiss et al., 2008; Kimura et al., 2008a; 
Kimura et al., 2008b; Kochl et al., 2006; Kovacs et al., 1982; Maday et al., 2012; 
Ravikumar et al., 2005). On the contrary, in S. cerevisiae, AP motility does not rely on 
the microtubule network, but instead AP movement depends on the actin cytoskeleton 
(Kirisako et al., 1999; Monastyrska et al., 2008; Reggiori et al., 2005).  
1.2.4 Degradation of autophagosome cargo 
To complete the autophagy cycle, the AP contents are ultimately degraded within the 
lysosome. Upon fusion of the AP or amphisome with the vacuole or lysosome, 
respectively, the outer membrane becomes contiguous with the lysosomal membrane 
while the inner membrane and AP contents are delivered to the lysosome lumen where 
they are degraded by the lysosomal hydrolases. In mammals, these degrading structures 
are often called ‘autolysosomes’ (ALs) or ‘autophagolysosomes’ (APLs). Once 
macromolecules, such as nucleic acids, proteins, polysaccharides and lipids, have been 
degraded, the breakdown products are exported by lysosomal efflux transports and 
permeases into the cytosol for reuse by the cell.  
 Prolonged stimulated autophagy results in a pool of lysosomes that have all 
undergone fusion with AP (Yu et al., 2010). As a result, fewer and enlarged lysosomes 
exist as AL hybrid organelles (Chen and Yu, 2013; Yu et al., 2010). However, upon 
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mTORC1 reactivation, cells undergo autophagic lysosome recovery (ALR) to regenerate 
their lysosomal organelles again (Chen and Yu, 2013; Yu et al., 2010). During ALR, 
tubules form from ALs that subsequently bud-off from the tips and form vesicles (Chen 
and Yu, 2013; Yu et al., 2010). The budding vesicles consists of “proto-lysosomes” that 
then must re-acquire the proper protein pumps and hydrolases in order to become 
functional lysosomes (Chen and Yu, 2013; Yu et al., 2010). 
1.2.5 Selective and nonselective autophagy 
As mentioned above, APs can be both selective and non-selective when sequestering 
their cargo. In brief, non-selective autophagy entails the in-bulk envelopment of 
neighboring cytosolic content, whereas selective autophagy relies on the recognition of 
cargo by autophagy receptors. The different types of selective autophagy that have been 
described include: ubiquitinated proteins, excessive or damaged organelles such as 
peroxisomes (pexophagy) (Dunn et al., 2005), ribosomes (ribophagy) (Kraft et al., 2008), 
ER (reticulophagy) (Bernales et al., 2006), mitochondria (mitophagy) (Kim et al., 2007), 
secretory granules (crinophagy) and invading bacteria (xenophagy) (Weidberg et al., 
2011). Specifically, autophagy receptors bind both to the cargo as well as to the 
LC3/Atg8 family of proteins via a specific LC3-interacting region (LIR), which links the 
cargo to autophagic membrane and targets it for degradation (Johansen and Lamark, 
2011; Knaevelsrud and Simonsen, 2010; Noda et al., 2008). The best studied autophagy 
receptor is p62, which targets ubiquitinated cargo for autophagy (Bjorkoy et al., 2005; 
Pankiv et al., 2007).  
1.3 PI3P and autophagy 
Although autophagy, like most cellular processes, is predominantly understood from a 
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protein-centric point of view, the lipid biology underlying the formation, maturation and 
degradation of an AP is also fundamental to understanding how this process is regulated. 
In particular, phosphoinositides (PI), a low abundance subclass of glycerophospholipids, 
are important for acutely regulating membrane dynamics and protein flow in a variety of 
fundamental biological processes (Di Paolo and De Camilli, 2006; Kutateladze, 2010). 
Seven PIs have been identified and are defined by the phosphorylation state of the 
inositol headgroup at the 3’-, 4’- and 5’-position, which is regulated reversibly by several 
lipid kinases and phosphatases (Di Paolo and De Camilli, 2006; Kutateladze, 2010). The 
seven PIs include three monophosphorylated (PI3P, PI4P, PI5P), three bisphosphorylated 
(PI(3,4)P2, PI(3,5)P2, PI(4,5)P2) and one triphosphorylated (PI(3,4,5)P3) species (Figure 
1.7). Notably, each of these lipids has a stereotypic spatial distribution within the cell and 
can serve as marker for various cell compartments. For example, PI(4,5)P2 and 
PI(3,4,5)P3 are concentrated at the plasma membrane, PI3P and PI(3,5)P2 are localized to 
the endosomal compartment and PI4P is enriched on the TGN and secretory vesicles 
(Fig. 7) (Di Paolo and De Camilli, 2006; Kutateladze, 2010). While some PIs are 
constitutively present on membranes, others are transiently produced in a spatio-temporal 
manner in response to certain stimuli (Di Paolo and De Camilli, 2006; Kutateladze, 
2010). PIs achieve direct signaling effects through their specific localization and their 
recruitment of proteins harboring a PI-binding module (Di Paolo and De Camilli, 2006; 
Kutateladze, 2010).  
  The importance of PI3P for autophagy regulation was first discovered in the late 
1990s when Meijer’s group discovered that PI3K inhibitors (e.g., 3-methyladenine) block 
autophagy in mammalian cells under autophagy stimulating conditions (Blommaart et al., 
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1997). At the time, this result was surprising given that the class I PI3K was the only 
known target of the PI 3-kinase inhibitors even though subsequent studies demonstrated 
that they broadly target the entire PI3K family(Backer, 2008; Falasca and Maffucci, 
2007). A follow-up study was the first to demonstrate that PI3P specifically stimulates 
autophagy (Petiot et al., 2000). In S. cerevisae, expression of a Vps34 kinase-dead mutant 
or ablation of Vps34, the sole PI3K and the only source of PI3P in budding yeast, showed 
that Vps34 synthesis of PI3P is essential for autophagy (Kihara et al., 2001b). Likewise, 
in higher eukaryotes, an important role for synthesis of PI3P by Vps34 in autophagy was 
confirmed in studies using molecular genetics (e.g., siRNA against Vps34) (Itakura et al., 
2008; Juhasz et al., 2008). Much of our understanding of the role of PI3P in autophagy 
has been learned through the discovery of autophagy-relevant PI3P effectors and the 
modulation of PI3P levels by modulating PI3P phosphatase activity, which is discussed 
in the following sections below (Dall'Armi et al., 2013).  
1.3.1 The role of PI3P and its effectors in autophagy 
Shortly after autophagy initiation by the Atg1 complex, PI3P is synthesized at the AP 
nucleation site. In yeast, PI3P is distributed on the inner (concave) surfaces of the IM as 
well as on uncharacterized organelles located in the vicinity of the IM, which have been 
hypothesized to supply a pool of PI3P necessary for the growth of the AP membrane 
(Obara et al., 2008a; Obara and Ohsumi, 2011). The asymmetric distribution of PI3P on 
the membrane has been postulated to intrinsically promote membrane curvature of the 
AP; however, whether the curvature of the AP is derived from intrinsic physiochemical 
properties of the lipid membrane, effector proteins or a combination of both is unclear 
(Obara and Ohsumi, 2011). Additionally, in mammals, PI3P has been observed along the 
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elongating tips of the IM, which may also facilitate curvature at this site or promote the 
expansion and/or sealing of the edges of this spherical structure (Obara and Ohsumi, 
2011). The actions of PI3P are predominantely attributed to the effector proteins that 
harbor PI3P-binding modules, such as FYVE (for conserved in Fab1, YOTB, Vac1, 
EEA1), pleckstrin homology (PH), phox (PX) and a FRRG or LRRG motif (Di Paolo and 
De Camilli, 2006). In fact, the highly localized production of PI3P helps establish a 
membrane platform to concentrate and spatially coordinate such effectors and promote 
downstream signal transduction events necessary for AP biogenesis (Dall'Armi et al., 
2013; Knaevelsrud and Simonsen, 2012; Obara and Ohsumi, 2011; Simonsen and Tooze, 
2009). Currently, PI3P is known to regulate effectors required for AP biogenesis, cargo 
selection, maturation and intracellular transport, which will be discussed below (Table 
1.1) (Dall'Armi et al., 2013). 
Several PI3P effectors have been implicated in the initiation step of autophagy. In 
mammals, DFCP1, an ER-resident protein that contains two zinc-finger binding FYVE-
domains, clusters at sites of AP nucleation along the ER membrane during starvation-
induced autophagy (Axe et al., 2008; Ktistakis et al., 2009). Interestingly, knock-down 
studies of DFCP1 do not produce any overt phenotypes, making its function difficult to 
discern (Axe et al., 2008; Ktistakis et al., 2009). A better-characterized family of PI3P 
effector proteins includes the PROPPIN family or WD-repeat proteins interacting with 
phosphoinositide (WIPI-1–4) proteins (Dove et al., 2004; Krick et al., 2012; Watanabe et 
al., 2012). The PROPPIN family is defined by its WD40 repeats, which adopt a seven-
bladed β-propeller fold containing two pseudo-equivalent PI3P-binding sites, and a 
FRRG motif, which binds PI3P, and are all required for the full autophagic function of 
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PROPPIN proteins (Baskaran et al., 2012). Three PROPPINs, WIPI-1, WIPI-2, and 
WIPI-4, are implicated in the initiation of mammalian autophagy. Specifically, WIPI-1 
and WIPI-2 are recruited to omegasomes upon autophagy induction and play a role in the 
formation and maturation of the isolation membrane, respectively (Polson et al., 2010; 
Proikas-Cezanne et al., 2004). These two proteins are phylogenetically similar to yeast 
Atg18, which has also been indirectly implicated in the initiation step, specifically 
through shuttling Atg9 together with Atg2 during autophagy to the PAS (Krick et al., 
2006; Nair et al., 2010; Obara et al., 2008b). While WIPI-4 has not been characterized in 
mammals, a Caenorhabditis elegans homolog of WIPI-4, EGF-6, is recruited to and 
controls the maturation of the omegasome. Importantly, unlike WIPI-2, EGF-6/WIPI-4 
appears to have a negative regulatory role and restricts omegasome expansion and 
autophagosome size (Lu et al., 2011). In addition to their roles in autophagy initiation, 
these PI3P effectors also serve as important tools for visualizing PI3P-synthesis at the 
nucleation site. 
In addition to its role in AP biogenesis, PI3P is important for recruiting effectors 
that promote selective cargo capture by the nascent AP. In particular, PI3P along the 
inner AP membrane serves as a docking site for the PI3P effector Alfy (autophagy-linked 
FYVE protein) to promote the selective engulfment of ubiquitinated protein aggregates 
(Filimonenko et al., 2010). Alfy is a nuclear scaffolding protein that interacts with Atg5 
and the ubiquitin-binding adaptor protein p62 via its WD40 domain as well as with PI3P 
through its FYVE domain (Clausen et al., 2010; Filimonenko et al., 2010; Simonsen et 
al., 2004). Additionally, TECPR1 Tectonin Beta-Propeller Repeat Containing 1), which 
possesses a PI3P-binding PH domain has been implicated in binding PI3P on the nascent 
28 
 
AP to promote selective autophagy of intracellular bacteria (Ogawa et al., 2011). 
PI3P also plays a prominent role in regulating membrane trafficking events along 
the endo-lysosomal system that are critical at the later stages of the autophagy pathway. 
For instance, in mammals, the PI3P-binding effector TECPR1 also serves as a tethering 
factor to promote AP–lysosome fusion (Chen et al., 2012; Ogawa et al., 2011). While 
evidence for an amphisome intermediate in yeast is still missing, there are PI3P effectors, 
such as Atg24 and Vam7, which are necessary for efficient autophagosome–vacuole 
fusion (Dall'Armi et al., 2013; Knaevelsrud and Simonsen, 2012; Obara and Ohsumi, 
2011).  
Lastly, PI3P has been shown to be important for AP motility. During starvation-
induced autophagy, FYCO1 (FYVE and coiled-coil domain containing 1) is recruited to 
the outer membrane of an AP by its direct interaction with Rab7, LC3 and PI3P (Pankiv 
et al., 2010). FYCO1 mediates the microtubule plus-end directed transport of the AP 
toward the periphery of the cell (Pankiv et al., 2010). 
In addition to the effectors highlighted in this section, there are likely to be more 
at various stages of the autophagy process that have yet to be identified. In the future, 
genetic screens for proteins that possess PI3P-binding domains will be helpful in 
identifying more PI3P effectors and, therefore, potentially more roles for PI3P in 
autophagy. 
1.3.2 Sources of PI3P in autophagy 
Although Vps34 and its lipid kinase activity are essential for autophagy in budding yeast, 
it is unclear whether this is the case in higher eukaryotes that possess alternate pathways 
to synthesize PI3P (Backer, 2008; Falasca and Maffucci, 2012; Hakim et al., 2012; 
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Vanhaesebroeck et al., 2001). For instance, in mammals, PI3P is also synthesized by the 
class II PI3Ks, which catalyze PI phosphorylation like Vps34, and inositol 4-phosphatase 
(Inpp4) type I and II, which dephosphorylate PI(3,4)P2 to PI3P (Falasca and Maffucci, 
2012; Norris et al., 1997; Norris and Majerus, 1994; Shin et al., 2005). Additionally, Sac1 
family members, such Fig4 can dephosphorylate PI(3,5)P2 to PI3P, accounting for yet 
another potential source of PI3P (Gary et al., 2002; Rudge et al., 2004). Previously, 
pharmacological and genetic studies have clearly demonstrated that Vps34 and its PI3K 
activity are important for autophagy in mammals, but whether Vps34 is essential for 
autophagy in mammals has not been determined. Recently, a Vps34 conditional genetic 
mouse model was generated which enabled the scientific community to address this 
question in a more qualitative way for the first time (see section 1.4.1.5). Identifying the 
sources of PI3P is critical to understanding autophagy regulation and a key question 
addressed in this thesis. 
1.3.3 Regulation of PI3P levels during autophagy 
During AP formation, tight control of PI3P levels through the coordination of PI3Ks and 
PI3P phosphatases at the site of AP formation is critical in determining both AP size and 
rate of production (Dall'Armi et al., 2013; Vergne and Deretic, 2010). In fact, the 
asymmetric distribution of PI3P along the isolation membrane may be achieved not only 
through spatially restricting synthesis of PI3P, but also through locally changing the 
metabolism of PI3P via the balance between kinases and phosphatases. In mammals, 
phosphoinositide 3-phosphatases, such as Jumpy (myotubularin-related protein 14, 
MTMR14) and MTMR3, have been implicated in dephosphorylation of a pool of PI3P 
synthesized for AP biogenesis (Dowling et al., 2010; Taguchi-Atarashi et al., 2010; 
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Vergne and Deretic, 2010; Vergne et al., 2009). Silencing of Jumpy resulted in an 
increase in WIPI-1 puncta and autophagic flux under both normal and starvation 
conditions (Vergne et al., 2009). Similarly, silencing of MTMR3 increases AP formation. 
On the contrary, overexpression of MTMR3 causes fewer and smaller AP (Taguchi-
Atarashi et al., 2010). So far, phosphatases have not been implicated in the early 
autophagy steps in yeast; however, PI3P regulation by phosphatases is important for later 
steps of autophagy. In yeast, two phosphatases, Ymr1, the sole myotubularin ortholog, 
and synaptojanin-like protein 3, via its Sac1 phosphatase domain, have been shown to 
promote the AP-vacuole fusion step (Krick et al., 2008). Despite these initial studies 
concerning PI3P regulation in autophagy, this topic still remains poorly understood. In 
the future, it will be important to address the following questions: Are there additional 
PI3P phosphatases that regulate autophagy? Do the phosphatases act in a similar manner 
or do they have specialized roles in their regulation of autophagy? How are PI3P-
phosphatases regulated? Is PI3P-phosphatase activity important for later, maturation steps 
of autophagy in mammals as in yeast? 
 
1.4 Synthesis of PI3P by the class II and class III PI3K  
All PI3Ks are defined by their ability to catalyze the phosphorylation of the 3-position of 
the inositol ring. In yeast, Vps34 is the sole PI3K; however, in mammals, Vps34 belongs 
to a family of PI3Ks that consists of eight isoforms grouped into three classes based on 
their substrate specificity and structure (Fig. 1.8) (Vanhaesebroeck et al., 2010). 
Specifically, in vitro, the class I converts PI(4,5)P2 to PI(3,4,5)P3, class II converts PI and 
PI4P into PI3P and PI(3,4)P2, respectively, and the class III converts PI to PI3P 
(Vanhaesebroeck et al., 2010). Each of the PI3K shares a kinase, helical and C2 domain 
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core in addition to possessing other, unique domains that define the function and cellular 
localization of each PI3K (Vanhaesebroeck et al., 2010). Given that PI3Ks share a 
structurally similar lipid kinase domain, it is unsurprising that PI3K inhibitors, such as 3-
methyladenine and wortmannin, inadvertently target other members of the family as well, 
albeit at different rates. As mentioned in a previous section, the class I PI3K is a major 
regulator of cell growth and the mTOR pathway; however, it will not be discussed further 
in this section. Here, we focus on the class II and class III PI3Ks which are the only 
known lipid enzymes that synthesize PI3P from PI in mammalian cells. Although the 
class II and class III each play unique roles and have different physiological functions 
within the cell, it is unclear whether these two classes can also produce PI3P for a 
common cellular process. This thesis work is particularly important to the PI field 
because we determine the contribution of PI3P synthesized by the class III PI3K, Vps34, 
in the cell and for autophagy and address whether synthesis of PI3P by the class II PI3K 
is also important for this process.   
1.4.1 Class III PI3K (Vps34) 
Vps34 was first discovered in the early 1990’s during genetic screen performed in S. 
cerevisae to identify vps (vacuole protein sorting) genes important for endosomal 
trafficking to the vacuole (Herman and Emr, 1990). Stevens, Emr and their colleagues 
classified the vps mutants into five classes (A-E) based on the different phenotypes 
observed and placed both Vps34 and its regulator, Vps15, in the category of Class D 
mutants, which displayed improper sorting and trafficking of vacuolar hydrolases (e.g. 
carboxy peptidase Y) from the late-Golgi to the vacuole (Raymond et al., 1992), as well 
as the Class C mutants, which are sensitive to growth at high temperatures and osmotic 
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stress and have abnormal cytoplasmic membranous structure (Banta et al., 1988; Herman 
and Emr, 1990; Robinson et al., 1988). It was not until the discovery of the mammalian 
class IA PI3K p110α and its lipid kinase activity that a homologous lipid kinase domain 
to S. cerevisae Vps34 was identified (Backer, 2008; Hiles et al., 1992; Schu et al., 1993). 
Later studies in S. cerevisae showed that the PI3K activity of Vps34 and its synthesis of 
PI3P were essential for regulating endo-lysosomal system trafficking events and 
autophagy (Kihara et al., 2001b). Vps34 is highly conserved with homologues in several 
species (S. cerevisae, C. albicans, C. elegans, Drosophila, all vertebrates) (Eck et al., 
2000; Herman and Emr, 1990; Linassier et al., 1997; Roggo et al., 2002; Volinia et al., 
1995).  
1.4.1.1 Protein structure and catalytic activity of Vps34 
Notably, Vps34 is the only PI3K family member in S. cerevisae and is the only class III 
PI3K isoform in mammals (Backer, 2008; Yan and Backer, 2007). As a member of the 
PI3K family, Vps34 possesses the characteristic core C2, helical and kinase domains. 
Although the C2 domain is more classically known for binding to calcium, the C2 
domains in the PI3K family are believed to interact with acidic phospholipids. In the 
class I PI3Ks, the helical domain serves as a kinase regulatory domain via its interaction 
with regulatory factors, such as p85 subunit, however, its function in Vps34 still remains 
unknown (Backer, 2008; Vanhaesebroeck et al., 2010). Unlike the other PI3Ks, Vps34 
specifically uses PI as a substrate and only produces the lipid product PI3P. The substrate 
specificity of Vps34 is largely attributed to its substrate recognition loop, which differs 
from that of the class I or II PI3K in that it is uncharged and, therefore, unable to 
accommodate negatively charged phosphate groups of phosphorylated PI headgroups 
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(Pirola et al., 2001). Although the helical domain does not appear to serve a regulatory 
function in Vps34, the catalytic activity of Vps34 is regulated by other means. 
Specifically, Vps34 is largely regulated through the binding of Vps15, a putative serine 
kinase, to its C-terminus (residues 837-864), which is believed to stabilize and 
appropriately target Vps34 to cellular membranes (Panaretou et al., 1997; Stack and Emr, 
1994; Stack et al., 1993). Additionally, the 11 residues at the extreme end of the C-
terminus of Vps34 required for lipid kinase activity independently of Vps15; however, 
the precise regulatory role of these residues is poorly understood (Budovskaya et al., 
2002). Lastly, Vps34 possesses a highly unstructured N-terminal region, although its 
interactors and function is currently unknown (Backer, 2008). 
So far, most of the studies on Vps34 have been focused on its lipid kinase 
activity; however, Vps34 is likely to have other important roles in the cell that are 
currently underappreciated. For instance, Vps34 has been shown to undergo 
autophosphorylation, suggesting that Vps34 may have protein kinase capabilities as well 
(Stack and Emr, 1994). Vps34 may also have kinase independent roles in the cell, 
including acting as a scaffold to organize complexes or to bring factors in close proximity 
to facilitate signaling events. Interestingly, in Candida albicans, the Vps34-null strain 
and the Vps34 kinase-dead strain display different osmotic and temperature responses, 
suggesting that other, noncatalytic domains of Vps34 have important functions as well 
(Gunther et al., 2005).  
1.4.1.2 Vps34 complexes  
Vps34 operates in several, largely conserved complexes that determine its different 
physiological roles and regulates its lipid kinase activity (Fig. 1.9). Vps34 forms a 
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constitutive heterodimer with Vps15, which promotes the recruitment of Vps34 to 
membranes as well as regulates its activity (Stack et al., 1995). In yeast, two major 
Vps34-Vps15 complexes exist: complex I (Vps34, Vps15, Vps30/Atg6, Atg14) and 
complex II (Vps34, Vps15, Vps30/Atg6, Vps38) (Kihara et al., 2001b). Vps34 complex I 
localizes to the PAS and functions in the initiation of autophagy (Obara et al., 2006; 
Suzuki et al., 2001), whereas complex II associates with the endosome and regulates 
endosomal trafficking events (Kihara et al., 2001b). In mammals, the Vps34 complexes 
are less clearly defined and more interactors regulate each complex. In brief, the 
mammalian equivalent of complex I consists of Vps34, Vps15, Beclin (the mammalian 
Vps30/Atg6 homolog) and Atg14 and also promotes the initiation step of autophagy 
(Itakura et al., 2008; Kihara et al., 2001a; Matsunaga et al., 2009; Zhong et al., 2009). 
Similar to yeast, the mammalian equivalent of complex II consists of Vps34, Vps15, 
Beclin and UVRAG (the mammalian Vps38 homolog) (Kihara et al., 2001a). In fact, 
Atg14 and UVRAG are mutually exclusive members of these complexes since they both 
bind the same site on Beclin (Matsunaga et al., 2009). Complex II in mammals is not well 
understood, but is thought to mainly participate in endo-lysosomal trafficking events, 
including autophagosome maturation, endocytic fusion, and multivesicular body 
formation. Additionally, this complex has been implicated in cytokinesis (Funderburk et 
al., 2010; Liang et al., 2008a; Thoresen et al., 2010; Zhong et al., 2009). Importantly, it is 
likely that Vps34 can also exist as a simple heterodimer with Vps15 at the endosome that 
interacts with myotubularin phosphatases, such as MTM1, to tightly regulate PI3P levels 
(Cao et al., 2007). Lastly, a third mammalian complex, Complex III, includes members of 
complex II plus Rubicon (Matsunaga et al., 2009). Complex III is primarily known for its 
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role in inhibiting fusion events along the endosome, including autophagosome 
maturation, by preventing the interaction between UVRAG and the C-VPS/HOPS 
tethering complex (Matsunaga et al., 2009; Sun et al., 2010; Tabata et al., 2010). In 
mammals, several accessory factors also associate with these complexes, such as BIF-1 
and Ambra, and serve as additional modulators of autophagy (Fimia et al., 2007; 
Takahashi et al., 2007). So far, we are at the beginning stages of understanding post-
translational modifications (e.g., phosphorylation) of Vps34 and how they regulate its  
localization, enzymatic activity and the stability of the various Vps34 complexes. The 
molecular basis governing the regulation and participation of these different Vps34 
complexes and complex members in various cellular functions is still unclear, but is an 
area of active investigation. In fact, in yeast, Atg38 was recently identified as novel 
Vps34 complex I member that forms a homodimer to bridge the Vps15-Vps34 and 
Atg14-Atg30 complex (Araki et al., 2013). 
1.4.1.3 Vps34 and the endocytic pathway  
Since the discovery of Vps34 in the early 1990’s, numerous studies have demonstrated 
that Vps34 and its synthesis of PI3P are important for multiple endocytic trafficking 
events, including homotypic fusion between early endosomes, phagocytosis, retrograde 
trafficking to the Golgi and MVB biogenesis (Backer, 2008; Lindmo and Stenmark, 
2006).  
Vps34 complexes are targeted to the early or late endosome via the direct 
interaction of Vps15 with Rab5 (Christoforidis et al., 1999; Stack et al., 1995) or Rab7 
(Stein et al., 2003), respectively. In yeast and mammals, complex II or the homolog 
equivalent is primarily recruited to the endosomal membrane; however, the heterodimer 
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of Vps34 and Vps15 may also be recruited the membrane alone or as a complex with the 
myotubularin phosphatase, MTM1 (Cao et al., 2007). One of the major functions of 
Vps34 is to promote the homotypic fusion of endosomes. Specifically, PI3P synthesis on 
the endosome recruits the effectors EEA1 and Rabenosyn-5 through their PI3P-binding 
FYVE-domains, which regulate homotypic fusion (Simonsen et al., 1998). EEA1 
regulates docking of membranes through the recruitment of SNARE proteins syntaxin 6 
and syntaxin 13 (McBride et al., 1999; Simonsen et al., 1999), whereas Rabenosyn-5 
binds Vps45, a negative regulator of SNAREs (Nielsen et al., 2000). Additionally, Vps34 
plays an important role in the maturation and fusion step of phagocytosis. Nascent 
phagosomes contain activated Rab5, which likely facilitates the recruitment of Vps34, 
and transiently accumulate PI3P required for their subsequent maturation and fusion with 
the late endosomes/lysosomes.  
As mentioned above, Vps34 was first identified in yeast for its essential role in 
the sorting and delivery of soluble hydrolases transported from the Golgi to the vacuole 
(Backer, 2008; Herman and Emr, 1990; Schu et al., 1993). This phenomenon was later 
attributed to the important role of Vps34 in regulating retrograde sorting and transport via 
the retromer complex. Retromer mediates the retrograde trafficking of Vps10p, the yeast 
homolog of the mannose 6-phosphate receptor that binds lysosomal hydrolases, from the 
endosome back to the TGN, which is important for its additional rounds of hydrolase 
sorting (Hurley and Emr, 2006; Lindmo and Stenmark, 2006; McGough and Cullen, 
2011; Seaman, 2012; Seaman et al., 1998). The synthesis of PI3P by Vps34 is important 
for the recruitment of retromer complex members Vps5 and Vps17 (the mammalian 
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equivalent of SNX1, SNX2, SNX5, SNX6), which contain PI3P-binding PX domains 
(Bonifacino and Hurley, 2008; McGough and Cullen, 2011).  
Lastly, the formation of intraluminal vesicle (ILVs) in multivesicular bodies 
(MVBs) is required for the degradation of endocytosed transmembrane proteins (e.g., the 
EGF receptor) is also regulated by PI3P synthesis by Vps34 (Fernandez-Borja et al., 
1999; Futter et al., 2001a; Schu et al., 1993). Specifically, PI3P recruits members of the 
ESCRT machinery, such as the FYVE-domain containing Vps27/HRS (ESCRT-0), and 
SNX3, via its PX domain, to promote the invagination and budding of endosomal 
membrane (Futter et al., 2001b; Katzmann et al., 2003; Raiborg and Stenmark, 2009; 
Saksena et al., 2007). Interestingly, PI3P not only participates in ILV formation, but is 
also sorted into ILVs and degraded upon reaching the late endosome and may be a means 
by which PI3P is physiologically downregulated (Gillooly et al., 2000). 
Vps34 and its synthesis of PI3P are critical for maintaining homeostasis and 
proper functioning of the endo-lysosomal system. Importantly, the role of Vps34 in the 
endo-lysosomal system is also critical for efficient autophagy, which relies on APs fusing 
with endosomes and MVBs during maturation, at least in the mammalian system, and the 
lysosome for degradation. 
1.4.1.4 Vps34 and mTOR signaling 
Although Vps34 is important for the induction of autophagy in response to nutrient 
stressors, a paradoxical role for Vps34 in positively regulating mTORC1 signaling (and 
thus theoretically downregulating autophagy) has recently emerged in mammalian cells 
(Backer, 2008; Yan and Backer, 2007). Specifically, studies have shown Vps34 is 
required for insulin- and amino acid- stimulated activation of mTOR and its substrates, 
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S6K1 and 4EBP1 (Byfield et al., 2005). In fact, amino acid withdrawal and glucose 
starvation inhibit Vps34 activity (Byfield et al., 2005; Nobukuni et al., 2005). Currently, 
the mechanism by which insulin and amino acids regulate Vps34 is not well understood. 
In the case of amino acid stimulation, one model suggests that the activated Vps34 is 
recruited to the late endosome and lysosome where it stimulates PLD1 (phospholipase 
D1) to synthesize phosphatidic acid (PA), which subsequently contributes to the 
activation of mTORC1 (Dall'Armi et al., 2013; Wiczer and Thomas, 2012). PI3P-binding 
Phox homology (PX) domain of PLD1 was shown to be important for both its 
translocation to the late endosomes and lysosomes upon amino acid starvation as well as 
its activation (Yoon et al., 2011); however, another group reported Vps34 depletion had 
no affect on PLD1 activity, which may be explained by experimental differences (Xu et 
al., 2011). Importantly, the Vps34-PLD1 pathway is necessary but not sufficient to 
stimulate the mTORC1 and requires additional, parallel amino acids to drive mTORC1 
signaling (Yoon et al., 2011). Additionally, activation of AMPK has also been shown to 
inhibit Vps34 to negatively regulate mTORC1 signaling (Byfield et al., 2005). Several 
studies have indicated that Vps34 does not mediate steady-state mTORC1 signaling, but 
rather mTORC1 signaling in response to acute cues (Jaber et al., 2012a; Juhasz et al., 
2008; Xu et al., 2011). The requirement for Vps34 in both mTORC1 activation and 
autophagy seems contradictory given our current understanding of both pathways and 
will require further investigation to be reconciled.  
1.4.1.5 Vps34 and autophagy 
As described in previous sections, Vps34 and its synthesis of PI3P play an important role 
in the regulation of autophagy at the biogenesis, maturation and lysosomal fusion steps. 
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While Vps34 is the only source of PI3P and required for autophagy in budding yeast, 
whether this lipid kinase plays an essential role in mammalian autophagy has been an 
outstanding question in the field. Previous molecular genetic (e.g., siRNA) and 
pharmacological studies using standard PI3K inhibitors, such as wortmannin or 3-
methyladenine (3MA), have suggested that Vps34 is critical for starvation-induced 
autophagy but Vps34-independent pathways for PI3P synthesis have yet to be ruled out 
(Axe et al., 2008; Blommaart et al., 1997; Dall'Armi et al., 2013; Itakura et al., 2008; 
Petiot et al., 2000). In fact, genetic studies in Drosophila were the first to hint that Vps34 
was not essential for AP biogenesis (Juhasz et al., 2008). Recently, several genetic mouse 
models have been generated to determine the role of mammalian Vps34 in autophagy and 
other physiological processes; however, conflicting conclusions have been drawn 
concerning its role in autophagy in particular (Table 2.2). For instance, studies in various 
conditional knockout (KO) mouse models have reported a spectrum of findings, ranging 
from no autophagy phenotypes in sensory neurons (Zhou et al., 2010) and T-lymphocytes 
(McLeod et al., 2011) to severe autophagy defects in the latter cell type (Parekh et al., 
2013; Willinger and Flavell, 2012), fibroblasts, cardiomyocytes, hepatocytes (Jaber et al., 
2012a), podocytes (Bechtel et al., 2013) and lens cells (Morishita et al., 2013) (See Table 
2). The answer to whether Vps34 plays an essential role in mammalian autophagy is 
more complex than originally anticipated. In fact, differences in autophagy requirements 
may not only reflect cell type, but also genetic background, cell state and type of 
autophagy-inducing stimuli, continuing to raise the question of whether sources of PI3P 
besides Vps34, such as the class II PI3K, can regulate autophagy. 
40 
 
1.4.2 Class II PI3K (PI3KC2) 
Of the three classes of PI3Ks, PI3KC2 is by far the most enigmatic. The PI3KC2 were 
first identified in Drosophila in which there is only one isoform, Pi3K68D (MacDougall 
et al., 1995). In mammals, three PI3KC2 isoforms have been identified, including the 
PI3KC2α, PI3KC2β, PI3KC2γ; however, the majority of the PI3KC2 studies have 
focused on the  and  isoforms which are the most ubiquitously expressed in tissues.   
1.4.2.1 Protein structure and catalytic activity of PI3KC2 
The PI3KC2s contain a helical, C2, and kinase domain core characteristic of the PI3K 
family. Like Vps34, the helical domain does not seem to possess any regulatory function  
and the C2 domain function is currently unknown for this class. The catalytic domain of 
PI3KC2 differs from Vps34 in that the substrate recognition loop of the PI3KC2 domain 
is similar to the class I PI3K in that it contains multiple basic charges allowing it to 
accommodate both unphosphorylated and phosphorylated PIs as their substrates. In fact, 
the PI3KC2 isoforms can use PI, PI4P and PI(4,5)P2 as substrates to synthesize PI3P, 
PI(3,4)P2 and PI(3,4,5)P3 in vitro, respectively. However, PI appears to be the preferred 
substrate even for the α isoform, which has shown increased preference toward PI4P and 
PI(4,5)P2 in the presence of clathrin and when participating in clathrin mediated 
endocytosis (CME) (Gaidarov et al., 2005; Posor et al., 2013). Although PI3KC2 does 
not possess a regulatory subunit like class I, there are several unique protein binding 
domains within the N- and C-terminus that likely control its localization and kinase 
activity. The N-terminus sequence of PI3KC2 defines each isoform and has the potential 
to regulate its lipid kinase activity by modulating protein conformation and/or regulating 
its localization (Arcaro et al., 1998). PI3KC2α contains a clathrin-binding region 
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(Gaidarov et al., 2005), whereas PI3KC2β contains proline-rich sequences (Wheeler and 
Domin, 2006). Additionally, similar to the class I isoform, the N-terminus of the PI3KC2 
contains a Ras binding domain, although its binding to Ras family members remains 
untested. The C-terminus of PI3KC2 is quite distinct from Vps34 in that it contains a PX 
(phox homology) domain and a second C2 domain (Stahelin et al., 2006). The PX 
domain in the C-terminus binds PI(4,5)P2 and may play a role in recruiting the PI3KC2 to 
the plasma membrane (Stahelin et al., 2006), whereas the second C2 domain possesses a 
nuclear localization motif that promotes the translocation PI3KC2 into the nucleus.  
1.4.2.2 Isoform specific functions of the PI3KC2s 
PI3KC2α  
Human PI3KC2α is ubiquitously expressed, although it has highest expression in the 
heart, placenta and ovary (Domin et al., 1997; Falasca and Maffucci, 2012). The α 
isoform has been found at the plasma membrane, endosome and trans-Golgi network and 
has been implicated in a variety of cellular functions. The best understood role for 
PI3KC2α is in the maturation and fission steps of clathrin mediated endocytosis (CME) 
(Posor et al., 2013). During CME, PI3KC2α is recruited to the plasma membrane through 
its clathrin-binding domain as well as its PX domain, which binds PI(4,5)P2 (Posor et al., 
2013).  The PI(4,5)P2 here is initially synthesized during the nucleation step of 
endocytosis but is then subsequently dephosphorylated by 5-inositol phosphatase to PI4P 
and can be used as a substrate by PI3KC2α (Posor et al., 2013). The catalysis of PI4P to 
PI(3,4)P2 by PI3KC2α leads to the recruitment of Snx9 and dynamin, the machinery 
required for the final vesicle fission step (Posor et al., 2013). PI3KC2α has also been 
implicated in dynamin-independent endocytosis although its mechanism is currently 
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unknown. Importantly, this was the first cell-based instance of PI(3,4)P2 synthesis by 
PI3KC2α; however, other roles for this isoform are still believed to depend on its 
synthesis of PI3P. PI3KC2α has also been implicated in other trafficking events such as 
translocating GLUT4 to the plasma membrane to regulate glucose transport (Falasca et 
al., 2007; Maffucci et al., 2003), releasing insulin β-cells and releasing neurosecretory 
granules containing hcG (Meunier et al., 2005; Wen et al., 2008), and is thought to 
promote vesicle fusion. In addition to its role in trafficking, PI3KC2α also seems to be 
important for several signaling pathways. PI3KC2α has been found to regulate β-cell 
insulin secretion in part through the upregulation of β-GK (glucokinase) (Leibiger et al., 
2010). Additionally, PI3KC2α has also been shown to promote cell growth and survival, 
although through an unclear mechanism that likely involves regulation of apoptosis (Elis 
et al., 2008; Eun et al., 2010; Kang et al., 2005; Ng et al., 2009). Lastly, PI3KC2α has 
been implicated in signaling muscle contraction via its stimulation of Rho (Wang et al., 
2006; Yoshioka et al., 2007). The precise mechanism by which PI3KC2α regulates this 
diverse set of pathways the will require further investigation. The first conditional knock-
out mouse model for PI3KC2α provided some insights to the protein’s function, however, 
it was not a bona fide knock-out because a kinase-dead, truncated form of the protein still 
remained (Harris et al., 2011). Nevertheless, this particular knock-out model showed the 
kinase activity of PI3KC2α to be important for postnatal development given that a 
significant number of mutant mice died by 6 months of age (Harris et al., 2011). The 
early death of the PI3KC2α knock-out mice was attributed to chronic renal failure (Harris 
et al., 2011). Since then, a second, a PI3KC2α complete null conditional mouse model 
was generated (Yoshioka et al., 2012). Global knockout or endothelial-cell-specific 
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ablation of PI3KC2α resulted in embryonic lethality due to abnormalties in multiple 
organs as well as severely impaired vascular formation (Yoshioka et al., 2012). Inducible 
deletion in endothelial cells demonstrated PI3KC2α is critical for vascular formation, 
which requires efficient endothelial cell migration, proliferation and tube formation and 
cell junction assembly (Yoshioka et al., 2012). Notably, a decrease in PI3P enriched 
endosomes and impairment in endosomal trafficking and defective endothelial cell 




Similar to the PI3KC2α, the PI3KC2β is ubiquitously expressed, but shows increased 
expression in certain tissues, including the placenta and thymus (Arcaro et al., 1998; 
Brown et al., 1997). The PI3KC2β has been found to localize to the plasma membrane 
and nucleus and regulate a wide range of cellular processes, including cell migration, K
+
 
channel activation, cell growth and survival and cell-cycle progression (Falasca and 
Maffucci, 2007; Falasca and Maffucci, 2012). Specifically, PI3KC2β has been shown to 
synthesize PI3P at the plasma membrane, which promotes motility by stimulating 
membrane ruffling and actin lamellipodia/fillipodia and decreasing adhesion (Domin et 
al., 2005; Katso et al., 2006; Maffucci et al., 2005). Notably, however, a role for 
PI3KC2β in motility may be cell type specific given that other studies did not observe a 
role for PI3KC2β in this process (Smith et al., 2007). Additionally, PI3KC2β has been 
found to act downstream of TCR activation to regulate a K
+
 channel (KCa3.1) via its 
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PI3P synthesis (Srivastava et al., 2009). Mutations and misregulation of PI3KC2β has 
been observed in several cancer cell lines. This finding corroborates with increased 
proliferation and protection from anoikis seen in cell lines overexpressing PI3KC2β and 
suggests it positively regulates cell growth and survival (Katso et al., 2006). PI3KC2β 
role in growth appears to be independent of Akt, but may instead help regulate a pathway 
that inhibits apoptosis (Das et al., 2007). Aside from its cytosolic roles, PI3KC2β also 
localizes to the nucleus. During G2/M phase increased levels of PI3KC2β are seen in the 
nucleus, suggesting it may have a role in cell cycle progression (Visnjic et al., 2003). 
PI3KC2β and its synthesis of PI3P have been implicated in several cellular processes; 
however, its precise mechanism of action remains unknown. Further work will need to be 
done to identify novel interactors and place the PI3KC2 within signaling networks. 
Lastly, a conditional mouse knock-out was generated for PI3KC2β, which showed no 
overt phenotype upon full body deletion (Harada et al., 2005). Given that there are three 
isoforms, it may be that PI3KC2β is compensated for here. A multiple isoform knock-out 
study may be required to better understand the role of PI3KC2 (Harada et al., 2005). 
PI3KC2γ  
Currently, very little is known about PI3KC2γ isoform. PI3KC2γ has a very limited 
expression pattern that includes the liver, prostate, breast and salivary glands with the 
liver being the major site of expression (Rozycka et al., 1998). Its function has yet to be 
studied(Falasca and Maffucci, 2012). 
1.4.2.3 An emerging role for PI3KC2 in autophagy? 
As mentioned previously, both Vps34 and PI3KC2 are the only enzymes in higher 
eukaryotes that catalyze the conversion of PI to PI3P. Whether the Vps34 and the 
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PI3KC2 can act together to both positively regulate the same function is unknown. 
Interestingly, pi3c2α, was recently identified as a "hit" in a large autophagy interaction 
network screen. Specifically, an interaction was detected between PI3KC2α and both 
Atg7 and MAP1LC3A (one of the six Atg8 orthologues in humans) (Behrends et al., 
2010). Additionally, siRNA knock-down PI3KC2α suggested a decrease in autophagy 
flux, warranting a further exploration of PI3KC2α’s potential regulatory role in 
autophagy (Behrends et al., 2010). A recent study in C. elegans reported the class II 
ortholog, PIK-1, produces a pool of PI3P on nascent phagosomes, which is then followed 
by sustained production of PI3P on these organelles (Lu et al., 2012). Here the production 
of PI3P by Vps34 depends on the initial production of PI3P by PIK-1 (Lu et al., 2012). In 
this model, PI3KC2 and Vps34 cooperate and act sequentially to regulate the autophagy 
process (Lu et al., 2012). Since mammalian cells have multiple isoforms it is uncertain 
which may participate in the autophagy process and, if so, whether they act in a 
hierarchical manner such as in C. elegans or whether they produce separate pools of 
PI3P.   
1.5 Objectives 
The main purpose of this dissertation is to better understand the role of PI3Ks in the 
regulation of autophagy. Given that the mammalian system has multiple ways to 
synthesize PI3P, we hypothesized that autophagy could still occur independently of 
Vps34 and that the class II PI3Ks synthesize PI3P during this process as well. The first 
part of this investigation was carried out using mouse embryonic fibroblasts (MEFs) from 
a Vps34 conditional genetic mouse model to generate Vps34 null cells. Using Vps34 null 
MEFs, we assessed the contribution of Vps34 to levels of PI3P synthesis at steady-state 
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and during autophagy. Additionally, using several standard autophagy assays we 
quantitatively assessed autophagy in the absence of Vps34. In the second part of this 
work, we used a molecular RNA interference approach to determine whether the class II 
PI3K plays a positive role in regulating autophagy. We aimed to determine the 
contribution of PI3P by the class II PI3Ks as well as assess its role in autophagy by 
performing standard autophagy assays and colocalization studies with autophagy 
markers. 
Additionally, the preliminary data from two side-projects are presented in the 
final chapters. The goal of the first project was to discover novel lipid interactions for 
Vps34 using a lipidomics approach. Since Vps34 and its synthesis of PI3P are 
responsible for numerous membrane trafficking events and maintaining endo-lysosomal 
homeostasis, we hypothesized that this lipid modifying enzyme may play a role in 
regulating lipid homeostasis in the cell. The aim of the second project was to determine 
whether the retromer complex, which is controlled by PI3P synthesis by Vps34, regulates 
autophagy. We hypothesized that the decline in retromer function observed in sporadic 
Alzheimer’s disease cases may contribute to the breakdown of the endo-lysosomal 
















Figure 1.1 Cellular degradative processes 
Figure 1.1 Cellular degradative processes. (A) The ubiquitin-proteosome system (UPS) 
is a cytosolic degradation pathway that consists of a proteosome that recognizes 
polyubiquitinated proteins and degrades them into small peptides. There are 3 modes of 
lysosomal degradation: chaperone-mediated autophagy (CMA), microautophagy and 
macroautophagy. (B) CMA occurs when soluble cytosolic proteins containing a targeting 
motif (e.g., KFERQ) are recognized by the cytosolic heat shock cognate 70 (Hs70) 
chaperone and translocated across the lysosomal membrane by LAMP-2A (lysosomal-
associated protein type 2A) for degradation. (C) During microautophagy, the surface of 
the lysosome or late endosomes invaginates and engulfs the adjacent cytosolic material in 
a selective or nonselective manner into the lumen for degradation. (D) Macroautophagy 
is characterized by the sequestration of cytoplasmic proteins and organelles, either 
selectively or nonselectively, by a double-membrane vesicle termed the autophagosome. 





Figure 1.2 mTORC1 regulation of mammalian autophagy 
Figure 1.2 mTORC1 regulation of mammalian autophagy. Mammalian target of 
rapamycin complex 1 (mTORC1) plays a central role in autophagy by coordinating 
multiple signaling inputs, including the growth factor and hormone induced class I 
phosphatidylinositol 3-kinase (PI3K) and small GTPase Ras, amino acid and AMP-
activated protein kinase (AMPK) signaling pathways. mTORC1 activation promotes 
cellular anabolism via phosphorylation of its downstream targets S6 kinase 1 (S6K1) and 
eIF4E-binding protein 1 (4E-BP1) and restricts catabolic processes such as autophagy by 
inhibiting the Ulk1/2 complex. When nutrient and energy supply is scarce, mTORC1 is 
inhibited and autophagy becomes activated. A negative feedback loop may exist whereby 
S6K1 downregulates growth factor receptor signaling to inactivate mTORC1. Adapted 





Figure 1.3 Regulation of Atg1 complexes by TORC1. 
Figure 1.3 Regulation of Atg1 complexes by TORC1. (A) In yeast, the active target of 
rapamycin complex I (TORC1) hyperphosphorylates Atg13 and prevents the association 
of Atg1 with Atg13, Atg17, Atg31 and Atg29 to inhibit autophagy induction. Upon TOR 
inhibition, TORC1 no longer phosphorylates Atg13 and can associate with the Atg1 
complex to promote autophagy. (B) In mammals, Ulk1/2 (the homologs of yeast Atg1) 
forms a stable, constitutive complex with Atg13, FIP200 (the mammalian homolog of 
Atg17) and Atg101. Activated mTORC1 associates with the ULK complex and 
phosphorylates ULK1 (or ULK2) and Atg13 to inhibit autophagy. Upon mTORC1 
inhibition, mTORC1 dissociates from the ULK complex, leading to the 
dephosphorylation and activation of Atg13 and ULK1 (or ULK2) and autophagy 
induction. ULK1 (or ULK2) phosphorylates Atg13, FIP200 and itself at constant low 
levels and hyperphosphorylates FIP200 when activated. Taken and adapted from (Chen 




Figure 1.4 Schematic overview of the macroautophagy process 
Figure 1.4 Schematic overview of the macroautophagy process. Autophagosome (AP) 
formation is a fundamental process in autophagy that depends on (i) an initiation step in 
which an isolation membrane (IM) cistern begins to wrap around the cytoplasm, (ii) an 
elongation step during which the membrane increases in size and (iii) a closure step in 
which the membrane seals around a section of the cytoplasm to form a double membrane 
AP. Unlike APs in yeast which directly fuse with the vacuole, APs of higher eukaryotes 
mature into amphisomes by fusing with endosomal organelles and then subsequently fuse 
with lysosomes to form autophagolysosomes (ALs). Once amphisomes have fused with 
the lysosomes, captured material is degraded by hydrolases and digested products are 






Figure 1.5 Schematic overview of autophagosome biogenesis  
Figure 1.5 Schematic overview of autophagosome biogenesis. During mammalian 
autophagy, Ulk1/2 protein kinase complex (Ulk1/2, Atg13, FIP200) is activated and 
relocalizes to the site of AP nucleation. A core Vps34 complex consisting of Vps34, 
Beclin 1 (a homologue of yeast Vps30/Atg6), Vps15 and Atg14L is directed to the AP 
nucleation site along the ER membrane by Atg14L to promote local synthesis of PI3P 
and initiate AP biogenesis at subdomains of the endoplasmic reticulum (ER), termed 
“omegasomes” (for their omega-like shape). PI3P acts as a membrane platform to 
concentrate and spatially coordinate specific effectors, such as WIPI (the mammalian 
orthologue of Atg18) and DFCP-1, which harbor PI3P-binding modules and are likely 
necessary for downstream signaling and the progression of autophagy. Taken and adapted  




Figure 1.6 Atg12 and Atg8 ubiquitin-like conjugation systems in autophagy.  
Figure 1.6 Atg12 and Atg8 ubiquitin-like conjugation systems in autophagy.  
(A) Atg12 and Atg8 (the yeast homolog of mammalian LC3) are both ubiquitin-like 
proteins that undergo a series of enzymatic reactions similar to that of the ubiquitin 
system during autophagy. Atg12 possesses a C-terminal glycine residue required for 
conjugation; however, Atg8/LC3 must first undergo cleavage by Atg4 to expose its 
glycine residue prior to its conjugation. During autophagy, Atg12 and Atg8 are activated 
by an E1-like enzyme (Atg7) and are conjugated by an E2-like enzyme (Atg10 and Atg3, 
respectively) to either Atg5 or phosphatidylethanolamine (PE), respectively. Conjugated 
Atg5-12 interacts with Atg16L to form the Atg5-12-16 complex, which subsequently 
recruits Atg8 (LC3) and acts as an E3-like ubiquitin ligase that facilitates the conjugation 
of Atg8/LC3 to PE on the AP membrane. The addition of the PE moiety to Atg8/LC3 
causes its conversion from a soluble Atg8/LC3-I form to a membrane bound Atg8-
PE/LC3-II form. Atg4 proteolytically deconjugates Atg8/LC3 from PE to release it from 
the membrane. (B) Distribution of the Atg12 and Atg8 conjugation system on the AP 
during AP biogenesis. The Atg5-12-16 complex is recruited to the outer surface of the 
AP and directs Atg8 conjugation to phosphatidlyethanolamine (PE) at this site. Atg8-
PE/LC3-II? promotes the expansion of the AP membrane. Upon closure of the AP, the 
Atg5-12-16 complex dissociates and Atg4 proteolytically releases Atg8-PE from the 




Figure 1.7 Metabolism and distribution of phosphoinositides 
Figure 1.7 Metabolism and distribution of phosphoinositides. (A) Structure of 
phosphatidylinositol. (B) Metabolic reactions required to generate the seven 
phosphoinostide species. Reactions demonstrated in vitro are represented in broken 
arrows and their relevance in living cells still remains unclear. (C) Subcellular 





Figure 1.8 Domain structure of mammalian phosphoinositide 3-kinases (PI3Ks) 
Figure 1.8 Domain structure of mammalian phosphoinositide 3-kinases (PI3Ks). All 
PI3Ks have a core structure consisting of a C2 domain, a helical domain and a catalytic 
domain and are grouped into three classes based on their substrate specificity and 
structure. Class I PI3Ks use PI(4,5)P2 as a substrate and forms heterodimer with a 
regulatory subunit. Class II PI3Ks use PI as a primary substrate; however, the α isoform 
can also use PI4P in cells for certain functions. Both the class I and class II PI3Ks have 
N- extensions, which likely mediate protein-protein interactions. Additionally, the class II 
PI3K possesses a unique C-terminal extension that contains a second C2 domain and a 
phox homology (PX) domain. Class III PI3K (Vps34) uses PI as a substrate and requires 
binding to Vps15 for activation. Reactions in italics have only been demonstrated in 





Figure 1.9 The major Vps34 complexes in yeast and mammals 
Figure 1.9 The major Vps34 complexes in yeast and mammals. (A) In yeast, complex 
I and II regulate autophagy and endocytic system, respectively. (B) In mammals, multiple 
complexes act at different stages of the autophagy process as well as in endocytic 
trafficking. Atg14L associates with the core Beclin1-Vps34-Vps15 to promote 
autophagosome formation (the mammalian equivalent of complex I). UVRAG binds 
Beclin in a mutually exclusive manner with Atg14 to form a complex with Beclin1-
Vps34-Vps15 (the mammalian equivalent of complex II). The UVRAG complex is 
required for endosome function and AP maturation, although it has also been implicated 
in AP biogenesis as well. Lastly, a third major complex consists the UVRAG complex 
bound to Rubicon, which has been shown to inhibit autophagosome maturation. Adapted 






Table 1.1 Glossary of PI3P autophagy effectors.  
Table 1.1 Glossary of PI3P autophagy effectors. PI3P-binding modules/motifs (shown 
in bold) include: BATS, Barkor/Atg14(L) autophagosome targeting sequence; FYVE, 
protein present in Fab1, YOTB, Vac1, and EEA1; PH, pleckstrin homology domain; PX, 
Phox homology domain; WD40, defined as a core unit of approximately 40 amino acids 
ending with the residues tryptophan and aspartic acid which adopts a 7-bladed beta 
propeller fold containing a PI3P-binding FRRG or LRRG motif. In the case of Alfy, 
however, the individual WD40 regions are shown (WD40∗) because it is unclear whether 




























































































































































































































Chapter 2: Regulation of mammalian autophagy by class II and III PI 3-kinases 
through PI3P synthesis 
2.1 Results 
2.1.1 Generation of Vps34 knock-out MEFs. 
To investigate the contribution of Vps34 to starvation-induced autophagy, Vps34
Flox/Flox 
MEFs were generated and characterized. Vps34
Flox/Flox
 MEFs were immortalized by 
multiple passages and infected with lentiviruses expressing either a catalytically-inactive 
or active, nuclear Cre recombinase fused to eGFP (green) or tdTomato fluorescent 
protein (red) to generate control and Vps34 KO cells, respectively (see Materials and 
Methods). Expression of active Cre, but not inactive Cre, resulted in the progressive loss 
of Vps34 immunoreactivity by Western blot analyses over the course of several days with 
complete loss of expression reproducibly achieved by 9 to 10 days (Fig. 2.1A,B). 
Importantly, although exons 17 and 18 were targeted, antibodies directed to the very 
NH2-terminus of Vps34 (i.e., amino acids 1-40) did not reveal any truncated fragments of 
Vps34 at day 10 post-infection (Fig. 2.1C). This finding together with the original 
analysis of Vps34 mRNA in Cre-expressing Vps34
Flox/Flox
 tissue (Zhou et al., 2010) 
confirms that this targeting strategy successfully produces a null mutant.  
2.1.2 Characterization of Vps34 KO MEFs and their autophagy machinery. 
To begin to characterize the Vps34 KO MEFs, various cellular compartments and levels 
of relevant autophagy and endosomal proteins were assessed. When membranous 
organelles were examined by immunofluorescence, no major alterations of the ER, Golgi
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complex and lysosomes were found at day 10 post-infection based on the 
immunofluorescent analysis of protein disulfide isomerase (PDI), giantin, and LAMP1, 
respectively (Fig. 2.2A). There was, however, an enlargement of the EEA1-positive early 
endosomal compartment, consistent with other studies (Futter et al., 2001a; Johnson et 
al., 2006; Morel et al., 2013; Zhou et al., 2010) (Fig. 2.2A). Notably, prolonged ablation 
of Vps34 for an additional 4-5 days (day 14-15 post-infection) consistently resulted in 
cell vacuolization (Fig. 2.2B), a breakdown of the lysosomal compartment (as evidenced 
by an aberrant LAMP1 compartment) (Fig. 2.2B) and impaired lysosomal degradation of 
the EGF receptor in response to EGF stimulation (Fig. 2.2C). These features, which have 
been reported elsewhere (Jaber et al., 2012a; Johnson et al., 2006), reflect the reduced 
viability resulting from the chronic loss of Vps34, a factor potentially confounding the 
analysis of the physiological function of Vps34 in autophagy. We thus focused our 
analysis at 10 days post-infection prior to the breakdown of the endolysosomal system.  
Additionally, we examined levels of relevant autophagy and endosomal proteins 
in Vps34 KO MEFs. Ablation of Vps34 resulted in a significant decrease in levels of 
Vps34 complex members, including Vps15/p150 and Beclin-1, as previously reported 
(Willinger and Flavell, 2012), as well as Atg14L and UVRAG. In contrast, Rubicon, a 
negative regulator of Vps34 (Matsunaga et al., 2009; Zhong et al., 2009), showed 
increased levels in the KO. Levels of proteins operating in the endosomal pathway were 
also assessed and no changes were found in the expression levels of the retromer subunits 
Vps26 and Vps35 or Rab5, although EEA1 levels were slightly decreased (Fig. 2.3). 
These data indicate that Vps34 ablation results in the destabilization of molecular 
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components previously reported to associate with Vps34 complexes as well as the 
endosomal PI3P effector, EEA1. 
2.1.3 Steady-state and starvation-induced PI3P is detected in Vps34 KO MEFs. 
To quantitatively determine the amount of PI3P produced by Vps34, phosphoinositides 
were measured in control and Vps34 KO MEFs. For such large scale biochemical studies, 
control and Vps34 KO cells were generated from Vps34
Flox/Flox 
Cre-ER MEFs (see 
Materials and Methods). Specifically, cells were radiolabeled with [
3
H] myo-inositol, 
high performance liquid chromatography (HPLC) was performed and phosphoinositide 
levels were detected by radioactivity. We found a 65% decrease in PI3P levels in Vps34 
KO MEFs relative to controls and no obvious alterations in other inositol lipids levels 
detected by the assay, such as PI, PI4P and PI(4,5)P2 (see also Fig. 2.12). Therefore, we 
conclude that in our fibroblasts, Vps34 accounts for the majority of cellular PI3P levels 
and that 35% of this lipid can be synthesized through alternate pathways.   
Additionally, we detected intracellular PI3P using fluorescence microscopy. 
Historically, the detection and localization of intracellular PI3P has relied on the use of 
the FYVE domain (i.e., a zinc finger originally identified in Fab1, YOTB, Vac1p, EEA1) 
as a genetically-encoded or purified PI3P-binding probe (Raiborg et al., 2013; Stenmark 
and Aasland, 1999; Stenmark et al., 1996)). The first of these biosensors consisted of a 
tandem FYVE domain from Hrs (2xFYVE
Hrs
) which showed PI3P concentrated on the 
limiting and intraluminal membranes of endosomes (Gillooly et al., 2000). Here control 
and Vps34 KO MEFs were transiently transfected with RFP-2x-FYVE
Hrs
. In control 
MEFs, RFP-2x-FYVE
Hrs 
localized to vesicular structures, consistent with previous 





 fluorescent signal was largely diffuse in Vps34 KO MEFs, which is also 
observed upon treatment with wortmannin and in MEFs where Vps15, the lipid kinase 
regulator of Vps34, is knocked out (Gillooly et al., 2000; Nemazanyy et al., 2013). In 
order to improve the sensitivity and threshold of PI3P detection knowing that other 
pathways synthesize ~35% of the total PI3P, a high affinity 4xFYVE
Hrs 
probe was 
generated, based on the work of others suggesting that combining multiple FYVE 
domains may enhance PI3P detection or sequestration through an avidity effect 
(Bohdanowicz et al., 2010). In fact, transfection with the GFP-4x-FYVE
Hrs
 probe 
produced a more robust signal and revealed a pool of PI3P underestimated by the 
traditional 2x-FYVE probes in Vps34 KO MEFs. Importantly, the 4x-FYVE
Hrs
 clearly 
confirmed PI3P synthesis occurs via other pathways (Fig. 2.4). 
Next, we wanted to assess whether PI3P synthesis still occurred during starvation-
induced autophagy in Vps34 KO MEFs. As mentioned previously, PI3P plays an 
important role in recruiting PI3P effectors to the site of AP biogenesis. WD repeat 
domain phosphoinositide-interacting proteins (WIPI-1 and 2), mammalian orthologues of 
yeast Atg18, are a major family of PI3P-binding effectors that localize to the site of 
nucleation and promote AP formation; therefore, they are often used to monitor PI3P 
synthesis during autophagy (Proikas-Cezanne et al., 2007; Proikas-Cezanne et al., 2004). 
Here, GFP-WIPI-1 was transiently transfected in control and Vps34 KO MEFs and its 
localization examined under normal media and starvation conditions (HBSS for 90min). 
As previously observed, GFP-WIPI-1 remained largely soluble under normal media, 




cells during starvation (Proikas-Cezanne et al., 2007) (Fig. 2.5). In Vps34 KO MEFs, an 
80% and 30% reduction in the number and size of GFP-WIPI-1 puncta was observed 
during starvation compared to control MEFs, respectively (Fig. 2.5). Importantly, 
however, some WIPI-1 recruitment still occurred in the absence of Vps34, suggesting 
that PI3P production during autophagy may occur through other synthesis pathways, such 
as the class II PI3Ks. 
2.1.4 Autophagosome formation is reduced, but not abolished in Vps34 KO MEFs. 
Since PI3P still formed in the absence of Vps34, we investigated the ability of Vps34-
deficient cells to form and clear APs in response to nutrient deprivation by measuring 
LC3 lipidation. Activation of autophagy results in the conversion of LC3-I to its lipidated 
form LC3-II, a process that can be monitored by Western blot analysis. Experiments are 
typically performed under normal media and starvation conditions in the presence or 
absence of proton pump blocker Bafilomycin A1 (Baf), which blocks the acidification of 
lysosomes and thus the clearance of APs and enables the assessment of autophagic flux. 
Levels of LC3-II were similarly low in both control and Vps34 KO cells under basal 
conditions (Nm), although more LC3-II was apparent in control cells after the addition of 
Baf (Nm+B), suggesting a slightly higher rate of basal autophagy. While LC3-II levels 
remained low with no genotype-specific differences after nutrient deprivation (St) for 90 
min, changes in autophagic flux were observed after the addition of Baf into the 
starvation media (St+B). Specifically, a more robust increase in the levels of LC3-II was 
seen in control cells (3.3-fold) compared to Vps34 KO cells (2.5-fold), suggesting a 
decline in the rate of AP biogenesis in the absence of Vps34 in response to starvation 
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(Fig. 2.6A). This result suggests that while Vps34 may be an important modulator of 
autophagy, it is not essential for starvation-induced autophagy.  
 Additionally, endogenous LC3 localization was examined by confocal 
microscopy during starvation-induced autophagy. Under normal media conditions, LC3 
immunofluorescence displayed a predominantly diffuse distribution with few basal LC3-
positive compartments in control and Vps34-deficient cells. After 30 min starvation, LC3 
was recruited to APs and an ~8-fold increase in the average number of fluorescent LC3 
puncta was observed in control MEFs, whereas a less robust, ~4-fold increase was 
observed in Vps34 KO MEFs. A more prolonged, 90 min starvation produced comparable 
results (Fig. 2.6B,C). Levels of p62, an AP cargo, as well as its relationship with the LC3 
compartment were also examined by immunofluorescence. In control MEFs, the baseline 
number of p62 puncta was low under normal media conditions, transiently increased by 
~2.5-fold after 30 min of starvation, but then returned back to basal levels by 90 min. 
Likewise, the amount of co-localization between LC3 and p62 increased at 30 min and 
then returned to basal levels at 90 min as clearance of p62 by APs occurred over time. In 
contrast, the number of p62 puncta was 2.5-fold higher in Vps34 KO MEFs under normal 
media compared to control cells and remained largely unaffected by starvation. Although 
the co-localization between p62 and LC3 significantly increased in the Vps34 KO cells 
after 30 min starvation, the higher co-localization persisted after 90 min (Fig. 2.6B,C). 
Altogether, our results suggest that LC3 can still be mobilized in response to autophagy 
stimulation in Vps34-deficient MEFs, but not as efficiently as in control MEFs. Also, 
given the persistent increase in p62 observed in the Vps34 KO MEFs, it seems that   
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although autophagy may be occurring in the absence of Vps34, levels are suboptimal for 
the efficient clearance of this cargo.  
To more quantitatively compare APs and autophagolysosomes (ALs) in control 
and Vps34-deficient cells, standard electron microscopy (EM) was performed. Under 
basal conditions, APs and ALs were rarely observed, and no genotype-specific 
differences were found (Fig. 2.7A-C). Starving cells for 30 min caused an increase both 
in the number and total surface area covered by APs and ALs with no genotype-specific 
differences. The number and surface area of APs and ALs further increased after 90 min, 
but not as robustly in Vps34 KO MEFs. The average size of APs and ALs also continued 
to increase with prolonged starvation, but was not affected by the genotype (Fig. 2.7B,C). 
Finally, immunogold-EM using an anti-LC3 revealed that APs observed upon starvation 
in Vps34-deficient cells are decorated with gold particles indistinguishably from control 
cells (Fig. 2.7D), indicating that LC3 is normally recruited to the AP membranes in the 
absence of Vps34. These data confirm that ablation of Vps34 does not prevent the 
formation of APs and ALs, but does result in the generation of fewer autophagic vacuoles 
in response to nutrient deprivation, consistent with the light microscopic observations.  
2.1.5 Vps34 mediates approximately half of autophagic protein degradation. 
Given that LC3 conjugation and APs and ALs were still observed in Vps34 KO cells, it 
was important to assess the functionality of the remaining autophagy. A [
14
C]-valine-
labeled long-lived protein assay was performed in the presence of PI3K inhibitors (3MA 
or wortmannin) to inhibit autophagy, or the weak base ammonium chloride to inhibit 
lysosomal degradation, allowing us to determine the contribution of (macro)autophagy to   
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the overall lysosomal degradation (see Materials and Methods). Since 3MA and 
wortmannin are generally thought to block autophagy by targeting Vps34, it was first 
necessary to determine whether this was, in fact, the case. Both 3MA and wortmannin 
dramatically reduced the lipidation of LC3 during starvation in both control and Vps34 
KO MEFs in the presence and absence of Baf (Fig. 2.8A,B). This finding demonstrated 
that these drugs have additional autophagy-relevant targets besides Vps34 and can, 
therefore, still can be used to effectively block (macro)autophagy in Vps34 KO MEFs. 
Here, we observed a 50% decrease in total starvation-induced proteolysis in Vps34 KO 
MEFs by protein degradation assay (Fig. 2.9A). Importantly, the 3MA-inhibitable 
component of lysosomal protein degradation, which corresponds to (macro)autophagy, 
was reduced by 50% in Vps34-deficient MEFs upon nutrient deprivation, accounting for 
this significant decrease in total lysosomal protein degradation (Fig. 2.9B). In contrast, 
Vps34 ablation only caused a decreasing trend in protein degradation through the 
microautophagy and/or chaperone-mediated autophagy pathways, suggesting that these 
lysosomal functions are not affected by the lack of Vps34 at this time-point of study (Fig. 
2.9B). Therefore, the reduction in autophagy function upon acute deletion of Vps34, most 
likely reflects a decrease in overall autophagosome number at Day 10 rather than 
impaired autophagosome clearance. However, prolonged ablation of Vps34 results in the 
progressive accumulation of p62 by Western blot analysis and immunofluorescence, 
possibly due to both reduced autophagy efficacy and a progressive decline in lysosomal 





2.1.6 Class II PI3Ks contribute a pool of PI3P in MEFs. 
After establishing that functional autophagy still occurs in Vps34 KO MEFs, we 
determined the contribution of PI3P synthesis by class II PI3Ks.  Phosphoinositide levels 
were measured as described above (see Materials and Methods). Control and Vps34 KO 
cells were treated with mock siRNA or both PI3K-C2 and siRNAs (the third isoform, 
PI3K-C2, appears to be mostly expressed in the liver (Falasca and Maffucci, 2012)). 
PI3K-C2 and expression was consistently abolished after 48hrs of PI3K-C2/ 
siRNA treatment with no major impact on Vps34 levels (Fig. 2.11). Interestingly, 
silencing of class II PI3Ks in control and Vps34 KO cells caused a comparable relative 
decrease in the overall levels of PI3P. Specifically, we observed a 20% decrease in PI3P 
levels in control cells treated with PI3K-C2/ siRNA as compared to mock siRNA (Fig. 
2.12). Likewise, an additional 15% reduction in PI3P levels was observed when the 
class II PI3Ks were silenced in the Vps34 KO background (Fig. 2.12). Taken together, we 
conclude that the contributions of Vps34 and class II PI3Ks to total PI3P levels are 
additive and non-compensatory. Additionally, we observed that class II PI3Ks produces 
approximately half of the amount of PI3P produced in Vps34 KO MEFs. 
2.1.7 Class II PI3Ks positively regulate autophagy. 
Since lack of Vps34 did not abolish autophagy and PI3P production, we next tested 
whether class II PI3Ks could be an additional source of PI3P required to promote AP 
biogenesis. To determine whether PI3K-C2/ may be regulating autophagy through 
PI3P production, we examined GFP-WIPI-1 puncta formation upon silencing of the 




caused a 30% decrease in the number of GFP-WIPI-1 puncta (Fig. 2.13A), compared to 
the 80% decrease observed in the Vps34-deficient cells (Fig. 2.5), which seemingly 
accounts for the totality of WIPI-1 puncta in response to starvation. Thus, although the 
contribution of the class II PI3Ks to the formation of WIPI-1 puncta is quantitatively 
minor relative to that of Vps34, they appear to be significant modulators of autophagy 
through production of PI3P. We next examined the effect of the class II PI3Ks on LC3 
localization during starvation-induced autophagy by siRNA silencing of PI3K-C2/ 
isoforms in control and Vps34 KO MEFs (Fig. 2.11). Under normal media conditions, a 
trend for a decrease in LC3 puncta number was observed upon siPI3K-C2/-treatment 
of control MEFs (Fig. 2.13B). While minor differences were observed during starvation 
for 30 min, changes in autophagic flux became more apparent in the presence of Baf (Fig. 
2.13B, 2.14). Indeed, knocking down class II PI3Ks in control MEFs produced a 40% 
decrease in the number of LC3-positive puncta in response to a 30 min starvation period 
in the presence of Baf, a decrease of the same magnitude as that achieved by knocking 
out Vps34 (Fig. 2.13B). When Vps34-deficient cells were treated with PI3K-C2/ 
siRNAs, the number of LC3 puncta was further decreased relative to siPI3K-C2/-
treated control or Vps34 KO MEFs (Fig. 2.13B). We also observed a decrease in LC3 
puncta size in siPI3K-C2/-treated control MEFs that was exacerbated by the absence 
of Vps34 (Fig. 2.13B). While silencing of class II PI3Ks in control and Vps34 KO MEFs 
did not prevent LC3 lipidation in response to starvation, an increase in p62 was observed 
in Vps34 KO MEFs treated with PI3K-C2/ siRNA, suggesting class II PI3Ks may be 
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playing a positive regulatory role in autophagy (Fig. 2.13C).  Importantly, these results 
indicate that PI3K-C2/ positively regulate autophagy in addition to Vps34.  
2.1.8 Initial characterization of the PI3K-C2 and  in autophagy. 
After establishing a role for PI3P synthesis by the class II PI3K in autophagy, our goal 
was to determine how the PI3K-C2 and  fit into the autophagy signaling network.  
Given that Vps34 and PI3K-C2 and  are in the same PI3K family, they possess 
structural homology and may share common interactors important for their regulation of 
autophagy (Falasca and Maffucci, 2012; Vanhaesebroeck et al., 2010). The conserved C2 
domain of Vps34 has been shown to directly interact with the central coil-coil domain 
(CCD) and evolutionarily conserved domain (ECD) domains of Beclin 1 (Funderburk et 
al., 2010; Furuya et al., 2005); therefore, we tested whether PI3K-C2 and  could also 
form a complex with Beclin 1. An immunoprecipitation experiment using an anti-Beclin 
1 antibody was performed in control MEFs. Consistent with previous observations 
(Furuya et al., 2005; Kihara et al., 2001b), Vps34 was efficiently coimmunoprecipitated 
with Beclin-1 (Fig. 2.15). In contrast, only a trace amount of PI3K-C2 and  was 
coimmunoprecipitated with Beclin-1. These results indicate that while Vps34 binds to 
and forms a complex with Beclin-1 in a near stoichiometric manner, PI3K-C2 and  do 
not significantly interact with Beclin-1 and are thus likely to modulate autophagy in a 
different complex from that of Vps34. 
  Next, co-localization studies were performed between PI3K-C2 and  and 
markers of autophagy. Due to antibody limitations, PI3K-C2-HA or PI3K-C2-MYC 
constructs were transiently transfected into MEFs in order to assess their localization with 
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anti-tag antibodies. Cells were cultured under normal media or starvation conditions (St; 
HBSS for 90min), fixed and immunostained with the appropriate antibodies. By confocal 
microscopy, a partial co-localization was observed between PI3K-C2-HA or PI3K-C2-
MYC and LC3 under starvation conditions (Fig. 2.16). Interestingly, very little co-
localization was observed between PI3K-C2-HA and Beclin-1-FLAG, while higher 
levels of co-localization was seen between PI3K-C2-MYC and Beclin-1-FLAG upon 
starvation-induced autophagy, suggesting that there may be isoform differences in 
autophagy regulation (Fig. 2.16). Notably, we observed a striking redistribution of PI3K-
C2-HA from a juxtanuclear to a more peripheral position when autophagy was induced. 
This pattern of PI3K-C2 re-localization during autophagy is reminiscent of that of Atg9, 
a transmembrane protein that predominately localizes to the trans-Golgi network (TGN) 
under basal conditions, but redistributes to the peripheral endosomal system during 
autophagy (Webber and Tooze, 2010b; Young et al., 2006). Therefore, we examined the 
co-localization between PI3K-C2-HA, Atg9 and Giantin (a marker of the TGN) under 
normal media and 90 min of starvation condition (Fig. 2.17). In fact, we observed some 
co-localization between PI3K-C2-HA, Atg9 and Giantin under normal media 
conditions. During starvation, co-localization of PI3K-C2-HA and Atg9 with Giantin 
diminished as both proteins moved to peripheral sites, whereas co-localization between 
PI3K-C2-HA and Atg9 persisted (Fig. 2.17). These preliminary data indicate that 
although Vps34 and the class II PI3K both synthesize PI3P during autophagy, they likely 
act in mechanistically different ways. In fact, there may be isoform specific differences in 
how PI3K-C2 and  are regulated and participate in autophagy. Further investigation is 
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2.2 Figures  
 
Figure 2.1 Vps34 ablation in Vps34Flox/Flox MEFs infected with CRE lentivirus  
Figure 2.1 Vps34 ablation in Vps34
Flox/Flox
 MEFs infected with CRE lentivirus. 
(A) Western blot analysis showing a time-course of Vps34 protein levels in Vps34
Flox/Flox 
MEFs infected with lentiviruses expressing either an inactive Cre (Δ) or active (CRE) 
full-length Cre recombinase for 7-13 days. (B) Western blot using antibodies directed to 
the COOH-terminus of Vps34 in control and Vps34 KO cell extracts. (C) Western blot 





 Figure 2.2 Acute and chronic loss of Vps34 differentially affects the endo-lysosomal system 
Figure 2.2 Acute and chronic loss of Vps34 differentially affects the endo-lysosomal 
system. (A) Confocal analysis of control and Vps34 KO MEFs immunostained for the 
following organelle markers: PDI, Giantin, EEA1 and LAMP1 (red). Nuclear inactive 
and active GFP-CRE is shown in green. Scale bar: 10 μm. (B) Right: DIC image of 
control and Vps34 KO cells on day 14 post-infection. Left: Confocal analysis of LAMP1, 
a late endosomal/lysosomal marker, immunostaining (red) in control and Vps34 KO 
MEFs on day 14 post-infection. DAPI is shown in blue. Scale bar: 10 μm. (C) Western 
blot analysis of Epidermal Growth Factor Receptor (EGFR) degradation in control and 
Vps34 KO MEFs on day 10 and day 14 post-infection. MEFs were serum starved 
overnight and stimulated with EGF (100ng/ml) for the indicated times. EGFR protein 
level is quantified relative to tubulin and represented as a percent EGFR at time 0 (n=4 




Figure 2.3  Ablation of Vps34 alters levels of Vps34 complex proteins complex proteins 
Figure 2.3 Ablation of Vps34 alters levels of Vps34 complex proteins. Western blot 
analysis of Vps34 complex components and endosomal protein levels in control and 
Vps34 KO MEF lysates. Quantification of protein levels after normalization to tubulin 






























Figure 2.4 A higher affinity PI3P-binding probe, 4x-FYVEHrs, reveals a larger pool of intracellular PI3P in the absence of Vps34 
compared to the conventional 2x-FYVEHrs probe. 
Figure 2.4 A higher affinity PI3P-binding probe, 4x-FYVEHrs, reveals a larger pool 
of intracellular PI3P in the absence of Vps34 compared to the conventional 2x-
FYVEHrs probe. Control and Vps34 KO MEFs were transiently transfected with both 
RFP-2x-FYVEHrs and GFP- 4x-FYVEHrs PI3P-binding constructs for 24hr, grown in 
normal media and fixed. Confocal microscopy analysis of RFP-2x-FYVEHrs (red) and 




Figure 2.5 Recruitment of WIPI-1, a PI3P-binding protein, to sites of AP biogenesis occurs in Vps34 KO MEFs but at diminished 
levels. 
Figure 2.5 Recruitment of WIPI-1, a PI3P-binding protein, to sites of AP biogenesis 
occurs in Vps34 KO MEFs but at diminished levels. Control and Vps34 KO MEFs 
were transiently transfected with GFP-WIPI-1 for 24 hrs, cultured in HBSS for 90 min 
(90 min St) and fixed. Left: Confocal microscopy analysis of GFP-WIPI-1 fluorescence 
(green). Nuclear inactive and active Tomato-Cre is shown in red. The contrast was 
enhanced to reveal the WIPI puncta over the cytosolic background fluorescence. Right: 









Figure 2.6 Vps34 KO MEFs show a decrease in LC3 conjugation and LC3 puncta 
formation upon starvation. (A) Control and Vps34 KO MEFs were cultured in 
normal medium (N) or HBSS (St) in the presence or absence of 50nM Bafilomycin 
(Nm+B or St+B, respectively) for 90 min. Right: Lysates were analyzed by 
immunoblotting using the indicated antibodies. Left: Relative LC3-II levels 
normalized to actin (n=4). (B) Control and Vps34 KO MEFs were cultured in normal 
media (Nm) or HBSS (St) for 30 and 90 min, fixed and immunostained. Confocal 
analysis of LC3, p62 and GFP-Cre fluorescence, which is artificially shown in green, 
red and blue colors, respectively. Arrowheads indicate LC3 and p62 colocalization 
(yellow). Scale bar: 10 μm. (C) Quantification of the number of LC3 (left panel) and 
p62 puncta (middle panel) per cell. Colocalization of p62 with LC3 puncta is also 
shown (right panel) (colocalization was defined as the number of pixels overlapping 




Figure 2.7 Lack of Vps34 decreases, but does not abolish the formation of autophagosomes and autophagolysosomes upon starvation 
80 
 
Figure 2.7 Lack of Vps34 decreases, but does not abolish the formation of 
autophagosomes and autophagolysosomes upon starvation. (A) Electron micrographs 
of control and Vps34 KO MEFs cultured in normal media or after 30 and 90 min (shown) 
of HBSS starvation. Arrows, autophagosomes. Arrowheads, autophagolysosomes. Scale 
bar: 1 μm. (B) Quantification of average number of autophagosomes (AP), average size 
(μm2) of APs and the total AP surface area/100μm
2
 of cytoplasm. (C) Quantification of 
average number of autophagolysosomes (AL), average size (μm2) of ALs and the total 
AL surface area/100μm2 of cytoplasm. In both AP and AL quantifications, 30 cells were 
analyzed. (D) Immuno-gold electron microscopic analysis of endogenous LC3 in control 





Figure 2.8 PI3K inhibitors 3-methyladenine and wortmannin block LC3-lipidation independently of Vps34 
Figure 2.8 PI3K inhibitors 3-methyladenine and wortmannin block LC3-lipidation 
independently of Vps34. (A) Western blot analysis showing LC3-II levels in WT and 
Vps34 KO MEFs upon 90 min of HBSS starvation alone or in the presence of 
wortmannin (Wort, 100 nM) or 3-methyladenine (3MA, 10 mM) and with or without 
Bafilomycin (Baf or simply B, 50 nM). (B) Quantification of the percent inhibition of 
LC3 conversion by each PI3K inhibitor during starvation in control and Vps34 KO MEFs 












Figure 2.9 Macroautophagy-mediated protein degradation is partially impaired in Vps34 null MEFs 
Figure 2.9 Macroautophagy-mediated protein degradation is partially impaired in 
Vps34 null MEFs. (A) Quantification of total [14C]-valine long-lived protein 
degradation induced by nutrient deprivation (HBSS) in control and Vps34 KO MEFs. (B) 
Assessment of autophagy efficiency in control and Vps34 KO MEFs by 
14
C-valine long-
lived protein degradation under starvation (HBSS), starvation with 3MA or starvation 
with NH4Cl conditions (see Methods) (n=8 for both A and B).  
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 Figure 2.10 Prolonged ablation of Vps34 causes an increase in p62 levels 
Figure 2.10 Prolonged ablation of Vps34 causes an increase in p62 levels. (A) Right: 
Western blot analysis of p62 levels in control and Vps34 KO cells 10 to 13 days post- 
infection with either inactive (Δ) or active (CRE) CRE-lentiviruses, respectively. Left: 
Quantification of protein signal intensities showing relative p62 levels normalized to 
actin (n=5). (B) Immunofluorescence showing endogenous p62 (green) in control and 
Vps34 KO MEFs on day 14 post-infection. Nuclear inactive and active tomato-CRE are 




Figure 2.11 Silencing class II PI3Ks in control and Vps34 KO MEFs  
Figure 2.11 Silencing class II PI3Ks in control and Vps34 KO MEFs. Western blot 
analysis demonstrating protein levels in control and Vps34 KO MEFs transfected for 48 
hrs with mock or PI3K-C2α/β siRNA. Efficiency of Vps34 ablation obtained by 4-HT or 
CRE lentivirus treatment was consistent. Silencing of PI3K-C2α/β in either KO model 






Figure 2.12 Quantification of Vps34-dependent and independent sources of PI3P in MEFs 
Figure 2.12 Quantification of Vps34-dependent and independent sources of PI3P in 
MEFs. Vps34 KO MEFs alone or transfected with mock or PI3K-C2α/β siRNA for 48 
hrs grown in normal medium supplemented with [3H] myo-inositol. [3H]-labeled 
phosphoinositides were extracted, deacylated and analyzed by HPLC and scintillation 
detection. Graph indicates relative levels of phosphatidylinositol (PI), 
phosphatidylinositol 3-phosphate (PI3P), phosphatidylinositol 4-phosphate (PI4P), 
phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2), as a percentage of total inositol lipid 











Figure 2.13 Silencing class II PI3Ks decreases autophagy in both control and Vps34 
null MEFs. (A) Control MEFs were transfected with mock or PI3K-C2α/β siRNA as 
well as GFP-WIPI-1 for 48 hrs, cultured in normal media or HBSS for 90 min and fixed. 
Right: Confocal microscopy images of GFP-WIPI-1 fluorescence in mock or PI3K-C2α/β 
siRNA-treated control cells after HBSS starvation for 90 min. Scale bar: 10 μm. Left: 
Quantification of the number and size (arbitrary units) of GFP-WIPI-1 puncta observed 
after 90 min HBSS starvation (n=11-15 cells). (B) Cells prepared as in (A) were fixed 
and immunostained. Right: Confocal microscopy images showing endogenous LC3 
(green) in cells cultured in HBSS in the presence of 50 nM Bafilomycin (St+B) for 30 
min. DAPI is shown in blue. Scale bar: 10 μm. Left: Quantification of the number and 
size (arbitrary units) of LC3 puncta observed under normal media (Nm), HBSS (St) and 
HBSS in the presence of Bafilomycin (St+B) conditions (n=12-19, 23-40 and 26-53 cells 
for Nm, St and St+B conditions, respectively). Scale bars: 10 μm. (C) Control and Vps34 
KO MEFs were transfected for 48 hrs with mock or PI3K-C2α/β siRNA, cultured in 
normal medium (N), HBSS (St) or HBSS with 50 nM Bafilomycin (St+B) for 30 min, 






Figure 2.14 LC3 puncta formation during starvation-induced autophagy upon silencing class II PI3K in control and Vps34 KO MEFs 
Figure 2.14 LC3 puncta formation during starvation-induced autophagy upon 
silencing class II PI3K in control and Vps34 KO MEFs. Control and Vps34 KO MEFs 
were transfected for 48 hrs with mock or PI3K-C2α/β siRNA, cultured in normal medium 
(N) or HBSS (St) for 30 min, fixed and immunostained. Representative confocal 
microscopy images showing endogenous LC3 (green) in cells cultured in normal media 
(top) or HBSS starvation conditions for 30min (bottom). DAPI is shown in blue. Scale 




Figure 2.15 PI3K-C2α and β only weakly interact with the Beclin-1 complex 
Figure 2.15 PI3K-C2α and β only weakly interact with the Beclin-1 complex. 
Uninfected Vps34
flox/flox 
MEFs lysates were immunoprecipitated (IP) with anti-Beclin1 
antibodies. The resulting immune complexes were analyzed by Western blot using the 






Figure 2.16 Minimal co-localization was observed between PI3K-C2α and β and various autophagy markers 
Figure 2.16 Minimal co-localization was observed between PI3K-C2α and β and 
various autophagy markers. Uninfected Vps34
flox/flox 
MEFs were transiently transfected 
with either PI3K-C2α-HA or PI3K-C2β-MYC alone or co-transfected with a Beclin-1-
FLAG construct for 24 hrs, cultured in HBSS for 90 min (90 min St) and fixed. Confocal 
microscopy images showing endogenous LC3 (MAP1LC3B isoform) (green) or 
exogenous Beclin-1-FLAG (green) colocalization with PI3K-C2α-HA (red) or PI3K-




Figure 2.17 PI3K-C2α colocalizes with Atg9, a transmembrane marker of AP biogenesis, at the TGN under steady-state conditions 
and in the periphery during starvation-induced autophagy 
Figure 2.17 PI3K-C2α colocalizes with Atg9, a transmembrane marker of AP 
biogenesis, at the TGN under steady-state conditions and in the periphery during 
starvation-induced autophagy. Uninfected Vps34
flox/flox 
MEFs were transiently 
transfected with PI3K-C2α-HA for 24 hrs, cultured in normal media or HBSS for 90 min 
(90 min St) and fixed. Confocal microscopy images showing endogenous Atg9 (red) co-







Determining the lipid signaling events required for AP formation is critical to our 
understanding of the regulation of autophagy. PI3P is known to play a critical role in 
orchestrating AP formation during starvation-induced autophagy (Burman and Ktistakis, 
2010; Dall'Armi et al., 2013; Knaevelsrud and Simonsen, 2012; Noda et al., 2010; 
Simonsen and Tooze, 2009), however, unlike lower eukaryotes, such as budding yeast, 
where Vps34 is the only source of PI3P, other pathways of PI3P synthesis have been 
described in higher eukaryotes, and mammalian cells in particular (Falasca and Maffucci, 
2012; Hakim et al., 2012; Vanhaesebroeck et al., 2001). These include generation of PI3P 
by class II PI3Ks, which catalyze a PI phosphorylation like Vps34, and inositol 4-
phosphatase (Inpp4) type I and II, which dephosphorylate PI(3,4)P2 to PI3P (Norris et al., 
1997; Norris and Majerus, 1994; Shin et al., 2005). Additionally, Sac1 family members, 
such Fig4 can dephosphorylate PI(3,5)P2 to PI3P, accounting for yet another potential 
source of PI3P (Gary et al., 2002; Rudge et al., 2004). Evidence that an alternative source 
of PI3P could potentially regulate mammalian autophagy originated from reports on 
conditional KO mice showing that APs can form in Vps34-deficient sensory neurons 
(Zhou et al., 2010) and T lymphocytes (McLeod et al., 2011). Additionally, the class II 
PI3K isoform, PIK3C2, was identified as a ‘hit’ in a recent autophagy interaction 
network screen (Behrends et al., 2010). Therefore, we aimed to assess the extent of 
autophagy occurring in the absence of Vps34 and determine whether the class II PI3K 
family contributes to autophagy regulation. Here we performed a comprehensive series of 
autophagy assays using Vps34 KO MEFs which confirmed that while Vps34 is important 
for autophagy, it is not the sole source of PI3P synthesis during autophagy. Importantly, 
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we showed that in addition to Vps34, the class II PI3Ks contribute a pool of PI3P that 
positively regulates AP biogenesis. 
2.3.1 Mammalian Vps34 and autophagy 
Several conditional Vps34 KO mouse models have been generated recently, with 
selective deletions in sensory neurons (Zhou et al., 2010), T-lymphocytes (McLeod et al., 
2011; Parekh et al., 2013; Willinger and Flavell, 2012), podocytes (Bechtel et al., 2013), 
fibroblasts, cardiomyocytes and hepatocytes (Jaber et al., 2012b) as well as lens cells 
(Morishita et al., 2013); however, the requirement for Vps34 in autophagy remains highly 
debated. Potential explanations for phenotype discrepancies include differential gene 
targeting strategies (e.g., deletion of proximal vs. distal exons), mouse genetic 
backgrounds, cell types and age-dependency of phenotypes. In our mouse model, we 
have confirmed by Western blot analysis using antibodies to both the NH2- and COOH-
terminus of Vps34 that no residual, truncated forms of the protein remain expressed in 
the KO despite the fact that our strategy targets distal exons in the catalytic domain (i.e., 
exons 17-18) (Zhou et al., 2010). Complete loss of Vps34 is important to ensure in KO 
models, considering truncated forms of the protein can in some cases provide partial 
function or even cause dominant negative effects. We note that Jaber et al. also 
characterized Vps34 KO MEFs and found a more robust defect in autophagy (Jaber et al., 
2012b). In addition to this apparent discrepancy perhaps due to differences in targeting 
strategy (e.g., proximal exon 4 targeting was targeted in Jaber et al.), it may be that 
differences in genetic background influence the regulation of the various PI3P synthesis 
pathways. Similarly, distinct cell types may differentially rely on the Vps34-dependent 
and -independent pathways. For instance, PI3P measurements showed that it is PI3KC2α 
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that contributes to the majority of steady-state PI3P in endothelial cells, demonstrating 
such cellular differences (Yoshioka et al., 2012). By identifying the class II PI3Ks as an 
additional source of PI3P during autophagy, our study provides a potential explanation 
for the difference in phenotypes observed among the various Vps34 conditional KO 
models (Yoshioka et al., 2012). Lastly, we noticed that prolonged Vps34 ablation caused 
a progressive breakdown of the endolysosomal function. In a recent study where Vps15 
(i.e., a key subunit of the Vps34 complex) was ablated in skeletal muscle, which 
subsequently caused a secondary loss of Vps34, similar findings were reported and 
reminiscent of the lysosomal storage disorders such as Pompe's disease (Nemazanyy et 
al., 2013). Importantly, like in our Vps34 KO MEFs, AP biogenesis was still evident in 
Vps15 KO skeletal muscle cells by EM; however, an accumulation of APs and ALs was 
also observed due to secondary endolysosomal dysfunction, likely as a result of defects in 
AP maturation and clearance. Because endolysosomal dysfunction impacts the 
functionality of autophagy, it can potentially confound the analysis and interpretation of 
the early autophagic role of Vps34. By performing our studies upon acute Vps34 ablation 
and prior to a collapse of the endolysosomal system, we aimed to more accurately 
delineate the specific requirements for Vps34 in the autophagy process. 
2.3.2 An emerging role for class II and autophagy 
Synthesis of PI3P by both class II and III PI3Ks during the same physiological process 
may be an emerging theme. In fact, a recent study in C. elegans reported the class II 
ortholog, PIK-1, produces an initial pool of PI3P on nascent phagosomes prior to that of 
Vps34, which is responsible for the sustained production of PI3P on these organelles (Lu 
et al., 2012). While the C. elegans data indicates that PIK-1 and Vps34 act sequentially, 
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we propose that in the mammalian system the effects of Vps34 and class II PI3Ks are 
additive, demonstrated by p62 accumulation, LC3 puncta formation and WIPI-1 
recruitment, suggesting they act in parallel pathways. The class II PI3Ks are an 
understudied class of PI3Ks and currently there is growing interest in determining 
whether they cooperate or function redundantly with Vps34. The  isoform has been 
implicated in processes such as glucose transport, insulin secretion and endocytosis, 
whereas the  isoform has been shown to promote cell migration, cell-cycle progression, 
growth and survival (Falasca and Maffucci, 2012; Posor et al., 2013; Yoshioka et al., 
2012). Less is known about the PI3KC2 isoform, whose expression may be limited to 
the liver (Falasca and Maffucci, 2012). While class II isoforms can synthesize PI3P, 
PI(3,4)P2 and PI(3,4,5)P3 in vitro, PI appears to be the preferential substrate; however, the 
α isoform increases its activity toward PI4P and PI(4,5)P2 substrates in the presence of 
clathrin (Falasca and Maffucci, 2012; Gaidarov et al., 2005). The majority of studies in 
intact cells have reported PI3P synthesis by the class II PI3Ks at the plasma membrane, in 
the nucleus, the Golgi complex, phagosomes and endosomes, although a recent study 
revealed a role for the α isoform in PI(3,4)P2 synthesis at the plasma membrane to 
promote clathrin-mediated endocytosis (Falasca and Maffucci, 2012; Posor et al., 2013). 
Here we provide novel evidence that class II PI3K  and  isoforms also supply a pool of 
PI3P during AP biogenesis, based on the partial loss of WIPI-1 puncta upon their 
silencing. Because WIPI-like proteins, such as Atg18, do not bind efficiently to PI(3,4)P2 
(Stromhaug et al., 2004), we conclude that the class II PI3Ks synthesize PI3P in the 
context of autophagy. Although the pool of PI3P produced by the class II PI3Ks during 
autophagy is smaller than that produced by Vps34 as assessed by WIPI-I recruitment, 
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knocking down PI3K-C2/ reduces LC3 puncta formation to the same extent as 
knocking out Vps34, indicating class II PI3Ks still plays a significant role in starvation-
induced autophagy. Importantly, although the class II PI3K isoform was identified as a 
"hit" in a genome wide screen looking for new components of the autophagy network and 
a potential interactor of Atg7 and MAP1LC3A in U2OS cells (Behrends et al., 2010), the 
same isoform was not identified as a hit in an independent study aiming to identify new 
regulators of autophagy among genes harboring FYVE and PX domains in 293T cells 
(Knaevelsrud et al., 2013). In our study, silencing of both class II PI3K  and  isoforms 
was required to cause an autophagy phenotype, suggesting there is some level of 
redundancy within the class II PI3K family. 
The precise molecular details concerning the class II PI3K  and  isoforms in 
regulating autophagy still remain unknown. Preliminary evidence suggests that Vps34 
and the class II PI3K have different mechanisms of action in regulating AP biogenesis. 
For instance, despite structural homology in the PI3K family, such as the core helical, C2 
and kinase domains (Falasca and Maffucci, 2012; Funderburk et al., 2010; Furuya et al., 
2005; Vanhaesebroeck et al., 2010), the C2 domain of Vps34 directly interacts with 
Beclin-1 whereas the class II PI3K shows a very weak interaction with Beclin-1 that is 
likely to be indirect. When co-localization was examined, very little overlap was 
observed between class II PI3K  and Beclin-1; however, some Beclin-1 did appear to 
co-localize with class II PI3K . Together the weak coimmunoprecipitation and minimal 
co-localization indicate that any association between the class II PI3K and Beclin-1 is 
likely to be indirect. In the future, it will be important to identify autophagy relevant 
interactors for the class II PI3Ks in order to better understand how they fit into the 
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autophagy pathway. Although the genome wide screen identified promising interactor 
hits, such as Atg7 and MAP1LC3A, for the class II PI3K isoform, these interaction still 
need confirmation (Behrends et al., 2010). Here we observed low levels of co-
localization between class II PI3K  and  and the MAP1LC3B isoform of the 
mammalian Atg8 family of ubiquitin-like conjugation proteins during autophagy. Co-
localization between other isoforms of the Atg8 family, particularly MAP1LC3A, still 
needs to be tested. Interestingly, we noticed that specifically the class II PI3K isoform 
moves from a juxtanuclear to peripheral localization during starvation-induced 
autophagy, which is a similar to the redistribution pattern of Atg9 seen during autophagy 
(Webber and Tooze, 2010b; Young et al., 2006). In fact, we observed some co-
localization between Atg9 and class II PI3K  during steady-state conditions that 
continued during starvation-induced autophagy. Future studies will need to be performed 
to determine whether Atg9 and class II PI3K  interact and how the redistribution of the 
class II PI3K  is regulated. These findings are a first step in providing insight into the 
mechanism of class II PI3K  and  isoforms in autophagy; however, more rigorous 
studies of the class II PI3K will be required to understand their role in the autophagy 
signaling network (see Future directions and concluding remarks). 
As mentioned above, the class II PI3K isoform can synthesize PI(3,4)P2 in 
certain biological contexts, such as clathrin mediated endocytosis (CME) (Posor et al., 
2013). In this study, we show that the class II PI3Ks synthesizes PI3P to positively 
regulate autophagy; however, whether class II PI3K isoform also synthesizes PI(3,4)P2 
during this process has yet to be ruled out since only WIPI-I recruitment, a PI3P-binding 
protein, was assessed in our study. In CME, vesicle scission by dynamin is regulated by 
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Class II PI3K synthesis of PI(3,4)P2 and the recruitment of SNX9, which contains a 
PI(3,4)P2-binding PX-BAR module (Posor et al., 2013). Interestingly, SNX9 is 
functionally redundant to SNX18, a recently identified positive regulator of autophagy 
(Knaevelsrud et al., 2013; Park et al., 2010). Specifically, SNX18 binds LC3 and Atg16 
as well as facilitates the tubulation of the recycling endosome, which has been shown to 
provide membrane to the growing autophagosome (Knaevelsrud et al., 2013). Given that 
SNX18 and SNX9 are functionally similar, a role for class II PI3K synthesis of 
PI(3,4)P2 at this step in AP biogenesis should be investigated, although alternative roles 
for PI(3,4)P2 in autophagy may also exist. 
2.3.3 PI3P sources in autophagy 
Our studies indicate that together Vps34 and the class II contribute to the majority of 
PI3P synthesis during autophagy. Notably, we observed few LC3 puncta in Vps34 KO 
MEFs upon concomitant knockdown of the class II PI3Ks, suggesting a small amount of 
autophagy may still be occurring in the absence of Vps34 and the class II PI3Ks. Whether 
PI3P can be produced via a third pathway, such as dephosphorylation of PI(3,4,5)P3 by PI 
5-phosphatases and PI 4-phosphatases (Inpp4 I and II) will require further investigation 
(Shin et al., 2005). As mentioned above, contribution of these different PI3P synthesis 
pathways to autophagy may be largely determined by cell type and genetic background. It 
will be important to determine whether the physiological context of autophagy 
stimulation, site of AP biogenesis and type of cargo dictate which pathways of PI3P 
synthesis are used. 
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2.3.4 Revisiting PI3K inhibitor specificity in the context of autophagy  
As previously shown in other studies, including in yeast (Itakura et al., 2008; Obara et al., 
2008a), our results indicate that Vps34 is not essential for LC3 lipidation per se. In fact, 
the Vps34 conditional KO models have reported findings that range from decreased LC3-
II levels (Willinger and Flavell, 2012); see also Fig. 4A), no change (McLeod et al., 
2011) or even an increase in LC3-II levels (Bechtel et al., 2013; Jaber et al., 2012a; 
Morishita et al., 2013; Parekh et al., 2013; Zhou et al., 2010). The findings are consistent 
with the view that Vps34 and more generally, PI3P, are involved in spatially restricting 
where LC3 lipidation (and AP biogenesis) occur, rather than controlling the enzymatic 
conjugation reaction itself. Importantly, our work suggests that pharmacological 
experiments utilizing wortmannin or 3MA should be interpreted with caution, as the 
robust effects these drugs typically exert on autophagy are likely to be caused in part by 
targets distinct from Vps34. We found that LC3-II levels were drastically reduced during 
starvation in both control and Vps34 KO MEFs treated with wortmannin and 3MA. 
Although class I PI3K are known to be susceptible to these inhibitors and may effect the 
production of PI(3,4,5)P3 and its subsequent dephosphorylation by 4- and 5-phophatases 
to PI3P, the alternate targets of wortmannin are unlikely to be class II PI3Ks, as these 
enzymes (particularly the  isoform) are less sensitive to wortmannin (Falasca and 
Maffucci, 2007) and silencing of class II PI3Ks does not alter LC3-II levels (Fig. 8C). 
Future studies identifying the additional targets of wortmannin and 3MA will be helpful 
to our understanding the regulation of LC3 conjugation during autophagy as well as to 




Overall our study highlights the complexity and plasticity of PI3P metabolism in 
mammalian cells and provides strong impetus for future studies exploring the precise role 
of Vps34-independent sources of PI3P in autophagy, including class II PI3Ks and 
potentially, the Inpp4 pathway, and their regulation during this essential process. 
Additionally, reports of noncanonical autophagy in the field have suggested that 
autophagy can occur independently of known factors, such as Beclin 1, Atg5 and Atg7 
for example (Codogno et al., 2012). The extent to which autophagy can occur without 
PI3P synthesis altogether remains undetermined. A better understanding of the lipid 
biology in autophagy, including key lipid species and their roles in regulating autophagy, 
is of both basic science and clinical significance since lipid enzymes serve as promising 
targets for modulating autophagy. 
2.4 Materials and Methods 
2.4.1 Generation of Vps34 KO MEFs.  
Primary mouse embryonic fibroblasts (MEFs) were generated from embryonic day 13.5 
Vps34 (pik3c3) Flox/Flox mouse embryos in which exons 17/18, encoding the catalytic 
domain, were flanked by loxP sites, as described previously (Zhou et al., 2010). MEFs 





(KO) cells were generated by 
infecting cells with a lentivirus carrying either a catalytically active Cre recombinase or 
catalytically-dead Cre recombinase (control), respectively. Both Cre recombinases 
encoded two nuclear localization sequences (NLS) and were fused to either eGFP or 
Tomato moieties containing a third NLS for enhanced nuclear targeting. Lentivirus was 
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produced in human embryonic kidney 293T cells according to Ho et al. with slight 
modifications (Ho et al., 2006). Virus-containing media was harvested 72 hrs after 
transfection, centrifuged at 2,800xg for 5 min, filtered through a 0.45mm filter 
(Millipore) and supplemented with 10ug/ml polybrene (Sigma-Aldrich) prior to adding to 
MEFs. Infection rate was estimated by determining the percentage of cells with nuclear 
EGFP or Tomato-fluorescent positivity. In addition, Vps34
Flox/Flox
; Cre-ER MEFs were 
generated for experiments requiring larger amounts of cells such as HPLC biochemistry 
studies using the protocol mentioned above. MEFs contain a Cre-estrogen receptor (Cre-
ER) fusion protein whereby Cre activity is inducible by tamoxifen (Hayashi and 
McMahon, 2002). To generate Vps34 KO and control cells, Vps34
Flox/Flox
; Cre-ER MEFs 
were incubated with either 3µM 4-hydroxytamoxifen (4-HT) (Sigma-Aldrich) diluted in 
ethanol or vector alone for 72hrs followed by culturing in normal growth media. In both 
MEF cell lines, KO efficiency was monitored by Western blot analysis using antibodies 
to the NH2- and COOH-termini of Vps34. A minimum of 10 days post-infection or 
tamoxifen treatment was required to abolish the expression of Vps34, therefore, all 
experiments were performed upon acute gene ablation 10 days after infection, unless 
indicated otherwise 
2.4.2 Cell culture and transfection.  
MEFs were cultured in DMEM-Glutamax (Invitrogen) supplemented with 10% fetal 
bovine serum (FBS), penicillin (200 units/mL)/streptomycin (200 μg/mL) (Invitrogen) at 
37 °C under 5% CO2. For starvation assays, MEFs were cultured in Hanks’ buffer 
(Invitrogen) for the indicated times. MEFs were transiently transfected using the 
Lipofectamine RNAiMAX (Invitrogen) and/or AMAXA MEF I Nucleofector Kit 
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(Lonza) according to the manufacturer’s instructions. Cells were incubated with siRNA 
for 48 hrs and efficient silencing was confirmed by Western blot for each experiment. 
Plasmids were transiently expressed for 24 hrs when transfected alone or 48 hrs when co-
transfected with siRNA. 
2.4.3 Reagents and antibodies.  
The following compounds were used in autophagy assays: Bafilomycin A1 (50nm, 
Wako), 3-methyladenine (10mM, Sigma), wortmannin (100nM, Billerica). Primary 
antibodies used for Western blotting include: anti-pan-actin mouse polyclonal antibody 
(1:4000 dil., Novus), anti-Atg5 rabbit polyclonal antibody (1:500 dil., Abgent; to detect 
free form), anti-Atg5 rabbit polyclonal antibody (1:1,000 dil., Sigma; to detect 
conjugated form), anti-Atg9 armenian hamster polyclonal antibody (1:100 dil., generous 
gift from Sharon Tooze) anti-Atg14 rabbit polyclonal antibody (1:500 dil., generous gift 
from Dr. Zhenyu Yue), anti-Beclin mouse polyclonal antibody (1:1000 dil., BD 
Biosciences), anti-EEA1 mouse polyclonal antibody (1:500 dil., Thermoscientific), anti-
EGFR rabbit polyclonal antibody (1:1000 dil., Millipore), anti-FLAG mouse monoclonal 
(M2, Sigma), anti-LC3 rabbit polyclonal antibody (1:1000 dil., Novus), anti-HA rat 
monoclonal antibody (3F10, Sigma), anti-MYC mouse monoclonal (9E10, Sigma), anti-
p62/SQSTM1 mouse monoclonal antibody (2C11; 1:2000 dil., Abnova), anti-PI3KC2 
rabbit polyclonal antibody (1:1000 dil.; Santa Cruz), anti-PI3KC2 mouse polyclonal 
antibody (1:1000 dil., BD Biosciences), anti-Rab5 621.3 mouse monoclonal antibody 
(1:500 dil., Synaptic Systems), anti-Rubicon rabbit polyclonal antibody (1:500 dil., 
generous gift from Dr. Zhenyu Yue), anti--tubulin mouse polyclonal antibody (1:4000 
dil., Sigma), anti-UVRAG mouse monoclonal antibody (1H4, 1:500 dil., MBL), anti-
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Vps15/p150 mouse monoclonal antibody (M02, 1:1000 dil., Abnova), anti-Vps26 rabbit 
polyclonal antibody (1:1000 dil., Abcam), anti-Vps34/PI3KC3 rabbit monoclonal 
antibody (D4E4, 1:1,000 dil., Cell Signaling Technology; to amino terminal sequence), 
anti-Vps34/PI3KC3 rabbit monoclonal antibody (D9A5; 1:1,000 dil.; Cell Signaling 
Technology; to C-terminal sequence) and anti-Vps35 mouse polyclonal antibody (1:1000 
dil., Abcam). Secondary antibodies used for western blot include HRP conjugated anti-
guinea pig (1:3000 dil., Santa Cruz), anti-mouse (1:3000 dil., Biorad), and anti-rabbit 
(1:3000 dil., Biorad). Immunofluorescence experiments were conducted using the 
following primary antibodies: anti-Atg16L1 rabbit polyclonal antibody (1:200 dil., 
Cosmo), anti-EEA1 goat polyclonal antibody (1:200 dil., Santa Cruz), anti-Giantin rabbit 
polyclonal antibody (1:1000 dil., Covance), anti-LAMP1 rabbit polyclonal antibody 
(1:500 dil., Abcam), anti-LC3 mouse monoclonal antibody (4E12, 1:100 dil., MBL), anti-
myc mouse monoclonal antibody (9E10, 1:400 dil., Roche), anti-p62/SQSTM1 guinea 
pig polyclonal antibody (1:1000 dil., Progen) and anti-PDI mouse monoclonal antibody 
(1D3; 1:50 dil., Stressgen). Fluorescent secondary antibodies used include: Alexa Fluor 
647 donkey anti-goat (1:100 dil., Jackson Immunoresearch), Alexa Fluor 647 donkey 
anti-guinea pig (1:100 dil., Jackson Immunoresearch), Alexa Fluor 488 donkey anti-
mouse (1:200 dil., Molecular Probes), Alexa Fluor 555 donkey anti-mouse (1:200 dil., 
Molecular Probes), Alexa Fluor 647 donkey anti-mouse (1:100 dil., Jackson 
Immunoresearch), Alexa Fluor 488 donkey anti-rabbit (1:200 dil., Molecular Probes), 
Alexa Fluor 555 donkey anti-rabbit (1:200 dil., Molecular Probes) and Alexa Fluor 647 
donkey anti-rabbit (1:100 dil., Jackson Immunoresearch). 
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 plasmids were gifts from Harald Stenmark 
(University of Oslo, Norway). To generate GFP-4x-FYVE
HRS
, the FYVE domain of HRS 
was amplified with XhoI/SalI sites and cloned twice into the XhoI site of the GFP-2x-
FYVE
HRS 
plasmid. GFP-WIPI-1 was a gift from Sharon Tooze (Cancer Research UK). 
Beclin-1-FLAG was a gift from Beth Levine (UT Southwestern). MYC-DDK-PIK3C2β –
HA-PIK3C2α was a gift from Volker Hauke (Leibniz-Institut fur Molekulare 
Pharmakologie, Berlin). Second generation lentiviral packaging plasmids VSVg and ∆8.9 
were gifts from Peter Scheiffele (University of Basel), whereas the EGFP-tagged active, 
full-length Cre recombinase and catalytically inactive, truncated Cre FUGW lentiviral 
constructs were a gift from Thomas Sudhof (Stanford University, California) (Kaeser et 
al., 2011). Active and inactive Tomato-tagged Cre FUGW lentiviral constructs were 
generated by EcoR1/BsrG1 replacement of EGFP in the CRE FUGW vector with a PCR-
amplified Tomato sequence that included EcoR1/BsrG1 overhangs and retained the third 
N-terminal NLS by using the following primers: forward, 5’- 
AAATAAGAATTCACAACCATGGTGAAGCGACCAGCAGCAACAAAGAAGGCA 
GGACAAGCAAAGAAGAAGAAGCTCGTGAGCAAGGGCGAGGAGG -3’ and 
reverse, 5’- AAATAATGTACAGCTCGTCCATGCC-3’. Gene silencing was achieved 
using pre-designed siRNA sequences against murine pik3c2 (5’-
TTGGCAGAAATTATAAACTTA-3’; SI02671011) and murine pik3c2 (5’-
CTGGCTCTGATCCCACCCTAA-3’; SI00935928) (Qiagen). As a negative control, an 




2.4.5 SDS-PAGE and Western blotting.  
MEFs cultured in 60 or 100mm plates were lysed in lysis buffer (50 mM Tris–HCl (pH 
7.2), 250 mM NaCl, 0.1% NP-40, 2 mM EDTA, 10% glycerol) containing protease 
(Complete Mini, EDTA-Free, Protease Inhibitor Cocktail; Roche) and phosphatase 
(phosSTOP; Roche) inhibitors. For immunoprecipitation, cells were lysed in RIPA lysis 
Buffer (0.025M Tris, 0.15M NaCl, 0.001M EDTA, 1% NP-40, 5% glycerol, pH 7.4 
(Pierce)) containing containing protease (Complete Mini, EDTA-Free, Protease Inhibitor 
Cocktail; Roche) and phosphatase (phosSTOP; Roche) inhibitors. The Pierce Co-
immunoprecipitation (Co-IP) Kit (ThermoScientific) was used according to the protocol 
using the indicated antibodies. Extracts were centrifuged at 16,000xg for 30 min at 4 °C 
and the protein concentration was measured using the Coomassie Plus Protein Assay Kit 
(Thermo-Scientific). Proteins were separated by SDS–PAGE and transferred to PVDF 
(Immobilon-P; Millipore) or nitrocellulose membranes (iBlot Transfer Stack; Invitrogen). 
Specifically, immunoprecipitations were performed from 1mg of protein extract and 1% 
of the initial extract (input) and half of the eluate were analyzed. Membranes were probed 
with the indicated primary antibodies and the appropriate HRP-conjugated secondary 
antibodies. Immunoreactive protein bands were visualized and imaged using a 
chemiluminescent HRP substrate kit (Immobilon Western; Millipore) and the Fuji 
LAS4000 Imaging unit (GE Healthcare), respectively. Densitometric quantification was 
performed using the ImageJ software (NIH). 
2.4.6 EGFR degradation assay.  
MEFs were grown in 60mm dishes and serum-starved overnight in DMEM-Glutamax 
(Invitrogen). Cells were then stimulated with 100 ng/mL EGF (Millipore) in serum-free 
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medium and harvested at the indicated time points.  
2.4.7 Immunofluorescence microscopy.  
MEFs grown on coverslips were fixed with 4% paraformaldehyde for 20 min at room 
temperature. After permeabilization with 200 μg/ml digitonin (Invitrogen) in PBS for 10 
min, cells were incubated with the specified primary antibodies for 1 hr at room 
temperature. Subsequently, cells were incubated with the appropriate Alexa-Fluor or 
Cy5-conjugated secondary antibodies for 1 hr at room temperature and coverslips were 
mounted in DAPI Fluoromount G (Southern Biotech). Images were acquired by confocal 
laser scanning microscopy (Zeiss LSM-700) and analyzed with Zeiss Zen and Image J 
Software (NIH). The number of LC3-positive compartments and their surface areas 
(expressed as number of pixels per field) were normalized to the number of cells in each 
field. The average size was obtained by dividing the surface area of the LC3-positive 
compartment (in pixel
2
) by the number of LC3 puncta. Similar measurements were made 
for Atg16L1- and p62-positive compartments. The colocalization between p62 and LC3 
was calculated as the number of pixels overlapping in the two channels per cell.  
2.4.8 Conventional electron microscopy and morphometric analysis.  
MEFs cultured on plastic coverslips (LF1, Sumitomo Bakelite, Tokyo, Japan) were fixed 
in 2.5% glutaraldehyde (Electron Microscopy Sciences) in 0.1 M sodium phosphate 
buffer (PB) (pH 7.4) for 2 hrs at room temperature. After washing with PB, the cells were 
post-fixed in 1% OsO4 in PB for 60 min at room temperature and washed with distilled 
water before being dehydrated in a series of graded ethanol solutions and embedded in 
epoxy resin. Ultra-thin sections were doubly stained with uranyl acetate and lead citrate 
and observed under an H7600 electron microscope (Hitachi, Tokyo, Japan). Electron 
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micrographs were taken of thin sections from three different parts of the plastic cover 
slips using a H7600 electron microscope (Hitachi, Tokyo, Japan) equipped with 
ORIUS™ SC200W 2k x 2k TEM CCD camera (Gatan Inc.CA) at a magnification of 
8,000. Thirty electron micrographs were taken per condition and analyzed by 
morphometry. The number and surface area of autophagosomes/amphisomes (AP) and 
autolysosomes/ lysosomes (AL) were measured using the software MacSCOPE 2.5 
(Mitani Corporation, Fukui, Japan). The surface area of APs and ALs was normalized to 
the cytoplasmic area.  
2.4.9 Immunoelectron microscopy.  
The pre-embedding gold enhancement immunogold method was used for 
immunoelectron microscopy as described previously (Dall'Armi et al., 2010) with slight 
modifications. Briefly, MEFs cells were cultured on plastic coverslips (LF1, Sumitomo 
Bakelite, Tokyo, Japan) and fixed in 4% paraformaldehyde in PB for 2 hrs at room 
temperature. After permeabilizing in 0.25% saponin diluted in PB for 30 min and 
blocking in 0.1% saponin, 10% bovine serum albumin, 10% normal goat serum and 0.1% 
cold water fish skin gelatin diluted in PB for 30 min, cells were incubated overnight in 
mouse monoclonal anti-LC3 antibody (Itakura et al., 2012a; Velikkakath et al., 2012) 
(clone LC3 1703, Cosmo Bio. Co. LTD Tokoyo, Japan) diluted in blocking solution. 
Subsequently, MEFs were incubated with colloidal gold (1.4 nm in diameter, 
Nanoprobes, New York, NY)-conjugated anti-mouse IgG Fab fragments diluted in the 
blocking solution for 2 hrs. The signal was intensified using a gold enhancement kit 
(GoldEnhance EM, Nanoprobes) for 2 min at room temperature. Cells were post-fixed in 
1% OsO4 containing 1.5% potassium ferrocyanide at room temperature and processed as 
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described above for conventional EM. 
2.4.10 Intracellular protein turnover.  
The long-lived protein degradation assay was adapted from previously reported protocol 
(Martinez-Vicente et al., 2010; Yamamoto et al., 2006). Control and Vps34 KO MEFs 
were plated in 6-well plates. The following day, MEFs were labeled with [
14
C]Valine 
(0.1uCi/ml, Perkin-Elmer) for 18 hrs at 37 °C. Cells were washed three times with PBS 
before chasing with radioactivity-free medium containing an excess of unlabeled valine 
(10mM, Sigma) for 3 hrs to allow for short-lived protein degradation. Again, cells were 
washed three times with PBS and cultured in complete medium or in serum-free medium 
(HBSS) either alone or in the presence of 3-methlyadenine (10mM, Sigma) or NH4Cl 
(15mM, Sigma).  A fraction of the medium was taken at different time points and 
precipitated with trichloroacetic acid (final concentration 15%, v/v, Sigma) in order to 
separate [
14
C]Valine incorporated into secreted proteins from that of free [
14
C]Valine 
released after intracellular proteolysis. After 4 hrs, cells were washed three times in PBS, 
lysed (0.1M NaOH, 0.1% Na deoxycholate) and TCA-precipitated. TCA-soluble and 
total cell radioactivity were measured by liquid scintillation counting. Proteolysis was 
estimated as the ratio of TCA-soluble radioactivity to the total cell radioactivity. 
Specifically, total lysosomal degradation was calculated as a percentage of protein 
degradation sensitive to NH4Cl. Contribution of macroautophagy calculated as a 
percentage of lysosomal protein degradation sensitive to 3MA. Microautophagy and/or 
chaperone-mediated autophagy (CMA) account(s) for the difference between total 
lysosomal degradation and macroautophagy-associated protein degradation. 
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2.4.11 Quantification of phosphoinositide levels by HPLC analysis.  
Control and Vps34 KO cells produced via the Cre-ER system were incubated with 
inositol-free DMEM (MP Biomedicals) supplemented with 10% dialyzed FBS 
(Invitrogen), L-glutamine, glucose and 5 µCi/ml 
3
H-myo-inositol (MP Biomedicals) 24 
hrs before transfection with siRNA duplexes. After transfection, cells were again 
incubated with 5 µCi/ml 
3
H-myo-inositol (MP Biomedicals) in inositol-free DMEM (MP 
Biomedicals) for an additional 48hrs. Prior to lipid extraction, cells were washed twice 
with PBS and incubated 15 minutes in inositol-free DMEM (MP Biomedicals) 
supplemented with 10% dialyzed FBS, glutamine and glucose. Cells were treated with 
0.7 ml 4.5% perchloric acid in ice for 15 mins, scraped and centrifuged.  Pellets were 
washed twice with ice-cold 1 ml 0.1 M EDTA, and deacylated as described (Kirk, 1990). 
Deacylated phosphoinositides were then separated using high performance liquid 
chromatography (Shimadzu Scientific Instruments). Peaks were identified using 
deacylated 32P-standards and detected by an online flow scintillation analyzer (B-RAM, 
IN/US) (Cremona et al., 1999).  
2.3.12 Statistical analysis.  
Quantitative results represent three independent experiments (unless indicated otherwise) 
and values denote mean±s.e.m, as indicated in each figure. Statistical analysis was 
performed using a two-tailed, equal variance Student’s t-test, except for data shown in 
Figure 1C, where the one-sample t-test was used. P-values of < 0.05 (*), < 0.01 (**), < 
0.001 (***) were determined to be statistically significant. All statistical data were 




Chapter 3: Lipidomic analysis of Vps34-deficient fibroblasts 
3.1 Introduction 
In comparison to our current understanding of the genome and proteome, the lipidome 
remains largely enigmatic. For many years, lipids were simply viewed as membrane 
structural units and sources of energy within the cell; however, in 1979, platelet-
activating factor was identified as the first biologically active lipid (Demopoulos et al., 
1979; Pinckard et al., 1979). Following studies revealed several additional lipid species 
endowed with bioactive properties in trafficking processes, the recruitment and regulation 
of membrane proteins, and cellular signaling (van Meer et al., 2008). Given the wide 
range of functions for lipids, it is not surprising that such a diverse set of chemically 
distinct molecules exists. The structural variation among lipids is derived from the 
numerous combinations of different fatty acid chains, which vary in length and 
saturation, and functional headgroups typically linked by a carbon based backbone (e.g., 
glycerol) (Fahy et al., 2005; Fahy et al., 2009; van Meer et al., 2008; Wenk, 2005). Eight 
major classes of lipids have been identified in mammalian cells: fatty acyls, glycerolipids, 
glycerophospholipids, sphingolipids, sterol lipids, prenol lipids, saccharolipids, and 
polyketides. Each is further divided into subclasses that are predicted to comprise over 
100,000 lipid species (Fahy et al., 2005; Fahy et al., 2009; Yetukuri et al., 2008). 
However, glycerolipids, glycerophospholipids, sphingolipids and sterol lipids are the 
most abundant classes in higher eukaryotes and together they probably account for less 
than 1,500 species. Since lipids are not genetically encoded, most functional knowledge 
comes from genetic and biochemical studies on lipid synthesis and modifying enzymes. 
Additionally, many diseases, such as cancer, lysosomal storage diseases, and infectious 
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diseases, that involve the disruption of lipid metabolic pathways have helped improve our 
understanding of lipids. However, we are still left with many unanswered questions in the 
field, including: How do cells synthesize such a diverse set of lipid species and what are 
their roles in the cell? How do lipids regulate and respond to changes in cellular 
physiology and pathophysiology? How do different lipids impact membrane structure and 
function? How are lipids distributed among various organelle membranes, and what is the 
relevance of this distribution? Through what effectors do lipids signal or change 
physiological outcomes? Finally, what metabolic crosstalks exist between the various 
lipid families?   
Technological advancements, especially in mass spectrometry and bioinformatics, 
in the past decade have been critical in the development of a systems-based approach to 
study lipids, termed lipidomics. Specifically, developments in mass spectrometry and 
liquid chromatography have allowed for a multitude of individual lipid species to be 
distinguished and accurately quantified from minute amounts of cell sample (Blanksby 
and Mitchell, 2010; Wenk, 2005; Wenk, 2010). Like its other sister "–omics," genomics 
and proteomics, lipidomics enables broad biochemical characterization of lipids in cells, 
tissues, and organisms. By capturing the lipid profiles of cells in different physiological 
states and genetic backgrounds, new insight into lipid metabolism, regulation, and 
function can be gained. Additionally, a systems based approach to studying lipids, such 
as lipidomics, is important because of the potential for discovery of new lipid networks 
and relationships between different parts of biological systems. Although lipidomics is 
still emerging as a field, its findings are of both basic bioscience and biomedical interest, 
and its use is becoming more widespread in an effort to better understand lipid biology. 
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Since Vps34 is a phosphatidylinositol 3-kinase (PI3K) that synthesizes the 
bioactive lipid phosphatidylinositol 3-phosphate (PI3P) and plays an important role in 
endo-/lysosomal trafficking, it is likely that Vps34 also interacts with other lipid 
networks besides that of the phosphoinositide subclass, which can be tested using a 
lipidomic approach. As mentioned in previous chapters, Vps34 was first identified in 
yeast for its essential role in the sorting and delivery of soluble hydrolases transported 
from the Golgi to the vacuole (the yeast equivalent of the mammalian lysosome) (Backer, 
2008; Herman and Emr, 1990; Schu et al., 1993). Later studies using PI3K inhibitors 
(e.g., wortmannin and LY294002) and siRNA approaches demonstrated this conserved 
role for Vps34 in higher eukaryotes and showed defects in maturation of the lysosomal 
hydrolase cathepsin D and the appearance of large, cytoplasmic vacuoles in the absence 
of Vps34's PI3K activity (Brown et al., 1995; Davidson, 1995; Johnson et al., 2006). As 
predicted, both Vps34 siRNA knock-down and genetic knock-out mouse models have 
demonstrated impairment in lysosomal degradation (e.g., of EGFR) upon ablation of 
Vps34 (chapter 2; (Devereaux et al., 2013; Jaber et al., 2012a)). Likewise, knocking out 
Vps15, an interactor and activator of Vps34, produced a secondary downregulation 
Vps34 in cells and subsequently resulted in lysosomal dysfunction and storage defects in 
the muscle (Nemazanyy et al., 2013). Failure to properly traffic and deliver hydrolases to 
the lysosome in the absence of Vps34 is largely attributed to the diminished recruitment 
of PI3P-binding effectors that mediate the retrieval and recycling of the hydrolase 
receptors from the endosomal system back to the TGN (e.g., Snx1-3). However, failure to 
recruit other key PI3P-binding effectors (e.g., EEA1, Rabenosyn-5, Hrs, Snx1-3, and 
KIF16B) that mediate vesicular transport, fusion and sorting at the endosomal system 
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likely impair endo-/lysosomal system function as well  (Lindmo and Stenmark, 2006; 
Raiborg et al., 2013). However, it is important to note that PI3P also serves as a unique 
substrate for phosphatidylinositol 3,5-bisphosphate, PI(3,5)P2, synthesis by the PI3P 5-
kinase PIKfyve (the mammalian homolog of yeast Fab1) (Ho et al., 2012). In fact, 
PI(3,5)P2 is important for maintaining lysosomal morphology, trafficking, membrane 
recycling ,and lysosomal acidification, and, when ablated, enlarged endosomes and 
endolysosomal dysfunction occur (Efe et al., 2005; Gary et al., 1998; Ho et al., 2012; 
Ikonomov et al., 2003; Ikonomov et al., 2001; Nicot et al., 2006; Rusten et al., 2006; 
Rutherford et al., 2006). Therefore, the breakdown of the endolysosomal system seen 
upon Vps34 ablation and the subsequent loss of PI3P likely reflect a secondary decline in 
PI(3,5)P2 levels as well. It is well known that the lysosome serves as a major catabolic 
site for lipids; therefore, the deletion of Vps34 would disrupt endolysosomal function, 
which in turn could result in altered lipid turnover and homeostasis in the cell. 
In addition to regulating the endo-/lysosomal system trafficking required for 
efficient delivery of hydrolases to the lysosome, PI3P synthesis by Vps34 promotes 
formation of intraluminal vesicles (ILVs) (Fernandez-Borja et al., 1999; Futter et al., 
2001a; Schu et al., 1993). ILVs are formed through the invagination and budding of 
endosomal membrane and serve as an important pathway for the degradation of 
transmembrane proteins. Although the heterogeneity in ILVs formation and composition 
is only beginning to be understood (Babst, 2011; Kobayashi et al., 2002; van der Goot 
and Gruenberg, 2006), it is known that PI3P synthesis by Vps34 is required to form ILVs 
via the Endosomal Sorting Complexes Required for Transport (ESCRT-0, I, II, III) 
pathway (Raiborg and Stenmark, 2009; Saksena et al., 2007) (see section 1.4.1.3 for 
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details). The primary fate of ILVs formed via the canonical ESCRT pathway appears to 
be lysosomal degradation, which is regulated by the fusion of multivesicular bodies 
(MVBs), an endosomal intermediate that contains multiples ILVs, with the lysosome 
(Babst, 2011; de Gassart et al., 2004; Hurley, 2010; Hurley and Hanson, 2010; Raiborg 
and Stenmark, 2009). So far, ILVs have been studied predominately in the context of 
transmembrane protein degradation; however, ILVs appear to have an important role in 
membrane and lipid turnover as well (Gillooly et al., 2000; Hurley, 2010; Mobius et al., 
2003; van der Goot and Gruenberg, 2006). Interestingly, PI3P not only participates in 
ILV formation but is also sorted into ILVs and degraded upon reaching the late endosome 
(Gillooly et al., 2000). Likewise, ILVs are also enriched in cholesterol early in the 
endosomal pathway; however, it is currently unclear whether cholesterol promotes ILV 
formation or whether it is incorporated once ILVs have formed (Gillooly et al., 2000; 
Hurley, 2010; Kobayashi et al., 1999; Mobius et al., 2003; van der Goot and Gruenberg, 
2006). In addition to PI3P and cholesterol, it is likely that the metabolism of other lipids 
are regulated through a Vps34-dependent ILV pathway. 
 Lastly, PI3P synthesis by Vps34 is also important for regulating autophagy. At the 
site of autophagosome (AP) nucleation, PI3P is synthesized and recruits downstream 
PI3P-binding autophagy effectors (e.g., WIPI, DFCP) that promote membrane expansion 
and curvature during AP biogenesis (Axe et al., 2008; F et al., 2013; Obara and Ohsumi, 
2008; Proikas-Cezanne et al., 2004). Given that an autophagosome is a transient 
organelle that is formed de novo during autophagy stimulation, a significant amount of 
membrane remodeling and lipid content is required to construct this large, double-
membraned organelle. Additionally, Vps34 regulates AP maturation steps and fusion 
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with the endo-lysosomal system. Importantly, autophagy is an important pathway not 
only for the bulk degradation of proteins but also for the turnover and degradation of 
organelles and lipids (He and Klionsky, 2009). Although phosphoinositide species such 
as PI3P have been the major subclass of lipids implicated in autophagy, other lipid 
subclasses likely participate in the regulation of or change during autophagy as well. 
Since Vps34 is an important regulator of this catalytic cellular process, it likely to 
interact, either directly or indirectly, with the lipid networks important this process. 
Here, we performed lipidomic analysis on control and Vps34 KO MEFs in order 
to determine the effects Vps34 and its synthesis of PI3P on lipid metabolism. The effects 
of both acute and prolonged ablation of Vps34 on the lipidome were analyzed, since 
endolysosomal breakdown and dysfunction occurs over time (data presented in Chapter 
2, Fig. 2.2B,C) and may differentially affect the lipid network. Lipidomic analysis is also 
ideal for identifying important lipid changes due to autophagy under normal 
circumstances and during impairment caused by absence of Vps34; therefore, we also 
analyzed changes in the lipidome and lipid metabolism during autophagy in both control 
cells and in Vps34 KO MEFs.  
3.2 Results 
3.2.1 Comparative lipid profiling of control and Vps34 KO MEFs. 
Vps34
Flox/Flox 
MEFs were infected with lentiviruses expressing either a catalytically-
inactive or active, nuclear CRE in order to generate control and Vps34 KO MEFs, 
respectively. Successful gene deletion of Vps34 reproducibly occurred 10 days after 
infection with lentivirus and was confirmed by Western blot analysis (previously shown 





MEFs, cells were harvested and lipids were extracted for analysis by mass-spectrometry 
either 10 or 14 days post-infection with lentivirus. Non-infected MEFs were also 
analyzed to control for the effects of lentivirus infection on lipid metabolism. 
Importantly, we found no significant differences between the lipid profiles of uninfected 
MEFs compared to lentivirus infected, control MEFs (data not shown). When the 
lipidome of control and Vps34 KO MEFs were analyzed, we observed a trend for an 
increase in free cholesterol (FC) and a significant decrease in cholesterol esters (CE) 
upon acute ablation of Vps34 (Day 10) (Fig. 3.1A). With prolonged ablation of Vps34 
(Day 14) an even further reduction in CE was seen (Fig. 3.1B). Notably, changes in other 
lipid subclasses were also observed in the absence of Vps34 over time. Specifically, an 
increase in sphingomyelin (SM), dihydrosphingomyelin (dhSM), ceramide (Cer), 
ceramide-lactose-N-acetylneuraminic acid (GM3), phosphatidylcholine (PC), 
plasmalogens phosphatidylethanolamine (PEp) was observed in Vps34 KO MEFs 14 days 
post-infection (Day 14) (Fig. 3.1B). Within each subclass of lipid, several lipid species 
that varied in fatty acid chain length and saturation were also measured for each 
genotype, and relative levels are displayed in a heat map (Fig. 3.4). In fact, many of the 
changes in specific species occurred within the subclasses observed to change in the 
Vps34 KO MEFs mentioned above; however, the heat map also revealed changes in 
several specific lipid species within a subclass that did not significantly change. For 
example, a decrease in bis(monoacylglycero)phosphate (BMP) species with a 36 carbon 
chain length and high saturation was observed (Fig. 3.4). In summary, lipidomic analysis 
of Vps34 KO MEFs revealed a novel relationship between Vps34 and cholesterol 




3.2.2 Vps34 ablation alters cholesterol homeostasis. 
Cholesterol is an essential structural lipid that can be acquired through cell uptake or 
synthesized endogenously. Although cholesterol resides predominately at the plasma 
membrane where it forms lipid rafts, it is also found in the TGN, recycling 
endosomes,and multivesicular bodies (Maxfield and Tabas, 2005; Mobius et al., 2003). 
Because of its importance and toxicity at high levels to cells, cholesterol levels are tightly 
regulated by enzymes that interconvert FC and CE (Maxfield and Tabas, 2005; Tabas, 
2002). Excess FC is esterified and stored within lipid droplets as CEs. In order to better 
understand the relationship between the increase in FC and decrease in CE observed in 
the Vps34 KO MEFs, we examined the ratio of these two lipid subclasses. The ratio of 
CE to FC was significantly decreased upon ablation of Vps34 and demonstrated a further 
decrease over time (Fig. 3.2A). In particular, continual decrease in CE over time in Vps34 
KO MEFs suggests that FC to CE metabolism is impaired. In order to confirm the 
increase in FC seen by lipidomic analysis as well as determine its localization in Vps34 
KO MEFs, cells were immunostained with filipin. Filipin is a polyene macrolide 
antibiotic and antifungal that fluoresces and can be used to detect unesterified free 
cholesterol (Bornig and Geyer, 1974; Lefevre, 1988). As expected, acute ablation of 
Vps34 produced an increase in filipin staining compared to control cells, a finding 
consistent with higher FC levels measured by lipidomic analysis (Day 10) (Fig. 3.2B). 
With prolonged ablation of Vps34, more and larger filipin-positive puncta were observed 
(Day 14) (Fig. 3.2B). These results further confirm that Vps34 is important for the 
regulation FC and CE levels in the MEFs. 
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3.2.3 Lipidomics of control and Vps34 KO MEFs during starvation-induced 
autophagy. 
In order to identify novel lipids and lipid metabolic networks implicated in autophagy, we 
examined the lipidome of control and Vps34 KO MEFs during starvation-induced 
autophagy. Control and Vps34 KO MEFs were cultured in normal media or starved for 
30min or 90min in HBSS prior to lipid extraction and mass-spectrometry analysis. When 
control cells were starved for 30 and 90mins, only plasmalogens 
lysophosphatidlyethanolamine (LPEp) increased significantly compared to steady state 
levels. Additionally, a trend for an increase in FC and a decrease in CEs was observed in 
control MEFs (Fig. 3.3). Interestingly, analysis of the lipidome in the absence of Vps34 
revealed changes only in CE upon autophagy induction when compared to control levels. 
Although there was a trend for a decrease in CEs in both genotypes during starvation-
induced autophagy, CE levels were significantly reduced in the Vps34 KO MEFs 
compared to the control MEFS at steady-state and during both 30 and 90 min of 
starvation.  Similar to the control MEFs, Vps34 KO MEFs showed an increase LPEp in 
response to 30 and 90mins of starvation when compared to its own steady-state levels 
(Fig. 3.3). Additionally, increase in lysophosphatidlyethanolamine (LPE) was also 
observed after 30 and 90mins of starvation in Vps34 KO MEFs (Fig. 3.3). Most changes 
in molecular species occurred in subclasses that changed as a whole. In particular, we 
observed a decline in many cholesteryl ester species during 30 and 90mins of starvation, 
as was observed under steady-state conditions in Vps34 KO MEFs (Fig. 3.4). 
Interestingly, short chained, unsaturated LPEp appeared to increase in control MEFs 
during autophagy, whereas both short and medium chained LPEps increased in the Vps34 
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KO MEFs. Additionally, the increase in these LPE species appears early at 30mins and 
further increases by 90mins, whereas there appears to be a delay in the Vps34 KO MEFs, 








































Figure 3.1 Effects of acute and prolonged Vps34 ablation on lipid composition 
123 
 
Figure 3.1 Effects of acute and prolonged Vps34 ablation on lipid composition. 
Vps34
Flox/Flox 
MEFs were infected with lentiviruses expressing either an inactive Cre (Δ) 
or active (CRE) full-length Cre recombinase for 10 or 14 days prior to harvesting cells 
and extracting lipids for analysis. (A) Levels of various lipid subclasses in control and 
Vps34 KO MEFs after 10 days of lentiviral infection. (B) Levels of lipid subclasses in 
control and Vps34 KO MEFs after 14 days of lentiviral infection. Values expressed as 



























Figure 3.2 Altered cholesterol homeostasis in Vps34 KO MEFs 
Figure 3.2 Altered cholesterol homeostasis in Vps34 KO MEFs. (A) Mean ratio of 
total cholesteryl esters to free cholesterol in control and Vps34 KO MEFs after 10 and 14 
days of lentivirus infection (n=7). (B) Confocal analysis of control and Vps34 KO MEFs 






































Figure 3.3 Effects of starvation-induced autophagy on lipid composition in control and Vps34 KO MEFs 
Figure 3.3 Effects of starvation-induced autophagy on lipid composition in control 
and Vps34 KO MEFs. Control and Vps34 KO MEFs infected for 10 days with lentivirus 
were cultured in normal media (Control Nm; KO Nm) or starved for 30mins (Control 
30m; KO 30m) or 90mins (Control 90m; KO 90m) in HBSS prior to harvesting and 
extracting lipids for analysis. Levels of various lipid subclasses in control and Vps34 KO 
MEFs after 10 days of lentiviral infection. Values expressed as mean relative mol % of 
total lipid species measured and error bars indicate s.e.m. (n=7). Statistical analysis was 
performed using two-way ANOVA followed by two-way unpaired Student's t-test, with 
additional Bonferroni correction for within-genotype comparisons. P-value < 0.05 was 
indicated as (*) when representing changes within a genotype when compared to normal 


































Figure 3.4 Comprehensive lipid profile of control and Vps34 KO MEFs. Heatmap 
shows changes in lipid species organized by subclass. The first four columns compare the 
relative mol % of total lipid for each species in Vps34 KO MEFs (KO) to control (C) 
MEFs when cultured in normal media conditions 10-days post-infection (Nm), normal 
media conditions 10-days post-infection (Nmd14), or starved for 30mins (30 m) or 90mins 
(90 m). The last four columns compare the relative mol % of total lipid for each species 
after 30mins or 90mins to normal media conditions within the control (C) and Vps34 KO 
(KO) MEF genotypes. Color bars represent the log2 ratio of mean relative mol% between 





In the first part of this study, we aimed to identify novel interactions between the class III 
PI3K, Vps34, and the lipidome using a lipidomic approach. Our analysis revealed a 
previously unrecognized relationship between Vps34 and cholesterol homeostasis in 
cells. Specifically, an increase in FC levels and a decrease in CE were observed upon 
ablation of Vps34. These findings raise several hypotheses discussed below and will 
require future studies to better understand how Vps34 regulates cholesterol metabolism. 
Cholesterol levels and its distribution within cells are tightly regulated through a 
combination of trafficking and enzymatic processes in the mammalian cells (Ioannou, 
2001; Maxfield and Tabas, 2005; Maxfield and van Meer, 2010; Maxfield and Wustner, 
2002). Intracellular cholesterol is derived either through its endogenous biosynthesis by 
the 3-hydroxy-3-methylglutaryl-coenzyme (HMG-CoA) reductase pathway or through 
the uptake of circulating plasma lipoproteins via the low-density lipoprotein (LDL) 
receptor pathway (Ioannou, 2001; Maxfield and Tabas, 2005; Maxfield and van Meer, 
2010; Maxfield and Wustner, 2002). In the uptake pathway, cholesterol is endocytosed as 
LDL-associated CE, which is trafficked to the late endosomes (LE) and lysosomes (LY) 
(Ioannou, 2001; Maxfield and Tabas, 2005; Maxfield and van Meer, 2010; Maxfield and 
Wustner, 2002). In the LE/LY, CE is hydrolyzed by lysosomal acid lipases (LAL) into 
FC and fatty acids. The liberated FC is first transferred to Niemann Pick type C2 (NPC2), 
a soluble protein within the lumen, and then to Niemann Pick type C1 (NPC1), a 
transmembrane protein within the limiting membrane of the LE/LY (Infante et al., 2008; 
Kwon et al., 2009). Importantly, BMP, a lipid that resides mainly in the ILVs of late 
endosomes, has been shown to enhance LAL and NPC2 activity as well as enhance the 
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cholesterol storage capacity of LEs  (Kobayashi et al., 1999; Xu et al., 2008). Once FC is 
delivered to NPC1 it is transferred to the limiting membrane of the LE/LY and 
transported via vesicles or carrier proteins to other membrane sites within the cell (Kwon 
et al., 2009; Maxfield and Wustner, 2002; Soccio and Breslow, 2004; Yang, 2006). FC 
may be transported to membranes, such as the plasma membrane, endosomes or TGN, 
where it plays a critical role in lipid raft functions (Mesmin and Maxfield, 2009). 
Alternatively, FC may be trafficked to the ER and undergo esterification by acyl-CoA 
cholesterol acyltransferase (ACAT) and stored in lipid droplets (Buhman et al., 2000; 
Chang et al., 1997). When levels of FC become too high, a "reverse cholesterol transport" 
program is upregulated through the activation of liver X/retinoid X receptors (LXR/RXR) 
to promote cholesterol efflux out of the cellsvia transporters (e.g., ABCA1) at the plasma 
membrane (Chawla et al., 2001; Costet et al., 2003; Oram, 2002; Stefkova et al., 2004). 
Conversely, if levels of FC become too low, sterol regulatory element-binding proteins 
(SREBP) undergo cleavage to allow for transcription factor release and upregulation of 
sterol-synthesizing genes (e.g., HMG CoA reductase, LDL receptor) (Brown and 
Goldstein, 1999). Cholesterol regulation is a complex pathway that makes the increase in 
FC and decrease in CE observed in Vps34 KO cells more challenging to understand due 
to the fact that perturbations could occur multiple steps.  
At this stage, it is unclear whether an upregulation in uptake and/or synthesis of 
cholesterol or a decline in efficient efflux and trafficking is causing the FC accumulation 
in Vps34 KO MEFS. First, it will be important to localize the excess FC in the Vps34 KO 
MEFs. In this study, filipin was used to confirm the increase in FC levels seen by 
lipidomic analysis in Vps34 KO MEFs; however, filipin colocalization studies with 
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various organellar markers also need to be performed in order to determine whether 
filipin puncta observed upon Vps34 ablation represent an accumulation of FC in LE/LYs. 
Additionally, determining whether FC accumulates on the luminal versus limiting 
membrane will likely be helpful in identifying whether cholesterol transfer to or efflux 
from the limiting membrane is impaired. For instance, when NPC1/2 is impaired FC 
accumulates in the lumen of the LE/LY; however, when cholesterol carrier proteins, such 
as the oxysterol-binding protein related protein 5 (ORP5), are impaired, FC accumulates 
within the limiting membrane (Du et al., 2011). Additionally, levels and localization of 
major regulators of the cholesterol metabolic pathway should be characterized in the 
Vps34 KO MEFs in order to better understand the cause(s) of FC accumulation. Major 
regulators that should be examined in the Vps34 KO MEFs include: LXR/RXR and 
SREBP transcription factors, HMGCoA reductase, LDL receptor, ACAT-1/2 (ACAT-2 
expression is limited to intestinal cells), ABCA transporters (e.g., ABCA1) and cytosolic 
nonvesicular transporters (e.g., MLN64, OSBPs, START proteins, Hrs). Interestingly, a 
recent study showed that Hrs, a PI3P-binding protein implicated in ESCRT-dependent 
MVB formation, plays a role in LDL-derived cholesterol trafficking from the endosome 
to the ER (Du et al., 2012; Petiot et al., 2003). Specifically, Hrs is thought to recruit lipid 
carriers, such as ORP5 (an OSBP family member), that facilitate cholesterol removal 
from the limiting membrane (Du et al., 2012). Additionally, Hrs is important for ILV 
formation, which plays a critical role in the storage and trafficking of luminal cholesterol 
(Du et al., 2012; Gruenberg and Stenmark, 2004). In previous studies, PI3P production by 
Vps34 has been has been shown to be important for recruiting Hrs to the endosomal 
membrane as well as promote ILV formation via the ESCRT-pathway, making this 
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process a likely candidate to be affected by Vps34 ablation (Fernandez-Borja et al., 1999; 
Futter et al., 2001a; Komada and Soriano, 1999; Petiot et al., 2003; Raiborg et al., 2001; 
Reaves et al., 1996; Urbe et al., 2000) 
In addition to studying FC in Vps34 KO MEFs, further investigation will be 
required to understand the progressive decrease in CE observed with prolonged ablation 
of Vps34. The studies proposed above will help determine whether ACAT is 
misregulated or mislocalized in Vps34 KO MEFs; however, its activity may need to be 
tested as well. ACAT is an ER resident enzyme that localizes to mitochondria-associated 
ER membranes (MAM), a subcompartment of the ER that is physically and 
biochemically connected to the mitochondria (Hayashi et al., 2009; Lewin et al., 2002; 
Rusinol et al., 1994). ACAT plays an important role in preventing an accumulation of FC 
cholesterol by converting FC to CE for lipid droplet storage. CEs in lipid droplets can be 
mobilized by cholesterol ester hydrolases residing in the cytoplasm or the lysosome, 
although lysosomal hydrolysis requires that lipid droplets first be delivered to the 
lysosome via autophagy (termed lipophagy) (Thiam et al., 2013; Walther and Farese, 
2012). In order to prevent excess conversion of FC into CE, the activity of ACAT is 
allosterically regulated by cholesterol (Tabas, 2002; Zhang et al., 2003b). ACAT activity 
can be assessed using a standard cholesterol esterification assay, whereby radioactive 
cholesteryl oleate is added to cell,s and its conversion to CE is measured. If localization 
and levels of ACAT are normal, but its activity declines, it may reflect two scenarios. 
Simply, there may be a kinetic delay in FC efflux and/or trafficking from the LE/LY to 
the ER. Alternatively, ACAT activity may be impaired due to a disruption of the MAM. 
ACAT activity and CE synthesis has been correlated with MAM function (Area-Gomez 
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et al., 2012). Specifically, MAM integrity can be examined by electron microscopy and 
ultrastructural analysis of the membrane as well as isolation of MAMs and checking for 
the presence of known markers. Recently, it was discovered that Vps34 associates with 
the MAM during starvation-induced autophagy to promote autophagosome biogenesis at 
this site (Hamasaki et al., 2013). Whether Vps34 has additional roles at the MAM that 
could be affecting ACAT activity at this site is currently unclear.   
Interestingly, a trend for an increase in FC and significant decrease in CE 
observed in Vps34 KO MEFs is reminiscent of an NPC disease phenotype.In NPC 
disease, mutations in NPC1 and 2 lead to accumulation of LDL-derived FC in the lumen 
of the LE/LY, which subsequently triggers upregulation of pathways that favor 
endogenous cholesterol synthesis and further uptake (Rosenbaum and Maxfield, 2011). 
Also, a decline in CE synthesis is observed and may reflect slowed FC efflux and 
trafficking to the ER from the LE/LY (Liscum, 2000; Pentchev et al., 1985; Rosenbaum 
and Maxfield, 2011). Importantly, in addition to the changes in FC and CE observed in 
NPC, there is a multitude of other lipid species that also accumulate in NPC, including 
sphingomyelin, sphingosine, GM2, GM3 and BMP (Lloyd-Evans and Platt, 2010; 
Walkley and Vanier, 2009; Zervas et al., 2001). Likewise, in the Vps34 KO MEFs there 
is an accumulation of specific lipid species, including dhSM, SM, Cer, GM3, PC, and 
PEp, with more prolonged ablation. Notably, BMP levels have been shown to correlate 
with an increase in FC level, as in NPC (Chevallier et al., 2008; Kobayashi et al., 1999); 
however, its overall level does not change in Vps34 KO MEFs and may reflect the fact 
that the increased in FC observed in the knock-out is not significant enough. Given that 
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Vps34 plays a major role in hydrolase trafficking to the lysosome, an accumulation in 
lipids is expected and may be secondary to insufficient lysosomal hydrolase activity. 
In the second part of this study, lipidomics was used to identify new lipid 
networks related to starvation-induced autophagy.  In our analysis, we found a specific 
increase in LPEp in control and Vps34 KO MEFs as well as an increase in LPE in Vps34 
KO MEFs during starvation-induced autophagy. LPE is a lysolipid subclass derived from 
PE through hydrolysis by lysosomal phospholipase A2 (PLA2) (Library; Makide et al., 
2009), although its role is currently unknown. LPEp and its purported precursor PEp are 
structurally similar, though as plasmalogens they contain a vinyl-ether bond at the sn-1 
position, rather than the typical ester linkage (Lohner, 1996).  Although all plasmalogen 
biosynthesis begins in the peroxisome, very little is known about LPEp specifically in 
terms of its synthesis, function and localization. Although a physiological explanation for 
an increase in these lipids unclear at this stage, PE is known to be important lipid 
subclass for AP biogenesis. During autophagy, LC3 (the mammalian homolog of Atg8) is 
conjugated to PE on the inner and outer leaflets of AP membrane by a ubiquitin-like 
conjugation system. Given that APs ultimately undergo fusion with the lysosome for 
degradation, PE may be delivered to the lysosome at a higher rate during this process and 
subsequently be metabolized to LPE, for example. Previous studies in yeast have 
demonstrated that Atg8 is conjugated to PE in yeast (Ichimura et al., 2000), but 
whether mammalian LC3 is conjugated solely to PE or to other PE-related lipids, 
such as PEp, has not been determined. Given that an increase in LPEp is observed in 
starved control and Vps34 KO MEFs, it would be interesting to test whether LC3-PEp 
conjugation could also occur in mammals. So far, it is unclear why an increase in LPE 
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is observed in Vps34 KO and not in control MEFs. Notably, the increase in LPE during 
autophagy is delayed in the Vps34 KO MEFs, which may reflect impaired kinetics in AP 
flux. However, in future studies, it will be important to determine whether the LPEp and 
LPE changes are, in fact, due to downstream maturation and degradation steps and not 
autophagy initiation. In order to distinguish between these scenarios, the lipidome of a 
mutant cells defective in AP biogenesis (e.g., Atg5) should be compared to cells in which 
fusion and lysosomal degradation is impaired (e.g., chloroquine).  
 In addition, we observed a trend for an increase in FC and a decrease in CE 
during autophagy stimulation in MEFs of both genotypes.  Recent studies have shown 
that during autophagy, lipid droplets, which are single membrane organelles that store CE 
and TGs, are engulfed by APs and taken to the lysosome where LAL enzymes hydrolyze 
CE into FC and fatty acids (Singh and Cuervo, 2012; Singh et al., 2009). Notably, a trend 
for an increase in FC and a significant decrease in CE was observed under starvation 
conditions in the Vps34 KO MEFs compared to control MEFs, reflecting the 
dysregulation in cholesterol homeostasis discussed above. Taken together, lipidomic 
analysis revealed fewer lipid changes than expected, considering the amount of 
membrane remodeling and cellular degradation that occurs during this process. In the 
future it would be interesting to analyze the lipid composition of various membranes in 
the cell by through subcellular fractionation, which may reveal important localized 
changes that were not observed during whole cell analysis.  
Lipidomics is instrumental in identifying and understanding lipids. Not only is 
lipidomics of basic science relevance, but also it is powerful technology that holds 
promise for identifying new biomarkers in disease and identifying and addressing lipid 
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dysregulation in numerous diseases. Recent advances in analytical technologies have 
enhanced our ability to detect a wide array of lipids; however, continuous efforts are 
required to improve detection capabilities and more comprehensively catalog the wide 
range of lipids. Combining lipidomics with genomics and proteomics is an emerging 
concept in the biological sciences that will be important for discovering new relationships 
between genes, proteins, and lipids.  
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3.5 Materials and Methods.  
3.5.1 Generating Vps34 KO MEFs. 
See Chapter 2 Materials and Methods. 
3.5.2 Annotation of Lipid Species 
Lipids were annotated in bar graphs and heat maps as follows:  
APG, acyl phosphatidylglycerol; BMP, bis(monoacylglycero)phosphate; CE, cholesteryl 
ester; Cer, ceramide; DG, diacylglycerol; LPC, lysophosphatidylcholine; LPCe, ether 
lysophosphatidylcholine;  LPE, lysophosphatidylethanolamine; LPEp, plasmalogens 
lysophosphatidylethanolamine; LPI,  lysophosphatidylinositol; FC, free cholesterol; 
GalCer, galactosylceramide; GluCer, glucosylceramide; GM3, ceramide-lactose-N-
acetylneuraminic acid; LacCer, lactosylceramide; MG, monoacylglycerol; NAPS, N-acyl 
phosphatidylserine; NAPE, N-acyl phosphatidylethanolamine; SM, sphingomyelin; 
dhSM, dihydrosphingomyelin; Sulf, sulfatide; PA, phosphatidic acid; PC, 
phosphatidylcholine; PCe, ether phosphatidylcholine; PE, phosphatidylethanolamine; 
PEp, plasmalogens phosphatidylethanolamine; PG, phosphatidylglycerol; PI, 
phosphatidylinositol; PS, phosphatidylserine; TG, triacylglycerol. 
3.5.3 Analysis of Lipids Using High Performance Liquid Chromatography-Mass 
Spectrometry 
Cell lipid extracts were prepared using a modified Bligh/Dyer procedure (Bligh and 
Dyer). Samples were spiked with an internal standard cocktail and analyzed using a 6490 
Triple Quadrupole LC/MS system (Agilent Technologies, Santa Clara, CA). 
Glycerophospholipids and sphingolipids were separated with normal-phase HPLC as 
before (Chan et al., 2012), with a few changes. An Agilent Zorbax Rx-Sil column (inner 
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diameter 2.1 x 100 mm) was used under the following conditions: mobile phase A 
(chloroform:methanol:1 M ammonium hydroxide, 89.9:10:0.1, v/v) and mobile phase B 
(chloroform:methanol:water:ammonium hydroxide, 55:39:5.9:0.1, v/v); 95% A for 2 min, 
linear gradient to 30% A over 18 min and held for 3 min, and linear gradient to 95% A 
over 2 min and held for 6 min. FC, CEs, and glycerophospholipids (GLs) were separated 
with reverse-phase HPLC using an isocratic mobile phase as before (Chan et al., 2012) 
with an Agilent Zorbax Eclipse XDB-C18 column (4.6 x 100 mm). GLs and 
sphingolipids were analyzed using both positive and negative mode ionization, while FC, 
CE and GLs were analyzed using only positive mode ionization. 
3.5.4 Data Analysis and Presentation 
Lipid levels were represented as relative mol %, which was calculated by normalizing 
individual lipid subclasses or species to the total lipids measured in all three LC-MS 
methodologies. The final data are presented as mean with error bars showing mean ± 
s.e.m. Statistical analysis was performed using a two-way ANOVA followed by two-
tailed unpaired Student s t-test for each comparison with an additional Bonferoni 





Chapter 4: A novel role for retromer in autophagy 
4.1 Introduction 
Alzheimer’s disease (AD), the most common form of age-related dementia, is a 
devastating neurodegenerative disorder that results in the progressive loss of memory 
function and cognition (Blennow et al., 2006; Querfurth and LaFerla, 2010; Thies and 
Bleiler, 2013). In an effort to better understand the molecular mechanisms underlying 
both familial and sporadic (or late-onset) AD, linkage analyses as well as genome-wide 
association studies (GWAS) have been performed in recent years and have revealed 
multiple genetic variants as risk factors (Elias-Sonnenschein et al., 2012). Although AD 
is a genetically complex disorder, two hallmark pathological features observed in the 
hippocampus and cerebral cortex regions of all AD patient brains include: 1) intracellular 
neurofibrillary tangles, which consist of hyperphosphorylated and aggregated forms of 
the microtubule-associated protein tau, and 2) extracellular amyloid plaques, which are 
composed of fibrillar aggregates of β-amyloid peptide (primarily Aβ42) derived from the 
proteolysis of amyloid precursor protein (APP) (De Strooper, 2010; Delacourte, 2008; 
Glenner and Wong, 2012; Mandelkow and Mandelkow, 2012; Masters and Beyreuther, 
2006). In addition to these findings, however, ultrastructural analysis of AD brains has 
consistently revealed less characterized features of pathogenesis, including enlarged 
endosomes (Cataldo et al., 1997; Cataldo et al., 2004; Cataldo et al., 2000) and the 
progressive appearance of swollen neurites filled with vacuolar structures, which were 
later identified as autophagosomes (APs) and autophagolysosomes (ALs), and lysosomal 
dense-bodies (Nixon et al., 2005; Suzuki and Terry, 1967; Terry et al., 1964). These 
findings, together with studies on fetuses with Down syndrome showing endosomal 
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anomalies preceding Aβ plaques and tangles by several decades (Cataldo et al., 2000), 
support a hypothesis in which endo-lysosomal system dysfuncton may be a major factor 
underlying many of the pathogenic features of AD (Nixon, 2007; Nixon and Yang, 2011).  
 Currently, the precise cause of this breakdown in the endo-lysosomal system that 
appears to occur in AD is unknown. However, several recent GWAS studies have 
identified important gene ‘hits’ encoding members of the retromer complex and its cargo, 
the vacuolar protein sorting 10 (Vps10) family of receptors, as significant risk factors for 
several neurodegenerative diseases, including late-onset AD (LOAD), Parkinson’s 
disease and frontotemporal dementia (Lane et al., 2012; Small, 2008; Small and Gandy, 
2006; Willnow and Andersen, 2013) and are likely contributory factors. In brief, retromer 
was first discovered in yeast for its role in recycling Vps10 (the yeast ortholog of the 
mannose 6-phosphate receptor (M6PR)) from the endosomal pathway to the TGN, which 
is essential for maintaining proper delivery of acidic hydrolases to the vacuole (the yeast 
equivalent of the lysosome) and lysosomal function (Bonifacino and Hurley, 2008; 
Seaman, 2005). Later studies showed that retromer is a highly conserved complex in 
mammals and is required for the retrograde endosome-to-TGN trafficking of M6PR, 
which is responsible for trafficking mammalian lysosomal hydrolases (Seaman, 2012), 
and of a subset of the Vps10 receptor family members (including sortilin, sorL1, SorCS1, 
SorCS2 and SorC2), which all contains a conserved Vps10-recognition domain and bind 
to a variety of ligands, including some lysosomal hydrolases and APP (Braulke and 
Bonifacino, 2009; Lane et al., 2012; Willnow et al., 2008). In mammals, the retromer 
complex consists of a cargo recognition domain (Vps35/26/19) and a membrane 
association domain composed of a dimer of the sorting nexin proteins SNX1 or SNX2 
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with either SNX5 or SNX6 (or possibly SNX32) (Bonifacino and Hurley, 2008; Haft et 
al., 2000; McGough and Cullen, 2011; Seaman, 2004; Seaman, 2005) (Fig. 4.1) The SNX 
proteins contains an N-terminal phox homology (PX) domain, shown to bind 
phosphatidylinositol-3-phosphate (PI3P) on the early endosomes (although the PX 
domain can also associate with other phosphoinositides such as phosphatidylinositol-3,5-
bisphosphate (PI(3,5)P2)) as well as a BAR domain, believed to sense and drive 
membrane curvature facilitating membrane evagination in the form of tubules (Carlton 
and Cullen, 2005; Cullen and Korswagen, 2012; Seet and Hong, 2006; Worby and Dixon, 
2002). Together, the components of the retromer complex facilitate cargo sorting and 
tubulation of the endosomes whereby vesicles can bud off and traffic to the TGN or other 
compartments, such as the cell surface (McGough and Cullen, 2011; Seaman, 2005; 
Seaman, 2012). The retromer was first implicated in AD when a study found deficiencies 
in Vps35 and Vps26 in the hippocampus of LOAD patients (Small et al., 2005). More 
recently, members of the Vps10 family of receptors (e.g. SorLA, SorCS1) (Lane et al., 
2012; Willnow and Andersen, 2013) as well as SNX1, SNX3 and RAB7A (Vardarajan et 
al., 2012), which all regulate the membrane association of retromer, were also identified 
as risk genes in LOAD. Further investigation is required to determine how risk factors 
implicated in retrograde trafficking may contribute to the pathogenesis of AD.  
So far, several studies have shown that the ablation of retromer complex 
members, including Vps35 (Muhammad et al., 2008; Small et al., 2005) and Vps26 
(Rogaeva et al., 2007), or members of the Vps10 receptor family, including SorL1 
(Andersen et al., 2005; Dodson et al., 2006; Rogaeva et al., 2007) and SorCS1 (Lane et 
al., 2010), causes an increase in Aβ production. In fact, it has been hypothesized that 
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efficient retrieval of APP from the endosome by retromer reduces its retention time in the 
endosome, where evidence suggests APP processing by BACE1 and cleavage into Aβ 
takes place (Lane et al., 2010; Small, 2008; Small and Gandy, 2006; Willnow and 
Andersen, 2013). 
In addition to an increase in Aβ42 production, the dysfunctional endo-lysosomal 
trafficking caused by retromer impairment is likely to contribute to other pathological 
features observed in LOAD. Previous studies have shown that retromer depletion results 
in a failure to recycle M6PR from the endosome back to the TGN, which leads to an 
accumulation of pre-mature hydrolases in the Golgi as well as mistrafficking of 
hydrolases into the secretory pathway and subsequent secretion extracellularly (Seaman, 
2004; Seaman, 2005). However, whether impaired retromer trafficking causes a decline 
in delivery of lysosomal hydrolases to the lysosome and compromised lysosomal 
function in AD has not been addressed. Interestingly, an immature form of cathepsin D, a 
hydrolase recognized and trafficked by the M6PR, was shown to be elevated in the 
cerebral spinal fluid of AD patients, which would be an expected consequence of a 
deficiency in retromer (Cataldo et al., 1995). Additionally, a concomitant upregulation of 
many lysosomal system components has been observed in AD and likely reflects a 
compensatory attempt by neuronal cells to try to rescue lysosomal system dysfunction 
(Cataldo et al., 1995; Cataldo et al., 1991; Cataldo et al., 1990). If retromer is, in fact, 
important for maintaining proper lysosomal function, its impairment likely would 
contribute to the formation of lysosomal dense bodies and an accumulation of AP and 
AVs observed in LOAD. Interestingly, presenilin 1 (PS1), a component of the gamma-
secretase and one of the most commonly mutated genes in familial AD (FAD), was 
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recently implicated in promoting the maturation and targeting of the vacuolar [H+] 
ATPase V0a1 subunit to the lysosome required for acidification (Lee et al., 2010). 
Acidification of lysosomes is not only necessary for endo-lysosomal trafficking and 
fusion events (Huotari and Helenius, 2011), but also for proper proteolytic maturation 
and activation of lysosomal hydrolases (Kokkonen et al., 2004). In fact, impairment in 
PS1 resulted in a defect in lysosomal acidification and cathepsin D maturation, which led 
to a decline in autophagic flux and an accumulation of APs and AVs as seen in AD (Lee 
et al., 2010). As mentioned in previous chapters, autophagy is largely responsible for 
clearing cells of protein aggregates; therefore, a defect in this process is likely to 
exacerbate the accumulation of intracellular tau aggregates observed in AD (Wong and 
Cuervo, 2010). Although mutations in PS1 are well known for causing aberrant APP and 
contributing to elevated levels of amyloidogenic Aβ42 in AD (Duff et al., 1996; Scheuner 
et al., 1996), this particular study demonstrates how a single hit can potentially cause 
multiple features of AD as well as provides an explanation for the endo-lysosomal 
dysfunction observed in FAD. Like PS1, retromer also holds the potential to contribute to 
multiple features of AD, specifically in sporadic AD cases; therefore, we hypothesized 
that in addition to its known role in APP trafficking, retromer is required for maintaining 
lysosomal homeostasis and autophagy.  
Identifying genes associated with familial and sporadic AD that cause common 
AD pathogical features is important for advancing our understanding of disease 
progression and therapeutic intervention strategies. We hypothesize that genetic risk 
factors associated with retromer complex in LOAD not only contribute to an increase in 
Aβ production and tau aggregation, but also contribute more broadly to other cellular 
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pathologies observed in AD. As mentioned in Chapter 2, lysosomal function is 
particularly important for maintaining homeostasis in non-dividing cells, such as neurons, 
which rely on autophagy for the removal of accumulated organelles and aggregates 
(Mizushima et al., 2008). In fact, much attention has been placed on the idea of 
modulating autophagy in proteinopathies such as AD in order to clear intracellular tau 
and Aβ protein aggregates and to promote neuronal survival (Wong and Cuervo, 2010). 
Importantly, the impairment in autophagy observed in AD is likely to be the result of 
lysosomal dysfunction rather than an inherent problem in the process itself, making it 
critical to determine and target the cause of the autophagy defect in order to improve its 
overall function. Here, we specifically focused on and tested whether Vps35 regulates 
autophagy in a variety of cell types, including HeLa cells, primary neurons and mouse 
embryonic fibroblasts (MEFs). Our results show that retromer is a negative regulator of 
autophagy by LC3 conjugation and immunofluorescence. Additionally, there is a strong 
colocalization between Vps35 and Atg9, the only transmembrane autophagy protein 
identified, suggesting a functional link between these two proteins. 
4.2 Results 
4.2.1 Knock-down of Vps35 in HeLa and primary neurons enhances LC3 
conjugation. 
In order to test our hypothesis that Vps35 plays a role in regulating autophagy, we first 
monitored the lipidation of LC3 upon Vps35 depletion. During AP formation, a 
ubiquitin-like enzymatic reaction occurs whereby LC3-I is conjugated to 
phosphatidylethanolamine PE to yield LC3-II, which can be monitored by a shift in 
protein migration on a Western blot. HeLa cells were transfected with mock and Vps35 
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siRNAs for 144 hrs to generate control and Vps35-depleted cells, respectively. 
Interestingly, an increase in the basal (Nm) levels of LC3-II was observed in Vps35 
depleted cells (~3-fold) compared to control cells (Fig. 4.2A). The addition of 
Bafilomycin (Nm+B), a proton pump inhibitor that prevents lysosomal acidification and 
thus the clearance of APs, produced an increase in LC3-II levels of a similar scale in both 
control (~2-fold) and Vps35 depleted (~2-fold) cells compared to their respective basal 
LC3-II levels. This result indicates that siRNA-depletion of Vps35 causes an increase in 
autophagic flux rather than an impairment in AP clearance. Likewise, LC3-II levels were 
higher in Vps35 depleted cells (~2.5-fold) compared to control cells after 3hrs of 
starvation (St) (Fig. 4.2A). Again, this increase in LC3-II observed in the Vps35 depleted 
cells is predominately due to an increase in autophagic flux since LC3-II levels were 
greatly enhanced upon Bafilomycin treatment (St+B). Notably, the addition of Baf 
caused a similar increase in LC3-II levels in both control (~2.5-fold) and Vps35 depleted 
(~2-fold) compared starvation alone (Fig. 4.2A). Levels of p62, an AP cargo, were also 
measured by Western blot in control and Vps35 depleted HeLa cells (Fig. 4.2B). A 
decrease in p62 levels is apparent in all conditions (Nm, Nm+B, St, St+B) upon Vps35 
depletion, reflecting an overall increase in autophagy. As expected, p62 levels were 
reduced in control and Vps35-depleted cells during starvation-induced autophagy. 
Additionally, in the presence of Bafilomycin, degradation of p62 was impaired in both 
conditions (Fig. 4.2B). Taken together, the enhanced LC3 conjugation and decreased p62 
levels in the Vps35 depleted cells suggest that Vps35 is a negative regulator of 
autophagy.    
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To test whether this phenomenon also occurs in another cell type, we examined 
LC3 conjugation in primary neurons treated with either mock or Vps35 shRNA lentivirus. 
Our neuronal studies showed an increase in LC3 lipidation under steady-state or basal 
conditions in Vps35 depleted compared to control neurons, which is consistent with our 
findings in HeLa cells (Fig. 4.2C). Since bafilomycin was not added to the media in this 
experiment, whether this finding also reflects an increase in flux rather than a decrease in 
AP clearance has not yet been determined. Additionally, we have yet to test whether 
induced autophagy is affected by Vps35 ablation in neurons. 




 mouse embryonic fibroblasts (MEFs) were generated from a Vps35 
conditional mouse model in order to verify these findings in a third cell type as well as 
employ a strategy that would enable a more efficient depletion of Vps35 in future 
experimentation. Vps35
Flox/Flox
 MEFs were immortalized by multiple passages and 
infected with lentiviruses encoding either a catalytically-inactive or active, nuclear Cre 
recombinase fused to eGFP (green) fluorescent protein to generate control and Vps35 KO 
cells, respectively (see Materials and Methods). Expression of active Cre, but not inactive 
Cre, resulted in the progressive loss of Vps35 immunoreactivity by Western blot analyses 
over the course of several days with complete loss of expression achieved by 9 to 10 days 
(Fig. 4.3A).  
 In order to compare autophagy in control and Vps35 KO MEFs, we monitored 
LC3 lipidation by Western blot as well as examined endogenous LC3 by confocal 
microscopy. Vps35 KO MEFs showed similar Western blot results to that of HeLa cells 
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treated with Vps35 siRNA (Fig. 4.3B). Specifically, LC3 conjugation increased under 
steady-state conditions (Nm) and after 3hrs of starvation (St) in Vps35 KO MEFs. 
Additionally, an increase in LC3-II levels was observed after treatment of Vps35 KO 
MEFs with Baf (Nm+B, St+B), indicating enhanced autophagic flux. Endogenous LC3 
was also examined in control and Vps35 KO MEFs by confocal microscopy during 
starvation-induced autophagy (Fig. 4.3C). After 90 minutes of starvation, a trend for an 
increase in LC3 puncta was observed in the Vps35 KO MEFs compared to control MEFs. 
Notably, the size of the LC3 puncta in the Vps35 KO MEFs was significantly larger, 
which may reflect larger APs or tightly clustered APs (Fig. 4.3C). Both an increase in 
LC3 conjugation as well as an increase in LC3 puncta and puncta size seen in the Vps35 
KO MEFs corroborate with the findings observed in HeLa cells and again suggests that 
Vps35 is a negative regulator of autophagy. 
4.2.3 Vps35 minimally colocalizes with Atg16, a preautophagosomal marker, and 
LC3 during starvation-induced autophagy. 
To better understand the role of Vps35 in the autophagy process, we examined the 
localization of Vps35 compared to autophagosome precursors and autophagosomes. 
Control
 
MEFs were immunostained for endogenous Vps35 and LC3 or Atg16 after 90 
minutes of starvation (Fig. 4.4). Atg16, a preautophagosomal marker, is recruited to the 
AP nucleation site in a complex with Atg5 and 12 and facilitates LC3 conjugation during 
AP biogenesis. Here we observed very minimal colocalization between Vps35 and Atg16 
upon starvation-induced autophagy (Fig. 4.4). Additionally, the colocalization between 
Vps35 and LC3, a marker of both immature and mature APs, was also minimal (Fig. 4.4). 
Taken together, these findings suggest that Vps35 does not participate in autophagy at the 
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site of AP biogenesis in a stable manner, but instead may transiently interact with APs or 
play an indirect role in autophagy perhaps by regulation of autophagy machinery or 
signaling pathways.
 
4.2.4 Vps35 strongly colocalizes with Atg9 during steady-state and starvation 
conditions. 
Interestingly, Atg9, an integral membrane protein that is essential for autophagosome 
formation (Mari et al., 2010; Puri et al., 2013; Webber and Tooze, 2010b), displays a 
similar trafficking pattern to CI-M6PR, a retromer cargo (Arighi et al., 2004; Seaman, 
2004; Seaman, 2005). Specifically, mammalian Atg9 predominately localizes to the 
trans-golgi network (TGN) during steady-state conditions; however, it re-distributes 
peripherally to the recycling endosome during autophagy induction (Puri et al., 2013; 
Webber and Tooze, 2010b; Young et al., 2006). Similarly, CI-M6PR, traffics between the 
TGN and endosomes and redistributes to peripheral endosome compartments during 
starvation (Orsi et al., 2012; Young et al., 2006). Given these similarities, we further 
explored the potential interaction between retromer and Atg9. Control MEFs were 
cultured in normal media or starved for 90 min and immunostained for endogenous 
Vps35 and Atg9 (Fig. 4.5). A strong colocalization was observed between retromer and 
Atg9 at the TGN under steady-state conditions. Colocalization persisted after starvation-
induced autophagy and Vps35 re-distributed with Atg9 in the periphery (Fig. 4.5). The 
high levels of colocalization observed between Atg9 and Vps35 under basal and 








Figure 4.1 The retromer complex. 
Figure 4.1 The retromer complex. The mammalian retromer complex consists of a 
cargo selection domain (Vps35/26/19) and a membrane association domain composed of 
a dimer of the sorting nexin proteins SNX1 or SNX2 (the mammalian homologs of the 
yeast Vps5) with either SNX5 or SNX6 (or possibly SNX32) (the mammalian homologs 
of the yeast Vps17). The SNX proteins contains a N-terminal phox homology (PX) 
domain that binds phosphatidylinositol-3-phosphate (PI3P) on the early endosomes as 



















Figure 4.2 Vps35 ablation in HeLa cells and primary neurons causes an increase 
LC3 conjugation during basal and starvation-induced autophagy. (A) HeLa cells 
treated with mock or Vps35 siRNA were cultured in normal media (N) or HBSS (St) in 
the presence or absence of 50nM Bafilomycin (Nm+B or St+B, respectively) for 3hrs. 
Right: Lysates were analyzed by immunoblotting using the indicated antibodies. Left: 
Relative LC3-II levels normalized to tubulin (n=4). (B) Western blot analysis of p62 
levels in HeLa cells treated with mock and Vps35 siRNA and cultured in normal media 
(N) or HBSS (St) in the presence or absence of 50nM Bafilomycin (Nm+B or St+B, 
respectively) for 3hrs (n=1) (C) Primary hippocampal neurons treated with mock or 
Vps35 shRNA lentivirus and cultured in normal media. Right: Lysates were analyzed by 
immunoblotting using the indicated antibodies. Left: Quantification of the relative levels 
















Figure 4.3 Vps35 KO MEFs show an increase in LC3 conjugation during basal and starvationnduced autophagy as well as larger LC3 
puncta during starvation-induced autophagy  
Figure 4.3 Vps35 KO MEFs show an increase in LC3 conjugation during basal and 
starvation-induced autophagy as well as larger LC3 puncta during starvation-
induced autophagy. (A) Western blot analysis showing a time-course of Vps35 protein 
levels in Vps35
Flox/Flox
 MEFs after infection with lentiviruses expressing either an inactive 
Cre (Δ) or active (CRE) full-length Cre recombinase for 6-12 days. (B) Control and 
Vps35 KO MEFs were cultured in normal media (N) or HBSS (St) in the presence or 
absence of 50nM Bafilomycin (Nm+B or St+B, respectively) for 90 min. Lysates were 
analyzed by immunoblotting using the indicated antibodies. (n=1). (C) Control and 
Vps35 KO MEFs were cultured in HBSS (St) for 90 min, fixed and immunostained. 
Right: Confocal microscopy images show endogenous LC3 (black). The image was 
inverted to allow for better visualization of LC3-positive structures. Scale bar: 10 μm. 
Left: Quantification of the average number and size of LC3 puncta per cell. Puncta size 










































Figure 4.4 Vps35 minimally co-localizes with Atg16 and LC3 during starvation-induced autophagy 
Figure 4.4 Vps35 minimally co-localizes with Atg16 and LC3 during starvation-
induced autophagy. Uninfected Vps35
Flox/Flox
 MEFs cells were cultured in HBSS for 
90min (90min St) and fixed. Confocal microscopy images show endogenous Vps35 (red) 











Figure 4.5 Vps35 strongly co-localizes with Atg9 under basal and starvation conditions. 
Figure 4.5 Vps35 strongly co-localizes with Atg9 under basal and starvation 
conditions. Uninfected Vps35
Flox/Flox
 MEFs cells were cultured in normal media or HBSS 
for 90min (90min St) and fixed. Confocal microscopy images show endogenous Vps35 





Given that retromer plays an important role in delivering hydrolases to the lysosome, we 
hypothesized that retromer depletion would cause lysosomal dysfunction and 
consequently impair autophagy. However, preliminary results showed minimal, if any, 
lysosomal impairment upon Vps35 depletion, and an unexpected role for retromer in the 
negative regulation of autophagy. Specifically, LC3 conjugation was increased upon 
Vps35 depletion both under basal conditions and during starvation, which clearly 
reflected enhanced autophagy rather than impaired AP turnover according to the 
Bafilomycin flux test. Additionally, Vps35 was found to strongly colocalize with Atg9, a 
transmembrane protein implicated in AP biogenesis that cycles between the TGN and the 
endosome in a similar manner to its well-known cargo, M6PR. Here we discuss potential 
reasons for the absence of lysosomal impairment observed upon Vps35 depletion as well 
as follow up studies that will be important for confirming and better understanding the 
role of Vps35 in autophagy. 
As described in the introduction, retromer has been shown to play an essential 
role in the trafficking of hydrolases to the lysosome, which we hypothesized to cause the 
impaired endo-lysosomal trafficking observed in sporadic AD cases displaying genetic 
variations in retromer complex members. Although lysosomal activity was not directly 
measured in this study, results from our autophagy flux assays suggest that sufficient 
levels of hydrolases are delivered to the lysosome since APs are still efficiently cleared 
upon Vps35 depletion. Retromer-independent pathways for lysosomal hydrolase 
trafficking have been described, such as the lysosomal integral membrane protein type 2 
(LIMP-2) receptor that targets β-glucocerebrosidase to the lysosome, which may be a 
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mechanism by which hydrolases are still delivered to the lysosome in retromer depleted 
cells and therefore, can still clear APs (Braulke and Bonifacino, 2009; Reczek et al., 
2007; Saftig and Klumperman, 2009). In fact, we speculate that these alternate pathways 
may be upregulated in Vps35 -depleted cells. Currently, it is unclear whether the M6PR 
can undergo retrograde transport independently of retromer; however, studies have 
demonstrated that ablation of Vps35 results in the impaired retrieval and subsequent 
lysosomal degradation of the M6PR, suggesting little redundancy in this retrograde 
pathway, at least in the cell type analyzed (Arighi et al., 2004; Seaman, 2004). 
Interestingly, in yeast, there is an alternate pathway for delivery of hydrolases to the 
vacuole, termed the cytoplasm-to-vacuole targeting (Cvt) pathway (Khalfan and 
Klionsky, 2002; Teter and Klionsky, 2000). Specifically, the Cvt pathway sequesters the 
precursor hydrolases (e.g., α-mannosidase and aminopeptidase I) into a vesicle using 
much of the same machinery as autophagy and delivers them to the vacuole (Khalfan and 
Klionsky, 2002; Teter and Klionsky, 2000). Although selective autophagy for hydrolases 
has yet to be described in mammals, it is plausible that autophagy could facilitate the 
delivery of hydrolases through its bulk degradation of organelles, such as the ER, trans-
Golgi and endosomes, that these enzymes typically traffic through to reach the lysosome. 
It is important to note that in our cursory studies, more minor changes in lysosomal 
function upon Vps35 depletion have not been ruled out and lysosomal function should be 
tested more rigorously in the future. In fact, the Vps35 KO MEFs an ideal tool for 
studying the pathways required for Vps35-independent lysosomal hydrolase trafficking, 
which are currently poorly understood.  
Although a couple of groups have examined the role of retromer in autophagy, 
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disparate findings have been reported which can be explained by potential differences in 
the model system and/or experimental design. For instance, Dengjel et al. reported a 
decrease in autophagy in cells null for the retromer components (e.g. Δvps5, Δvps17, 
Δvps29, Δvps35) in yeast; however, a single autophagy assay was used in this study (e.g. 
alkaline phosphatase (ALP) activity) and its readout does not exclude the possibility of a 
confounding impairment in lysosomal degradation (Dengjel et al., 2012). Additionally, if 
retromer modulates autophagy through an interaction with Atg9 function in mammals, 
this functional interaction is not necessarily conserved in yeast. For instance, cytoplasmic 
N- and C-terminal domains of Atg9 vary significantly between yeast and mammals and 
they likely display different interactions and behaviors, demonstrated by differences in 
their trafficking patterns (Young et al., 2006). In a more relevant study performed by Orsi 
et al. in mammalian HEK cells, siRNA knock-down of Vps26 did not appear to affect 
LC3 conjugation or localization of Atg9 (Orsi et al., 2012). Although a change in LC3 
conjugation was not observed in their study, knock-down of Vps26 was suboptimal in 
these studies (~50%) and may not be sufficient to detect the same phenotype seen in our 
studies (Orsi et al., 2012). Additionally, since there are two isoforms of Vps26, Vps26a 
and Vps26b, compensation can occur when only one is ablated, leading to minimal 
impairment of retromer function in their experiments (Collins et al., 2008; Kerr et al., 
2005). Here we have efficiently knocked-down Vps35 in HeLa cells and neurons to 
effectively inhibit the function of the retromer complex. Additionally, we generated 
Vps35 KO MEFs that are null for Vps35 to test autophagy. 
 Our preliminary data suggests that Vps35 plays a negative role in regulating 
autophagy; however, further studies are required to better understand how Vps35 fits into 
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the autophagy pathway. In addition to assessing LC3 conjugation and localization upon 
Vps35 ablation, other standard autophagy assays should be performed in order to more 
quantitatively assess autophagy. Specifically, long-lived protein degradation should be 
tested to assess autophagy efficiency in Vps35 depleted cells. Additionally, electron 
microscopy analysis and morphometry should be performed to compare the size and 
shape as well as the number of APs and ALs in Vps35 depleted cells relative to control 
cells. Although the bafilomycin flux assay did not show any overt defects in AP 
clearance in the Vps35 depleted cells, it may be that Vps35 depletion causes more minor 
changes in lysosomal function and requires a more sensitive assay for its detection. For 
instance, monitoring the ratio of autophagosomes to autophagolysosomes by electron 
microscopy or using a tandem GFP-RFP-LC3, whereby the GFP fluorescence is 
quenched upon delivery to an acidic, lysosomal environment, are considered more 
sensitive read-outs of autophagy flux that should also be performed. Since lysosomal 
function and nutrient recycling is an important regulator of mTOR activity (Zoncu et al., 
2011), it will also be important to test mTORC1 activity in Vps35 depleted cells in order 
to ensure mTORC1 is not misregulated. For instance, if lysosomal function is impaired in 
Vps35 depleted cells, mTORC1 may be inhibited, resulting in autophagy stimulation. 
Lastly, it will be important to characterize Vps35 in relation to additional autophagy and 
organelle markers by performing immunostainings under steady-state and autophagy 
stimulation in order to better understand the role of Vps35 in the autophagy pathway. In 
our preliminary studies, little colocalization was observed between Vps35 and Atg16 
(early AP marker) or LC3 (early and late AP marker); however, we did notice significant 
co-localization between Vps35 and Atg9 (early AP marker), which is discussed below.  
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Given the strong colocalization between Vps35 and Atg9, it is possible that these 
two proteins may functionally interact during autophagy. Atg9 is the only integral 
membrane protein in autophagy and is essential for AP biogenesis in yeast and mammals 
(Lang et al., 2000; Noda et al., 2000; Webber and Tooze, 2010b; Young et al., 2006). In 
mammals, Atg9 resides in the TGN during steady-state conditions and re-localizes to the 
early endosomes and recycling endosomes upon autophagy induction (Webber and 
Tooze, 2010b). Atg9 redistribution is one of the first events observed during autophagy 
and requires both Ulk1 activation and PI3K activity (Young et al., 2006). Notably, Atg9 
minimally colocalizes with other Atgs, similar to Vps35, since it is a highly dynamic 
protein that transiently delivers lipid and membrane to the growing autophagosome (Orsi 
et al., 2012). Interestingly, CI-M6PR, a known retromer cargo, and Atg9 have also been 
previously shown to colocalize and display a similar pattern of redistribution to the 
periphery during autophagy (Orsi et al., 2012). Additionally, the PI3P effector WIPI 
protein (the yeast homolog of Atg18) has been shown to be important for the trafficking 
of both Atg9 and M6PR (Jeffries et al., 2004), which may reflect a functional link 
between these two proteins. In a recent study, it was proposed that Atg9 localizes to the 
plasma membrane during autophagy and undergoes clathrin-mediated endocytosis and 
trafficking to the early and recycling endosome, where it heterotypically fuses with 
endocytosed Atg16-positive vesicles to generate autophagic precursors (Puri et al., 2013). 
Notably, little colocalization was observed between Vps35 and Atg16, suggesting that 
Atg9 may interact with Vps35 in a different compartment. Although mechanisms of Atg9 
trafficking are still being understood, a recent study showed that ablation of p38α MAPK 
causes a redistribution of Atg9 to the periphery and increases autophagy in both fed and 
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starved conditions (Webber and Tooze, 2010a). Although this phenotype is similar to that 
observed upon Vps35 depletion, whether Atg9 is mislocalized to the periphery in this 
case is unclear. In future studies, it will be important to characterize Atg9 localization and 
determine whether the retromer machinery is required for its endosome-to-TGN 
trafficking. 
 If retromer controls autophagy, a fundamental question is the type of factor 
mediating its recruitment to membranes in this specific context. There is a growing role 
for the sorting nexin (SNX) family of proteins in autophagy (Knaevelsrud et al., 2013). 
SNX proteins possess a characteristic BAR domain that can sense membrane curvature 
and induce tubule formation as well as a PX domain that binds phosphatidylinositol 3-
phosphate (PI3P) (Carlton and Cullen, 2005; Cullen and Korswagen, 2012; Worby and 
Dixon, 2002). Recently, a screen using a single knock-down approach was used to 
identify SNX18 as a positive regulator of autophagy that promotes LC3 lipidation and 
tubulation of recycling endosomes to provide membrane during autophagosome 
biogenesis (Knaevelsrud et al., 2013). Although the SNX proteins of the retromer 
complex (SNX 1, 2, 5, 6, 27) were not identified in these screens, they cannot be ruled 
out as regulators of autophagy since SNX1 and SNX2 as well as SNX 5 and SNX6 (and 
possibly SNX37) act redundantly (Rojas et al., 2007; Schwarz et al., 2002; Wassmer et 
al., 2007; Wassmer et al., 2009). Additionally, SNX3, a non-BAR containing that directly 
associates with and recruits retromer to PI3P positive membranes independently of the 
other SNXs, also possesses redundant functions to another SNX, SNX12, and may be 
implicated in autophagy (Cullen and Korswagen, 2012; Pons et al., 2012). In order to 
more thoroughly assess whether the SNX proteins of the retromer complex and SNX 
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proteins in general regulate autophagy, double knock-down experiments may be required. 
Mammalian SNX proteins have been shown to have cellular roles independent from 
retromer; therefore, they may also participate in autophagy separately from the retromer 
complex (Nisar et al., 2010; Prosser et al., 2010).   
 In addition to understanding how retromer regulates autophagy, it will also be 
important to more generally characterize how retrograde transport is regulated during 
autophagy. Since endosome-to-TGN recycling of M6PR and Atg9 changes during 
autophagy, retrograde trafficking does not appear to be constitutive pathway but rather 
one controlled by certain stimuli. In future studies, it would be interesting to determine 
the signaling pathways and mechanism regulating retrograde transport. For instance, it is 
possible that cargoes undergo a conformation change or a post-translational modification 
to reduce their affinity for recycling machinery. Conversely, the recycling machinery 
may be inhibited and unable to bind the cargo during certain stimuli. Additionally, it may 
be that intracellular trafficking and motors are regulated differently under autophagy 
stimulating conditions and subsequently slow retrograde transport by the retromer.  
 Identifying retromer as a novel regulator of autophagy is not only of basic science 
interest but also of disease relevance. In AD, the progressive appearance of swollen 
neurites filled with APs and ALs is commonly observed; however, the underlying cause 
is unknown (Nixon et al., 2005; Suzuki and Terry, 1967; Terry et al., 1964). Genetic 
mouse models for AD have suggested that both an increase in autophagy as well as an 
impairment in clearance underlies the observed increase in APs and ALs (Nixon et al., 
2005; Yu et al., 2005). Our preliminary data suggests that retromer deficiencies may in 
fact be contributing to an increase in AP structures seen in LOAD; however, determining 
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whether these retromer deficiencies also impair AP clearance will require additional 
experimentation. Although many risk factors have been associated with LOAD, it will be 
important to try to understand which factors cause common pathological features in all 
AD cases in order to improve therapeutic intervention and disease outcome.      
4.5 Materials and Methods 
4.5.1 Cell culture and transfection/infection.  
HeLa cells were cultured at 37°C in a 5% CO2 incubator in DMEM-Glutamax 
(Invitrogen) supplemented with 10% fetal bovine serum (FBS) (Invitrogen) and penicillin 
(200 units/mL)/streptomycin (200 μg/mL) (Invitrogen). HeLa cells were siRNA 
transfected twice at a 72 hr interval using Lipofectamine 2000 (Invitrogen) according to 
the manufacturer’s instructions and experiments were performed 144 hrs after the initial 
transfection. 
Hippocampal neurons were dissected from postnatal day 0 wild type mice, 
trypsinized for 30 minutes at 37°C, dissociated by passing through a Pasteur pipette and 
finally plated on 6 well plates (ELISA) at a density of 40,000-50,000 cells/cm
2
. Media 
was changed 24 hours after plating. Neurons were cultured for 14 days in Neurobasal-A 
media supplemented with B-27, Glutamax and u-FDU, in a 5% CO2 incubator. shRNA 
Vps35 lentivirus was generated by transfecting control or a combination of two Vps35 
shRNA vectors and pPACK-H1 packaging mix (System Biosciences) into HEK-293T 
cells using Lipofectamine 2000 according to the manufacturer’s protocol. Media was 
collected 72 hours post-transfection and spun in an ultracentrifuge at 22,000xg for 1.5 
hours. The lentiviral pellet was re-suspended in Neurobasal-A media and added to cells at 
7 days in vitro. Vps35 ablation occurred consistently at 7 days post-infection (methods 
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cited in (Bhalla et al., 2012)). 
4.5.2 Generation of Vps35 KO MEFs.  
Primary mouse embryonic fibroblasts (MEFs) were generated from embryonic day 13.5 
Vps35
Flox/Flox
 mouse embryos in which exons 3-5 were flanked by loxP sites (a kind gift 
from collaborator, Dr. Scott Small, Columbia University). MEFs were cultured at 37°C in 
a 5% CO2 incubator in DMEM-Glutamax (Invitrogen) supplemented with 10% fetal 
bovine serum (FBS) (Invitrogen) and penicillin (200 units/mL)/streptomycin (200 
μg/mL) (Invitrogen). MEFs were immortalized by multiple passaging and were used for 




(KO) cells were 
generated by infecting cells with a lentivirus carrying either a catalytically active Cre 
recombinase or catalytically-dead Cre recombinase (control) (see Chapter 2 Materials and 
Methods for more detail). A minimum of 9 days post-infection was required to abolish 
the expression of Vps35 by Western blot.  
4.5.3 shRNA and RNAi.  
shRNA vectors were generated using the lentivector pSIH-H1 shRNA (System 
Biosciences). A control, pSIH1-H1-copGFP Luciferase shRNA lentivector and two 
hVps35 pSIH-H1 shRNA lentivectors were designed and used to make the lentivirus. The 
target sequences for the two hVps35 shRNA lentivectors include: 
vps35-1 shRNA, 50TCAGAGGATGTTGTATCTTTACAAGTCTC-30 ; vps35-2 
shRNA, 50-GCTTCACACTGCCACCTTTGGTATTTGCA-30. 
RNAi gene silencing was achieved using two pre-designed sequences against human 
Vps35 (5’-CACCATACTCCTTTCCATGTA-3’, S104268131; 5’-
AGCACTTATCTTGGCTACTAA-3’, S104279296) (Qiagen). As a negative control, an 
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siRNA scramble sequence (5’-AATTCTCCGAACGTGTCACGT-3’; 1027310) was 
used. 
4.5.4 Reagents and antibodies, SDS-PAGE and western blotting and 
immunofluorescence microscopy.  
See Chapter 2 Materials and Methods section. Additional primary antibodies used in this 
chapter include: anti-Vps35 mouse monoclonal antibody (1:1000 dil., Abnova) and anti-




Chapter 5: Concluding remarks and future directions 
The goal of this thesis work was to better understand the regulation of autophagy from a 
lipid biology perspective. So far, the majority of our knowledge concerning AP 
biogenesis has been largely derived from genetic screens in S. cerevisae which have 
identified several key protein players in this process, namely a subset of the factors 
encoded by ATGs (Harding et al., 1996; Klionsky et al., 2003b; Thumm et al., 1994; 
Tsukada and Ohsumi, 1993). Interestingly, the class III PI3K, Vps34, did not appear as a 
hit in these initial screens and it was not until later autophagy studies, which identified 
Vps34 as a regulator of autophagy in the yeast Hanensula polymorpha and human cells, 
that its synthesis of PI3P was found to be essential for autophagy in S. cerevisae (Kiel et 
al., 1999; Kihara et al., 2001b; Petiot et al., 2000). Due to limitations in genetic screens 
and the fact that higher eukaryotes have multiple PI3P synthesis pathways, we questioned 
whether Vps34 was the sole source of PI3P during autophagy in the mammalian system. 
Here we discovered that in addition to Vps34, the class II PI3K  and  isoforms 
synthesize PI3P to positively regulate autophagy. In this final section, some of the major 
outstanding questions that still remain surrounding regulation of autophagy by the class II 
PI3K and by other lipids in general will be discussed that were not discussed in the 
chapter discussions. 
 In the phosphoinositide field, there has been growing interest in determining 
whether the class II and class III PI3Ks can synthesis PI3P for the same process (Falasca 
and Maffucci, 2012). Recent evidence in mammalian cells has shown that in addition to 
Vps34, the class II PI3K  can also synthesize PI3P at the endosome (Yoshioka et al., 
2012). However, whether Vps34 and the class II PI3K  contribute to the same or distinct 
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subdomains of PI3P or whether the source dictates a specific role for the PI3P at the 
endosome will require further investigation. Additionally, in C. elegans, the homologs of 
the class II and class III PI3K produce PI3P at the site of phagosome biogenesis. In this 
case, it is clear that each class plays a distinct roles and act in a hierarchical and 
sequential manner to promote phagocytosis (Lu et al., 2012). Interestingly, the roles of 
Vps34 and the class II PI3Ks in the mammalian system appear different from that of C. 
elegans. Our work is the first to demonstrate that the class II and class III PI3K 
synthesize PI3P independently of one another and in an additive manner during 
mammalian autophagy (Devereaux et al., 2013). Although we have demonstrated here 
that synthesis of PI3P by class II PI3K  and  isoforms positively regulate autophagy, it 
still unknown how the class II PI3K fit into the larger autophagy pathway and their 
relationship to Vps34 during this process. Key questions that remain include: Are the 
Vps34 and the class II PI3Ks regulated differently during autophagy? Do they all share 
downstream effectors and, if not, what effectors are specific to the class II PI3K? Are 
there multiple sites of PI3P synthesis during AP biogenesis? Where do Vps34 and the 
class II PI3K synthesize PI3P during autophagy? Lastly, is the pool of PI3P synthesized 
by each class differentially regulated by phosphatases? 
 Despite the fact that the class II and III PI3Ks are in the same lipid kinase family 
and synthesize PI3P during autophagy, preliminary studies suggest that they may operate 
in distinct pathways from one another. For instance, the class II PI3K  and  isoforms 
did not appear to strongly interact or co-localize with Beclin-1, a core complex member 
of multiple Vps34 complexes. To better characterize the class II PI3Ks in the autophagy 
pathway, immunoprecipitation and mass-spectrometry proteomic analysis can be 
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performed to identify novel autophagy-relevant interactors of the class II PI3K. 
Additionally, a more comprehensive study of the class II PI3K in relation to various 
autophagy markers should be performed to better understand where they fit into the 
hierarchical autophagy network. As mentioned in previous chapters, an autophagy 
interaction network screen hinted of an interaction between PI3KC2 and both Atg7 and 
MAP1LC3A (one of the six Atg8 orthologues in humans) (Behrends et al., 2010); 
however, further confirmation of this interaction is still required. Interestingly, in our 
preliminary characterization studies we observed that PI3KC2 displays a similar 
distribution pattern to and co-localized with Atg9. In future studies, it will be interesting 
to determine how the redistribution of the class II PI3K  is regulated and whether it 
interacts with Atg9. Notably, the class II PI3K  did not possess the same cellular 
distribution pattern as the class II PI3K , which suggests that there may even be isoform 
differences in autophagy regulation. 
 So far, PI3P synthesis has only been observed at the ER during autophagy; 
however, other organelles have also been shown to contribute to AP formation (Axe et 
al., 2008). In future studies, it would be interesting to determine where Vps34 and the 
class II PI3K synthesize PI3P and whether they regulate different membrane sources 
required for AP biogenesis in the cell. Differences in the classes of PI3K have already 
been suggested by the fact that the PI3KC2 redistributes from a juxtanuclear location to 
the periphery during starvation, whereas Vps34 has been seen in close proximity to the 
ER, particularly at MAM sites, during autophagy (Hamasaki et al., 2013; Webber and 
Tooze, 2010b; Young et al., 2006). However, the function of the class II  isoform and 
whether it is catalytically active at these peripheral, Atg9 positive sites still needs to be 
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determined. Interestingly, different autophagy stimuli have been shown to induce non-
canonical autophagy pathways, which do not require core autophagy machinery. For 
instance, when proapoptotic compounds and reservatrol are used to stimulate autophagy, 
autophagosomes are still able to form in the absence of Beclin-1 (Grishchuk et al., 2011; 
Proikas-Cezanne and Codogno, 2011; Scarlatti et al., 2008; Tian et al., 2010; Zhu et al., 
2007). Likewise, autophagosome have been shown to form independently of Atg5, Atg7 
and LC3 when autophagy is induced by staurosporine, etoposide or starvation (Nishida et 
al., 2009). The fact that different autophagy machinery regulates autophagy in response 
to particular types of autophagy stimulation is intriguing when considering the 
relationship between Vps34 and the class II PI3K in autophagy. In the future, it will be 
interesting to determine whether Vps34 and the class II PI3Ks synthesis PI3P at different 
membranes to promote AP biogenesis and whether they differentially respond to various 
autophagy stimuli. 
At the site of AP biogenesis, PI3P levels are tightly regulated through the 
coordination of PI 3-kinases and phosphatases. Prior to the discovery that the class II 
PI3K could also synthesis PI3P during autophagy, the phosphatases implicated in 
autophagy, including Jumpy (myotubularin-related protein 14, MTMR14) and MTMR3, 
were believed to act on Vps34 derived PI3P (Dowling et al., 2010; Taguchi-Atarashi et 
al., 2010; Vergne and Deretic, 2010; Vergne et al., 2009). Currently, it is unknown 
whether PI3P phosphatases have specificity for those pools of PI3P synthesized by Vps34 
the class II versus the class II PI3Ks during autophagy. Studies have shown that the 
phosphatase MTM1 can directly associate with Vps34 and Vps15 in a mutually exclusive 
manner with Rab GTPases to control endosomal levels (Cao et al., 2007). MTM1 has 
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also been linked to the regulation of PI3P generated by the PI3K-C2β isoform, although it 
is unclear whether they form a complex as well (Razidlo et al., 2011). A more careful 
investigation of the relationship between Vps34 and the class II PI3Ks and PI3P 
phosphatases is not only required to fully understanding PI3P metabolism during 
autophagy, but also PI3P regulation more generally in the cell. 
In addition to PI3P, other PIs are beginning to emerge as important regulators of 
autophagy. For instance, in S. cerevisiae, two PI 4-kinases that synthesize 
phosphatidylinositol 4-phosphate (PI4P) at either the TGN or the plasma membrane have 
been shown to positive regulate of autophagy in an Atg9-dependent and independent 
manner, respectively (Wang et al., 2012). Additionally, in higher eukaryotes, synthesis of 
PI(3,5)P2 by the PI3P 5-kinase Fab1/PIKfyve has been shown to play an important role in 
the maturation step of autophagy, although it is unclear whether its role in autophagy is 
secondary to its more homeostatic role in maintaining endo-lysosomal function 
(Dall'Armi et al., 2013; de Lartigue et al., 2009; Dove et al., 2009; Ferguson et al., 2012; 
Ferguson et al., 2009; Ferguson et al., 2010; Rusten et al., 2007). Lastly, the class II 
PI3K isoform has been shown to synthesize PI(3,4)P2 in certain biological contexts, 
such as clathrin mediated endocytosis (CME) (Posor et al., 2013); however, whether the 
class II PI3K produces PI(3,4)P2 during autophagy should be tested in the future. 
Specifically, we showed that knockdown of the class II PI3K in our experiments 
produced a decrease in autophagy by decreased LC3 conjugation and p62 which was 
largely attributed to the decline in PI3P synthesis and subsequent recruitment of the PI3P-
binding autophagy effector WIPI-I, but did not address PI(3,4)P2 synthesis. Because 
antibody detection of PIs is limited, PI effectors and/or their PI-binding domains are 
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widely used as lipid probes in the phosphoinositide field when studying the localization 
and crudely quantifying a particular lipid species (Rusten and Stenmark, 2006). While 
additional PIs are starting to be appreciated for their role in autophagy, determining their 
precise role becomes challenging until effectors are identified. Additionally, it is difficult 
to know whether the synthesis or conversion of a PI species is responsible for mediating a 
cellular action. More extensive screens are required to identify the lipid kinases and 
phosphatases as well as the autophagy-relevant lipid effectors. 
Although PIs are critical in mediating acute membrane signals important for 
orchestrating processes such as autophagy, other lipid classes and subclasses have been 
shown to be important for autophagy as well (Dall'Armi et al., 2013; Di Paolo and De 
Camilli, 2006; Knaevelsrud and Simonsen, 2012). For instance, our lab has shown that 
phospholipase D1 (PLD1) hydrolyzes phosphatidlycholine (PC) to produce phosphatidic 
acid (PA), a ‘cone’ shaped lipid with negative curvature-inducing properties that 
positively regulates both AP biogenesis and maturation likely through its structural 
properties (Dall'Armi et al., 2010). Given the extent of membrane remodeling that occurs 
during autophagy there is likely to be additional, previously unrecognized lipids that 
regulate this process. Recent advances in large-scale lipid analysis have opened up an 
entirely new field termed lipidomics, which will be critical for constructing a map of the 
lipidome and expanding our current understanding lipids in various biological, including 
autophagy. In our studies, we compared the lipidomic profiles of cells under steady-state 
and starvation conditions in hopes of identifying new lipids relevant for autophagy. 
Although few lipid changes were observed during autophagy, such as an increase in LPE, 
it is important to note that analysis was performed on a more global, cellular level. In 
171 
 
fact, it may be that there are important, local changes in the lipid composition of various 
organelle membranes during autophagy; therefore, purification and lipidomic analysis of 
different membranes should be performed in the future. In fact, there continues to be 
great interest in understanding the protein and lipid composition of an autophagosome in 
the field; however, analyzing purified APs is complicated by the fact that APs contain 
cytoplasmic protein and organelle cargo and are constantly in a state of transition as they 
fuse with the endolysosomal system during maturation. Although technological 
advancements have improved our lipid identification and quantification capabilities over 
the past few years, there are still limitations in lipid detection due to the large structural 
diversity and chemical composition among lipids (Lam and Shui, 2013; Wenk, 2005; 
Wenk, 2010). Improvements in lipid analytics will not only enhance our detection 
capabilities but will also provide a more comprehensive picture of the lipidome and will 
be critical to fully understand lipid dynamics and how various lipid networks interact 
within the cell. 
Detailed molecular insight into the regulation of autophagy is invaluable due the 
numerous disease states, such as neurodegenerative diseases, cancer, infectious disease, 
that display impaired autophagy and the consequential pathologies.  
Modulating autophagy is now widely viewed as a promising approach to alleviate 
symptoms of, if not, treat diseases where autophagy is misregulated. Understanding the 
molecular mechanisms underlying autophagy regulation from both a protein and lipid 
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